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ABSTRACT 
 
The nematode Caenorhabditis elegans has been a powerful experimental organism for almost half a 
century.  Over the past ten years, researchers have begun to exploit the power of C. elegans to 
investigate the biology of a number of human pathogens.  This work continues to uncover mechanisms 
of host immunity and pathogen virulence that are either analogous to those involved during 
pathogenesis in alternative animal hosts or mechanisms which are, thus far, unique to the worm.  In 
this thesis, we present data that describes an immunological balance in C. elegans, whereby 
heightened tolerance to one pathogen, the enteric bacteria Salmonella Typhimurium, comes at the cost 
of increased susceptibility to another, the fatal fungal human pathogen Cryptococcus neoformans.  We 
find that this susceptibility trade-off is mediated by the reciprocal activity of two immune genes: the 
lysozyme lys-7 and the tyrosine kinase abl-1.  We suggest that ABL-1 controls two different DAF-16-
dependent pathways to regulate this balance.  Both pathways are necessary for wild type resistance to 
C. neoformans, whilst the activity of only one pathway is a requirement for the tolerance phenotype to 
S. Typhimurium.  We infer from sequence data that LYS-7 has an atypical mode of action in C. 
elegans, which we hypothesise to be detrimental to the worm during S. Typhimurium pathogenesis and 
thus a contributing factor to the tolerance phenotype.  Furthermore, we find that this tolerance has a 
Salmonella-dependency which we propose to be under the control of the alternative sigma factor, 
RpoS.  Taken together, we describe an immunological balance in C. elegans for the first time, one that 
is mediated by both host and pathogen factors.  We therefore suggest that the innate immune 
response of C. elegans has a higher level of immune complexity than previously believed, and that 
such trade-offs are evolutionarily ancient mechanisms. 
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THESIS OVERVIEW 
 
The nematode Caenorhabditis elegans has been utilised as a model organism for over 40 years.  
These animals offer many experimental advantages that make their application to the field of infectious 
disease particularly useful: animals can be infected simply by substituting their normal bacterial feeding 
strain with the pathogen of choice and researchers are able to make use of the wide-reaching 
investigative tools available for this organism.  
 
In this thesis, I present data that begin to dissect a balance of immunity that we describe for the first 
time in C. elegans.  Chapter one introduces our growing understanding of C. elegans as a model host 
in infectious disease since its first description as a model for bacterial infection in 1999 (Tan et al., 
1999, Mahajan-Miklos et al., 1999).  Next, chapter two describes all the methodology utilised in this 
work, before I move on to detail my own findings in the results chapters (three to six). 
 
In chapter three, we describe a balance in immunity of a genetic knockout strain that lacks an 
important defensive lysozyme, LYS-7.  We find that these animals are hypersensitive to infection with 
the fungal pathogen Cryptococcus neoformans, but tolerant to the gastrointestinal pathogen, 
Salmonella Typhimurium.  The chapter further examines the role of a compensatory mechanism in the 
nematode that may confer the observed tolerance to this pathogen.  
 
In chapter four, we explore the potential regulation of this balance by the three best characterised 
immune defence pathways in C. elegans; the TGF-β- and IGF-mediated signalling pathways and the 
p38 MAPK cascade.  Conversely, in chapter five, we approach the tolerance phenotype to S. 
Typhimurium from the perspective of the pathogen and examine the bacterial strain dependency of the 
phenotype.  We return to the C. elegans immune response in chapter six, by specifically investigating 
the LYS-7 protein itself and the potential molecular function of this enzyme. 
 
Finally, in my discussion chapter, I attempt to draw the four results chapters together with reference to 
the concept of balanced immunity and how it may be regulated and determined by both the host and 
pathogen.  These findings are discussed in relation to published work and with respect to the future 
experiments needed to continue this project. 
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1.0   INTRODUCTION 
 
1.1 Host-pathogen interactions 
Host-microbe interactions can be studied on many levels, given that not all interactions lead to disease, 
and those that do have a complex progression that leads to this state.  The study of these interactions 
is becoming increasingly important as a result of recurrent outbreaks of hospital-acquired ‘super-bugs’, 
other therapy-resistant infections and the emergence of new pathogens.  There are a number of ways 
of investigating host-pathogen interactions.  The various molecular approaches include mutagenesis, 
cell-based assays with reporters, tissue-based methods, and adhesion-based assays.  These methods 
are complemented by animal studies which examine the infection at the whole organism level.  Amidst 
ever-growing concerns for the welfare of animals in scientific research, there is a heightened need to 
find ethical organisms in which to study such interactions.  Therefore, the discovery that a number of 
simple and genetically tractable model organisms: Arabidopsis thaliana (Dodds and Rathjen, 2010), 
Drosophila melanogaster (Ferrandon et al., 2007), Caenorhabditis elegans (Millet and Ewbank, 2004) 
and Zebrafish (Danio rerio) (Trede et al., 2004), are susceptible to a number of human pathogens has 
been a remarkable advance in this field.  This work continues to reveal common mechanisms of 
immunity across animals and plants including the identification of universal defence genes and the 
pathways which control their expression in response to infection (Rahme et al., 1995).  Thus the use of 
these models to understand host-pathogen interactions gives insights into the components from both 
the host and the microbe that are required for a successful interaction.  These studies are critical, as 
understanding the mechanisms involved in immunity may subsequently lead to therapeutic advances 
for higher animals (Breger et al., 2007, Haine et al., 2008).     
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1.2 Caenorhabditis elegans: a model organism 
C. elegans is a free-living nematode that is found in soil and in compost heaps.  The population is 
dominated by self-fertilising hermaphrodites (XX) with a rare occurrence of males (X0) who have a 
distinct morphology (Figure 1).   The animals were first adopted as a laboratory model by Sydney 
Brenner over 40 years ago (Brenner, 1974).  At this time the nematodes were used to study 
development and behaviour, work which resulted in the Nobel Prize in Physiology or Medicine being 
awarded to Brenner and his colleagues in 2002 (Frängsmyr, 2003).  In the intervening period, C. 
elegans has been used as a model in which to study a wide-range of biological phenomena. 
 
The transparent animals are cultured on a modified agar substrate, termed nematode growth medium 
(NGM), seeded with an Escherichia coli uracil auxotroph, OP50, as a food source (Brenner, 1974).  
The incubation temperature of this culture significantly alters the progress of the animals through four 
larval stages to the 1mm-long adult (Figure 2) and as such animal development can be regulated; a 
feature most advantageous to the laboratory setting.  The animals have a generation time of four days 
and a lifespan of approximately three weeks at 20°C.  Interestingly, the animal also has an alternative 
third larval arrest stage, called dauer.  Animals enter this state upon over-crowding, starvation or upon 
the production of a dauer hormone (Golden and Riddle, 1982).  As dauer larvae, nematodes are hyper-
resistant to stress and they do not age (Kenyon et al., 1993, Hu, 2007).  Given these advantageous 
characteristics, there has been a large investment in understanding the mechanisms that lead to dauer 
larvae. 
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Figure 1: The male and hermaphrodite worm 
Schematic and microscope images of hermaphrodite (A) and male (B) animals.  Characteristic features 
include the eggs and vulva in the hermaphrodite and the fan shaped tail of the male.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Images sourced from WormAtlas 1.0 
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Figure 2: The C. elegans lifecycle 
The lifecycle of C. elegans consists of four larval stages to the fertile adult.  This development can be 
bypassed by an alternative larval stage, called dauer, in unfavourable conditions.  These animals later 
rejoin the cycle when conditions improve. 
 
 
 
 
Image sourced from WormAtlas 1.0 
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Over the past 40 years, C. elegans has been extensively studied: there are vast amounts of genotypic 
and phenotypic data available as the organism is genetically tractable.  The entire nervous system of 
the animal has been reconstructed (White et al., 1986) and the essentially invariant lineage of each 
somatic cell is known (Sulston et al., 1983, Kenyon, 1988).  Furthermore, C. elegans was the organism 
in which both the process of programmed cell death (Horvitz, 2003) and RNA interference (Fire et al., 
1998) were characterised.  The genome sequence of the animal was initially published ten years ago 
identifying approximately 19,000 genes and significantly increasing the volume of information biologists 
have at their fingertips about the animal (C. elegans Sequencing Consortium, 1998). 
 
Like many model organisms, laboratory strains of C. elegans have been subjected to a series of 
genetic bottlenecks with continual adaptation to amenable culture conditions.  Potentially the 
application of wild C. elegans isolates to laboratory research may provide one solution to this problem 
(Barriere and Felix, 2005); in fact, we know surprisingly little about the natural behaviour of C. elegans.  
The advantages that C. elegans brings to the laboratory have furthered the development of other, 
closely-related, Caenorhabditid species as model organisms.  One other hermaphroditic species is C. 
briggsae, which, despite having an almost indistinct morphology from C. elegans (Nigon and 
Dougherty, 1949), is believed to have diverged around 100 million years ago (Coglan and Wolfe, 
2002).  The genome of C. briggsae was published in 2003, providing a platform for comparative 
genomics with C. elegans (Stein et al., 2003).  Despite extensive similarity between the two genomes, 
around 800 genes were found to be unique to C. briggsae, possibly being pseudogenes or genes 
under very rapid evolution.  Moreover, this new sequence provided evidence for over 1,000 new genes 
in C. elegans, centred upon similarities between the species (Stein et al., 2003).  Within the genus, the 
other best-described species are gonochoristic, and include the species remanei and brenneri (the 
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latter named in honour of Sydney Brenner).  Together, this offers a rich platform for biological study 
from an evolutionary perspective when utilising the Caenorhabditis nematodes. 
 
Model organisms are employed in biological research because understanding biological processes and 
mechanisms at the simple level of these animals can have significant consequences for the 
understanding of homologous mechanisms at a more complex level.  C. elegans shares a number of 
biological features and pathways with higher vertebrates.  Rigorous studies on C. elegans can 
therefore provide important insights into homologous processes in these higher organisms; identifying 
lead genes and pathways which help to focus the field of investigation.   
 
1.3 C. elegans and Immunity 
Any organism must be able to defend itself against pathogenic attack to ensure its subsequent survival 
and propagation.  Despite an intense research focus on adaptive immunity, the vast majority of 
organisms (including C. elegans) rely exclusively on the innate immune system for disease resistance, 
a relatively non-specific response.  Even in organisms with adaptive immunity, it is often the innate 
immune system that triggers the onset of an adaptive immune response.   
 
For a number of years, adaptive immunity has been thought to be restricted to vertebrates, but 
increasing evidence is suggesting that there is more of a cross-over than previously believed.  For 
instance, the processing of mRNA has been found to confer adaptive features onto invertebrate innate 
immunity in Drosophila melanogaster and Anopheles gambiae.  In the former case, the 
immunoglobulin-like Down syndrome cell adhesion molecule is alternatively spliced to create around 
18,000 isoforms which have functional diversity in the innate response (Watson et al., 2005); in the 
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mosquito, alternative splicing is used to produce hypervariable antibody-like molecules to bring a new 
level of complexity to its immune response (Garver et al., 2008). 
 
Although, as mentioned, the innate immune system is a non-specific response, in some higher 
organisms there is a remarkable complexity, mediated by the action of phagocytes and the 
complement system.  In addition, it had been assumed that evolutionarily conserved secreted 
antimicrobial peptides, such as lysozyme, act universally on the front line of innate defence in all 
organisms upon pathogen exposure.  However, a recent study in beetles (Tenebrio molitor), has 
shown that antimicrobial peptides which act against S. aureus infection are not induced until the 
majority of the infection has been cleared from the haemolymph.  This suggests that the peptides do 
not act as general “natural antibiotics”, and are instead specifically induced to contain and clear any 
bacteria that are intrinsically resistant to the constitutive immune defence, and thus act as a more 
specialised “last line of defence” (Haine et al., 2008).   
 
C. elegans provides a number of benefits as a model host for studying innate immunity.  Providing that 
the pathogen of choice is a suitable nutritional source for the animals, it can simply be substituted in 
place of the normal feeding bacteria OP50, thus the primary site of the infection is the intestine (Figure 
3), although there are some exceptions.  Phenotypes such as animal survival, motility, pharyngeal 
pumping rate, pathogen burden and so forth, can subsequently be easily and non-invasively examined.  
Work by a number of groups has revealed a complex innate immune approach in C. elegans 
comprising avoidance behaviours and physical barriers.  However, systemic immunity is believed to 
rely purely upon the secretion and action of antimicrobial molecules, including lectins, lysozymes and 
antibacterial factors (Schulenburg et al., 2004).   
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Figure 3: The internal structure of C. elegans 
This TEM cross-section of the worm highlights the positions of both gonads and the intestine in the 
body cavity.  The intestine is comprised of 20 large epithelial cells that associate as pairs to form a 
tube around the lumen that runs in parallel to the gonad along the body.  At the apical side of each 
epithelial cell is the microvilli brush border, anchored to the terminal web.  This is also where a series 
of adherens junctions run between cells to provide a tight seal against the contents of the lumen. 
 
 
 
Image sourced from WormAtlas 1.0 WormViewer 
Dorsal Nerve Cord 
Epithelial Cell Nucleus 
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Intestinal Lumen 
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1.3.1 C-type Lectins 
A number of proteins with Calcium-dependent carbohydrate binding C-type lectin domains (CTLD) 
have been identified in C. elegans that are related to, although different from, those found in mammals 
(Drickamer and Dodd, 1999, Zelensky and Gready, 2005).  Certainly in vertebrates CTLD have a key 
role in the humoral response; the recognition and binding of pathogen-associated molecular patterns 
(PAMPs) is believed to be one of the most crucial ways of identifying non-self from self and eliciting an 
immune response (Zelensky and Gready, 2005).  However, their function in the worm is less clear.  
The family comprises 278 genes, the seventh most abundant gene family in this species (C. elegans 
Sequencing Consortium, 1998), that appear to elicit pathogen-specific responses; the proteins have 
been shown to be induced and secreted in response to infection (Mallo et al., 2002, O'Rourke et al., 
2006, Wong et al., 2007, Schulenburg et al., 2008).  Thus the proteins are ostensibly involved in the C. 
elegans immune response and may be the source of pathogen-specificity, perhaps by acting as PAMP 
receptors (Nicholas and Hodgkin, 2004, Schulenburg et al., 2008).  In opposition to this hypothesis 
however, 85% of the proteins are predicted to be non-carbohydrate binding (Zelensky and Gready, 
2005) indicating that the animal may simply, yet specifically, respond to the individual stresses caused 
by the pathogen; a hypothesis that has also been proposed by the Ewbank laboratory (Ewbank, 2006).  
Together, CTLD proteins have an, as yet, unknown antimicrobial function in the worm. 
 
1.3.2 Lysozyme 
Lysozyme is a ubiquitous defence enzyme found across many forms of life.  In C. elegans, lysozymes 
are one family of antimicrobial enzymes that are believed to be actively lytic against the invading 
pathogen; the lys gene family appear to be homologous to lysozymes in the protozoan Entamoeba 
histolytica, and are thought to eradicate Gram-positive bacteria by working synergistically with 
amoebapore-like peptides also found in C. elegans (Leippe, 1999, Nickel et al., 1998).  Using reporter-
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gene constructs, lysozyme proteins in C. elegans were found to be localised to the intestine, consistent 
with the site of bacterial infection (Mallo et al., 2002). Yet the defensive function of these enzymes is 
thought to be secondary, having evolved from the essential role of these enzymes in the digestion of 
the animals’ bacterial food source (Bachali et al., 2002).  Unlike other organisms which have only one 
or two lysozyme genes, C. elegans has a family of ten differentially regulated lysozyme genes of the 
protist-type, which fall into two clades (Figure 4).  Those of clade one are thought to have the primary 
immune function; these include the lysozymes 1, 2, 3, 7, and 8, which have all been implicated in the 
immune response of the animal to a range of pathogens (Mallo et al., 2002, O'Rourke et al., 2006, 
Evans et al., 2008b, Murphy et al., 2003, Troemel et al., 2006, Shapira et al., 2006, Huffman et al., 
2004, Wong et al., 2007, Alper et al., 2007).  Additionally, the animal has five invertebrate-type 
lysozyme genes, which together with clade two, are suggested to be involved in digestion.  This large 
gene repertoire is thought to have arisen by both ancient and more recent gene duplications, permitting 
the unusual functional diversity believed to be present in the animal (Schulenburg and Boehnisch, 
2008). 
 
 1.3.3 Antibacterial factors 
Another antimicrobial gene family homologous to the antibacterial factor found in the human 
pathogenic nematode Ascaris suum (Ascaris suum antibacterial factor, ABASF) has been identified in 
C. elegans.  The family appears to consist of six genes (WormBase), though only two, abf-1 and abf-2, 
have been described in detail and of which only the antimicrobial activity of abf-2 has been confirmed 
in vitro (Kato et al., 2002).  In C. elegans, abf-2 expression was found to be localised to the pharynx 
indicating that the peptide might be secreted into the intestinal lumen of the worm where it may defend  
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Figure 4: Lysozyme Evolution 
Phylogenetic relationships between the C. elegans lysozymes and its close relatives; the tree was 
constructed using amino acid sequences and maximum likelihood, it is unrooted.  The C. elegans 
family is grouped into 2 clades, with a third distinctly related group being the invertebrate-type 
lysozymes. 
 
 
 
 
Image sourced from (Schulenburg and Boehnisch, 2008) 
Clade One 
Clade Two 
Invertebrate-type 
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against pathogenic attack: the recombinant protein has potent activity against Gram-positive bacteria 
and to some extent both Gram-negative bacteria and yeasts are susceptible to its action.   
 
Sequence analysis revealed that the peptides were encoded together on an operon and were believed 
to have diverged from a common ancestor (Kato et al., 2002).  This organisation would allow 
coordinated expression upon infection, although the genes were not always secreted synchronously 
(Kato et al., 2002).  The antimicrobial function of the five annotated ASABF genes in A. suum were 
investigated further; these nematodes being large enough to easily inject with non-pathogenic bacteria 
and to subsequently retrieve the pseudocoelomic fluid for analysis.  All the ABASF-type peptides 
tested were induced upon the injection of non-pathogenic OP50 into the intestine, but not after the 
injection of sterile saline into the gut.  This indicated that there must be some form of recognition 
system in A. suum, which enables the nematode to mount a specific immune response to pathogen, as 
opposed to a more general induction of stress response genes (Pillai et al., 2003).  There is potential 
for the same to be true in C. elegans. 
 
As a natural host, only three pathogens of C. elegans have been described: the Gram-negative 
bacteria Microbacterium nematophilum, the fungal infection Drechmeria coniospora and more recently, 
the microsporidian parasite Nematocida parisii. 
 
 1.3.4 Microbacterium nematophilum 
M. nematophilum was discovered through chance contaminations of C. elegans laboratory cultures, as 
infected animals displayed an unusual and visible tail swelling, or deformed anal region (Dar), 
previously believed to be a spontaneous, and seemingly heritable, morphological mutation that arose 
during a routine genetic cross.  However, later analysis of these animals, and others, demonstrated 
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that the Dar phenotype was the result of a novel pathogen of C. elegans (Hodgkin et al., 2000).  These 
bacteria establish a specific rectal infection owing to their strong extracellular adherence to the cuticle 
that, in turn, causes a localised swelling response in the host (Hodgkin et al., 2000, Nicholas and 
Hodgkin, 2004).  Additional work showed that this Dar phenotype was a consequence of the limited 
activation of the ERK MAPK cascade in the region, perhaps as a defence mechanism raised against 
the infection (Nicholas and Hodgkin, 2004), although this remains unclear (Hodgkin et al., 2000, 
Gravato-Nobre et al., 2005).  Although not lethal, the animals develop slowly when feeding on pure M. 
nematophilum lawns and show signs of constipation (Hodgkin et al., 2000).  The isolation of a series of 
mutant animals resistant to the infection, exhibiting a bacterially unswollen (Bus) phenotype, 
demonstrated that a number of C. elegans genes are responsible for the Dar response.  These 
mutations have implications for both the host (capability to elicit a swelling response) and the bacteria 
(ability to adhere and colonise) (Gravato-Nobre et al., 2005) and many of these genes are clustered on 
the C. elegans genome (O'Rourke et al., 2006).  Some of the Bus mutants were not colonised by the 
pathogen, indicating that mutations in the formation of the cuticle may have prevented the 
establishment of an infection (Hodgkin et al., 2000, Gravato-Nobre et al., 2005).  bus-2 mutant 
nematodes, for instance, secrete far fewer core-1 O-glycans, required for a pathogenic interaction with 
the bacteria, into the exterior coat of the cuticle and the structure is compensated for with the secretion 
of alternative carbohydrates (Palaima et al., 2010).  The hypothesis is that these carbohydrates mask 
any other core-1 O-glycans present in the cuticle coat and lead to the resistance phenotype (Palaima 
et al., 2010). 
 
A further study examined the genes induced by the animal in response to a six hour infection with M. 
nematophilum.  89 genes were demonstrated to be differentially expressed, of which 68 were up-
regulated and 21 were down-regulated (O'Rourke et al., 2006).  The genes induced upon pathogen 
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infection included a number of proteins with C-type lectin domains, lysozymes and other putative 
pathogen receptor molecules.  Notably, lys-7 was one of the key genes that was up-regulated in 
response to infection, and these data were supported by the observation that lys-7 mutant nematodes 
were severely constipated and exhibited a strong Dar phenotype when infected with the bacteria.  In 
the same vein, knockdown of selected CTLD genes with RNAi changed the response of the animals to 
the infection; again these worms were more susceptible to the infection.  The induced genes were 
located in domain-specific clusters on chromosomes IV and V, potentially enabling the synchronised 
expression of these genes upon infection (O'Rourke et al., 2006).   
 
 1.3.5 Drechmeria coniospora 
D. coniospora, on the other hand, is a nematode parasite that adheres to the mouth and vulva of 
animals and penetrates throughout the entire worm by means of proteinaceous conidia (Jansson, 
1994).  This colonisation of C. elegans triggers an immune response in the host, predominantly 
through the induction of neuropeptide-like proteins (NLPs) (Couillault et al., 2004).  Some of the 32 
NLP genes, identified via their homology to other invertebrate neuropeptides, are thought to act as 
non-classical neurotransmitters, whilst others have gained alternative functions.  Most genes are 
expressed in the neurons of the worm, but a large number are also expressed in the intestine, perhaps 
due to a proposed role for them in the animals’ behavioural muscle contractions (defecation) (Nathoo 
et al., 2001).  In the immune response, a cluster of these genes, the nlp-29 cluster, is induced by the 
activity of the p38 MAPK cascade upon D. coniospora infection (Couillault et al., 2004, Pujol et al., 
2008a).  These proteins not only cluster together on Chromosome V, but also form an independent 
structural group of C. elegans NLPs (Nathoo et al., 2001, Pujol et al., 2008b).  The proteins localise to 
the epidermis of the animal (Pujol et al., 2008a) where they can respond to fungal-induced or 
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mechanically-induced epidermal wounding; the regulation of these peptides in response to both D. 
coniospora infection and cuticle wounding is discussed later.   
 
Another group of antimicrobial molecules activated in response to infection with D. coniospora are the 
Caenacin (for Caenorhabditis bacteriocin, or CNC) proteins (Couillault et al., 2004, Zugasti and 
Ewbank, 2009).  Despite being structurally related to the NLP immune genes, and also being situated 
in a cluster on Chromosome V, the CNC proteins are a discrete group of antimicrobials.  The artificial 
over-expression of these peptides renders the animal resistant to fungal infection and their induction in 
response to D. coniospora infection is dose-dependent upon TGF-β signalling, by means of the C. 
elegans homologue dbl-1 (Zugasti and Ewbank, 2009).  The specific role of both the NLP and CNC 
peptides in response to the fungal infection remains elusive. 
  
1.3.6 Nematocida parisii 
In the case of Nematocida parisii, this intracellular parasite is a member of the microsporidia phylum, 
although it is both a novel genus and species.  The pathogen was discovered when a newly isolated 
wild C. elegans strain from a compost heap in Franconville, France was found to be infected with an 
unknown pathogen that could be transferred horizontally through an animal culture, but not vertically.  
The microbe was unable to be cultured in vitro, thus animal survival was assessed using ‘infectious 
extracts’ from an infected plate, and animals at all developmental stages were found to be susceptible 
to the pathogen.  The parasite progressed through its infection cycle, from meront to spore, the latter 
being the infectious stage though the former appears to do the most damage to the host.  The spores 
cause specific damage to the terminal web of the intestinal epithelium structure, targeting intermediate 
filaments in particular, but not altering the microvilli structure.  Later, the infection overwhelmed the 
intestine of the animal, and the spores associated together in extracellular vesicles.  The host response 
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to this infection appears to be unique; the infection did not induce fundamental response genes known 
to be crucial to other pathogenic infections, nor did the abolition of vital components of the immune 
signalling (p38 MAPK and IGF) pathways have any effect on animal survival.  Further, other wild 
isolates of C. elegans from France, Portugal and India, were found to harbour different strains of the 
parasitic infection, indicating that it may be a relatively common natural pathogen of the worm (Troemel 
et al., 2008) . 
 
Lessons learned from these studies with natural pathogens of C. elegans are particularly informative, 
as they provide evidence of the ‘true’ immune response in these animals.  The results can then be 
applied to those collected from pathogenesis studies using human pathogens, to validate these data 
sets. 
 
1.4 C. elegans as a model host 
1.4.1 Pseudomonas aeruginosa 
The Gram-negative bacteria P. aeruginosa is ubiquitous to the environment and a common 
opportunistic pathogen of both animals and plants.  In humans, it is of particular danger to immuno-
compromised individuals, being strongly associated with hospital acquired infections, cystic fibrosis 
and burn injuries (Kerr and Snelling, 2009).  C. elegans was successfully infected and killed with a 
clinical isolate of the pathogen, strain PA14, known to be virulent in mice and plants.  In the worm, its 
mechanism of pathogenesis was demonstrated to be medium-dependent; when grown on a minimal 
medium PA14 caused an infection-like process in the intestine of the animal killing over the course of 
several days, termed “slow” killing.  However, PA14 was also found to kill C. elegans in a matter of 
hours, named “fast” killing, when grown on a rich medium (Mahajan-Miklos et al., 1999, Tan et al., 
1999).   
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Slow killing is completely dependent upon the accumulation and active replication of bacteria in the 
animals’ gut, yet animals can recover from the infection if removed from the pathogen source following 
a brief exposure and providing a ‘threshold’ has not been breached.  Once the pathogenic exposure 
has reached this threshold, the infection becomes persistent and the animals are unable to recover 
(Tan et al., 1999).   This is in stark contrast to the lethal toxin-based fast killing exhibited on rich media, 
believed to be mediated by phenazines, pigment compounds secreted by Pseudomonads (Mahajan-
Miklos et al., 1999).  The work also showed that PA14 mutants with attenuated virulence in mice and 
plants were also attenuated in C. elegans, suggesting that P. aeruginosa used common mechanisms 
to elicit its pathogenic effect across divergent host groups (Mahajan-Miklos et al., 1999, Tan et al., 
1999).  This, coupled with the rapid identification of multiple factors required for a successful interaction 
between the host and pathogen, by means of screens for essential genes on both sides of the 
interaction, implied that C. elegans had the potential to be a powerful model for elucidating universal 
mechanisms of pathogenesis (Tan et al., 1999). 
 
This work was replicated for a second P. aeruginosa clinical strain, PAO1, one which is known to be 
less pathogenic than PA14, and a third mechanism of killing was described; that of a rapid and lethal 
paralysis mediated by an unidentified diffusible toxin (Darby et al., 1999).  By screening mutant 
libraries of both the pathogen and the host, the lethal pathogenesis was shown to be dependent upon 
regulation of the toxin by two quorum-sensing genes, LasR and RhlR, in the bacterium, combined with 
the expression of the egg-laying protein EGL-9 in the host.  At this time, the toxin was unknown as 
bacterial mutants for a number of known secreted proteins, including exotoxin A, were unchanged in 
their pathogenesis of C. elegans (Darby et al., 1999).  It has since been described that PAO1 fast-
killing is mediated by cyanide poisoning (Gallagher and Manoil, 2001).  On the part of the host, further 
molecular characterisation of egl-9 suggested that the gene was involved in the contraction of both 
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pharyngeal and body muscles.  As loss-of-function mutants for egl-9 became resistant to the infection, 
the authors propose that the bacterial toxin activated host muscle paralysis through the activity of EGL-
9 (Darby et al., 1999).  These animals are also resistant to killing by cyanide in the absence of 
pathogen, suggesting that wild type animals’ susceptibility to PAO1 may involve the suppression of a 
hypoxia response by EGL-9, or conversely the activation of a stress-response pathway by EGL-9 that 
induces death (Gallagher and Manoil, 2001). 
 
PAO1 is also able to induce the rapid onset of “red death”, the presence of a red coloured material in 
the C. elegans pharynx and intestine, in nematodes exposed to physiological stress (such as starvation 
or heat-shock) and subsequently infected with PAO1 grown on low phosphate media (Zaborin et al., 
2009).  Transcriptomic analysis of PAO1 grown on high or low phosphate media identified 323 genes 
that were up-regulated in the response to low phosphate, and which may be causative of the “red 
death” phenotype.  Three regulatory systems were found to be essential in the induction of “red death” 
in both worms and mice: the bacteria activate their phosphate uptake system through PhoB, induce a 
number of quorum sensing-associated genes, including phenazines, and activate pyoverdin 
biosynthesis in order to acquire iron and initiate phosphate signalling (Zaborin et al., 2009).   
 
A comparative genomic and transcriptomic analysis for both PA14 and PAO1 confirmed that the two 
strains, despite being remarkably similar, had distinct mechanisms for virulence in C. elegans (Lee et 
al., 2006). 
 
An alternative approach highlighted an evasive mechanism by P. aeruginosa to aid C. elegans 
pathogenesis (Kawli and Tan, 2008, Evans et al., 2008b).  Long-lived daf-2 (an insulin-like receptor; 
Figure 5) mutant animals are resistant to a number of bacterial infections, including P. aeruginosa 
Chapter 1: Introduction 
19 
 
(Garsin et al., 2003).  However it appears that P. aeruginosa can suppress the C. elegans immune 
response by activating DAF-2-mediated signalling, inhibiting the downstream DAF-16-directed 
activation of immunity genes by sequestering this forkhead transcription factor in the cytoplasm of 
epithelial cells, thus preventing nuclear transcription (Kawli and Tan, 2008).  The intestinal expression 
of DAF-16 was shown to be essential for C. elegans resistance to the pathogen (Evans et al., 2008b).  
The host genes specifically down-regulated by P. aeruginosa include the lysozyme lys-7, the saposin-
like protein spp-1, and, perhaps surprisingly, an antifungal protein thn-1.  This suppression pattern was 
not mirrored upon exposure to other bacteria, indicating that it is an immune adaptation specific to P. 
aeruginosa, and it was shown to be dependent upon the quorum sensing regulators LasR and RhlR 
once more, and a two-component response regulator, GacA (Evans et al., 2008b).  Given this 
adaptation, there is some potential that P. aeruginosa may be a natural pathogen of C. elegans.   
 
From the host perspective, a screen of C. elegans immunity genes, which also have possible 
candidates for mammalian and fly immunity orthologues, identified 59 genes required for strong 
expression of clec-85 (Alper et al., 2008), which is strongly expressed by C. elegans during the 
pathogenesis of P. aeruginosa (Alper et al., 2007), and nematode survival during the infection.  In 
addition, these genes have some potential to be developed as novel targets for pharmaceutical 
development as these immuno-modulated ‘control’ genes identified in C. elegans were also found to 
have a role in regulating cytokine production during the mammalian defence response against E. coli in 
murine macrophages (Alper et al., 2008). 
 
More recently, the pathology of the PA14-mediated slow killing of C. elegans has been described 
through intestinal cross-sections imaged by transmission electron microscopy (Irazoqui et al., 2010a).  
The initial stages of the infection appeared to have involved intestinal distension but little bacterial 
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colonisation, although those bacteria that had begun to accumulate appeared to be surrounded by 
outer membrane vesicle-like structures.  As the infection progressed to 24 hours, large numbers of 
bacteria formed sizeable clumps in the distended intestine, surrounded by an unknown extracellular 
matrix structure, and associated with microvilli.  By 48 hours, some of the bacteria appeared to have 
invaded the epithelium and spread to other tissues, the intestine was grossly distended, the microvilli 
had shortened and a large number of autophagosomes were present.  These pathologies were not 
observed in a P. aeruginosa gacA mutant, which is attenuated for C. elegans killing (Irazoqui et al., 
2010a).   
 
1.4.2 Salmonella enterica 
The genus Salmonella encompasses a number of species, further subdivided into serovars, of Gram-
negative bacteria capable of causing enteric disease in animals and humans.  The acute systemic 
illness typhoid fever, characterised by malaise, high fever and non-bloody diarrhoea, is caused by 
Salmonella enterica serovar Typhi, and is transmitted by contaminated water sources, foodstuffs and 
poor hygiene (Tam et al., 2008).  The World Health Organisation has recently reported the global 
burden of the disease to be 21.5 million illnesses with over 200,000 cases proving to be fatal during the 
year 2000 alone (Crump et al., 2004).  The pathogen is, however, restricted purely to humans, thus 
presenting the problem of studying the host-microbe interaction and subsequent infection on a whole-
organism scale in an ethical manner.   
 
Another serovar, Salmonella Typhimurium, causes a gastric infection in humans that can become 
severe and occasionally systemic in the immunocompromised.  As a principal cause of gastroenteritis 
world-wide (Haraga et al., 2008), there is good reason to study the infection in its own right.  
Additionally, the bacterium causes a systemic disease analogous to ‘human’ typhoid fever in 
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susceptible mice with a polymorphism at the Slc11a1 (Nramp1) locus, an innate immunity gene 
responsible for bacterial resistance and macrophage activation.  Thus the bacterium S. Typhimurium is 
exploited together with the murine host, and alongside tissue-culture systems, as a model for 
investigating the more critical human pathogen, S. Typhi (Tam et al., 2008). 
 
The progression of S. Typhimurium infection in the murine model is now well understood.  Briefly, the 
bacteria are consumed orally and immediately begin to evade innate host defences, such as the low 
pH of the stomach (Haraga et al., 2008).  The site of colonisation and infection for Salmonella is the 
small intestine; here the bacteria preferentially utilise the protective role of specialised epithelial 
microfold (M) cells which engulf and transport the bacterial cells directly to lymphatic Peyer’s patches 
within the mucosa (Haraga et al., 2008, Tam et al., 2008).  The bacteria are also able to cross the 
epithelial barrier and disrupt tight-junctions by inducing membrane ruffles and their subsequent 
endocytosis into non-phagocytic epithelial cells (Tam et al., 2008).  This substantial change in the 
ordered structure of the intestinal brush border is a contributing factor towards diarrhoea production 
(Haraga et al., 2008, Viswanathan et al., 2009).  Following invasion, typhoidal serovars exploit 
macrophages to assist their systemic spread through the blood (Tam et al., 2008, Mastroeni et al., 
2009).  Non-typhoidal strains remain localised to the intestine and the subsequent host inflammatory 
response leads to a restricted enteric disease, which, in healthy individuals, is generally cleared within 
a few days (Haraga et al., 2008).  Salmonellae make use of a number of virulence factors to achieve 
their translocation across the epithelium indicating how crucial this step is in the progression of the 
mammalian infection.   
 
One such major regulator of S. Typhimurium virulence is the PhoP/PhoQ trans-membrane two-
component system which controls the expression of many genes involved in invasion, survival and 
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lipopolysaccharide (LPS) composition amongst others (Groisman, 2001, Prost and Miller, 2008).  Upon 
encountering low cation concentrations after internalisation into the host, it is understood that the 
membrane-bound sensor kinase, PhoQ, undergoes a conformational change which phosphorylates 
PhoP, its response module in the cytosol, enabling PhoP to modulate the transcription of downstream 
genes; hundreds of virulence genes are regulated in this manner (Groisman, 2001, Prost and Miller, 
2008).  Moreover, it has been shown that sub-lethal concentrations of host-produced antimicrobial 
peptides (AMPs) are able to compete with the cation binding sites, act as PhoQ ligands and 
subsequently initiate PhoP-directed cellular responses resulting in the activation of a number of 
virulence mechanisms (Bader et al., 2003, Kindrachuk et al., 2007, Prost and Miller, 2008, Groisman 
and Mouslim, 2006). 
 
One of the genes regulated by the PhoP/PhoQ system is HilA (Groisman, 2001), a Salmonella 
pathogenicity island one (SPI-1) transcriptional regulator that, with others, controls the expression of 
the SPI-1 Type III secretion system (T3SS) (Cornelis, 2006).  This system encodes a needle-like 
mechanism used to inject effector proteins directly into the host cell in order to drive the manipulation 
of their host cell targets; for instance, the induction of ruffling through the manipulation of the host actin 
cytoskeleton which facilitates the uptake of Salmonellae by non-phagocytic cells (Cornelis, 2006, 
McGhie et al., 2009).  The S. Typhimurium genome encodes around fourteen of these pathogenicity 
islands, although the two best-described systems are SPI-1 and SPI-2, both of which encode 
independent T3SSs (McGhie et al., 2009).  The SPI-1 system is involved in the invasion of bacteria 
into the host cells, whereas the SPI-2-encoded T3SS is required for survival and proliferation within 
macrophages and is induced independently of PhoP/PhoQ once the Salmonellae are internalised 
(Beuzon et al., 2001, Waterman and Holden, 2003).   
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Another such virulence factor, the stationary-phase sigma factor RpoS (previously known as KatF), is 
induced to control the expression of a number of genes upon starvation and other stresses.  This 
sigma factor is found in a number of other bacteria, including Escherichia coli where the regulon has 
been heavily studied (Dong et al., 2009, Patten et al., 2004, Tian et al., 2008, Hengge-Aronis, 2002).  
In Salmonella, this alternative sigma factor appears to be dispensable in S. Typhi where mutants for 
rpoS appear frequently in clinical isolates; 15 out of the 41 strains tested.  However, the same is not 
true for S. Typhimurium, suggesting that these mutants were selected against and thus indicating that 
RpoS is essential for the pathogenesis of this serovar (Robbe-Saule et al., 2003).   
 
Indeed, RpoS controls the expression of a number of virulence genes in S. Typhimurium including the 
plasmid genes spvRABCD, which are important for the systemic spread of the bacterial infection (Fang 
et al., 1992, Norel et al., 1992); the role of rpoS in S. Typhimurium infection appears to be in the 
establishment of a systemic infection and not in the production of a local enteric illness (Fang et al., 
1992, Nickerson and Curtiss, 1997).  In mice, an rpoS mutant strain requires a 1000-fold greater oral 
lethal dose than wild type S. Typhimurium (Fang et al., 1992).  Further, a common laboratory reference 
strain for S. Typhimurium, LT2, is avirulent in mice; an avirulence entirely attributable to an alternative 
start codon (UUG) of the rpoS gene that significantly reduces the quantity of RpoS protein produced 
(Swords et al., 1997a, WilmesRiesenberg et al., 1997).   
 
 1.4.2.1 Salmonella infection in C. elegans  
Following the discovery that the human pathogen P. aeruginosa kills C. elegans, it was postulated that 
S. Typhimurium infections may also be modelled in the worm.  Two back-to-back publications 
demonstrated that this specialised bacterium was capable of persistently infecting C. elegans with a 
colonisation process that required only a small bacterial load to become established.  The infection of 
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the animals was found to be limited to the gut; the bacteria were not internalised into the epithelium.  
This colonisation caused the intestine to become distended before being subsequently destroyed by 
live bacteria that had escaped the action of the grinder.  This persistent infection exhibited by S. 
Typhimurium is unlike the other model infections of C. elegans tested to date, and indicates that the 
bacteria may form a strong interaction with the host reminiscent of a ‘true’ infection of the worm 
(Aballay et al., 2000, Labrousse et al., 2000). 
 
The observation that some animals displayed a strong endomitotic oocyte phenotype, where the parent 
animal dies containing fertilised eggs that never develop (Aballay et al., 2000), indicated that germ line 
development may somehow be involved with S. Typhimurium infection.  The protective function of 
germ line cell death mediated by the action of ced-3 and ced-4 was later described (Aballay and 
Ausubel, 2001), though these data have not been supported by our laboratory or others (Jia et al., 
2009).  This immune role of a programmed cell death (PCD) response may activate an unknown 
defence pathway given that it seems unlikely that protection from a strictly intestinal infection would be 
dependent upon gonadal cell death.  The role of the PCD response was upheld in a further study 
examining the replication of vaccinia virus in C. elegans: animals lacking components of the cell death 
pathway had significantly higher viral loads; however, this did not translate to survival rates (Liu et al., 
2006). 
 
As with C. elegans susceptibility to P. aeruginosa (Kim et al., 2002), animals with mutations in the p38 
MAPK cascade are hypersensitive to S. Typhimurium infection.  It was subsequently shown by 
epistasis analysis that this pathway activates the Salmonella-elicited PCD response (Aballay et al., 
2003).  Interestingly, the attenuated S. Typhimurium PhoP/PhoQ mutants did not instigate germ line 
PCD or a persistent infection (Aballay and Ausubel, 2001, Aballay et al., 2003, Alegado and Tan, 
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2008), implying that the PhoP/PhoQ regulon manages essential virulence factors for nematode 
pathogenesis.  Indeed, its expression (along with other virulence factors such as SPI-1 and SPI-2), are 
induced by the bacteria upon colonisation of C. elegans (Alegado and Tan, 2008).  One of the crucial 
factors for Salmonella pathogenesis could be lipopolysaccharide (LPS), whose synthesis is under the 
control of PhoP/PhoQ.  In support of this hypothesis, bacterial mutants with a modified LPS structure 
were not able to induce an immune response or establish a persistent infection in the host.  This 
suggests that a component of the LPS may be the pathogen-associated recognition factor for S. 
Typhimurium infection in C. elegans, as it is in mammals (Aballay et al., 2003). 
 
A screen of 960 S. Typhimurium insertion mutants identified 15 strains with attenuated killing in C. 
elegans, which, in each case, were attributable to a single TnphoA insertion.  Seven of these 
mutations, in turn, corresponded to a number of novel virulence genes, including spi4-F, cstA and 
leuO.  Most of these strains were also attenuated in a tissue culture cell-based mammalian infection 
model, as they were significantly reduced in their ability to both induce polymorphonuclear leukocyte 
migration and invade epithelial cells in comparison to the wild type strain SL1344; characteristics of S. 
Typhimurium infection (Tenor et al., 2004).  A further four of these S. Typhimurium mutants encoded 
components of the SPI-1 T3SS: hilA and hilD, both of which regulate the expression of the T3SS, invH 
which is required for its assembly, and sptP which is one of the translocated effector proteins of the 
system ((McGhie et al., 2009, Cornelis, 2006, Cain et al., 2008).  Together, this suggests that the T3SS 
has a significant role in C. elegans killing.  In support of this, S. Typhimurium strains lacking either 
hildD or the entire SPI-1 gene cluster are significantly attenuated in C. elegans killing.  Conversely, 
mutants that over-express hilA kill C. elegans faster than the wild type control (Tenor et al., 2004).  
SptP is responsible for inhibiting the p38 MAPK response in mammalian cells (McGhie et al., 2009); is 
this feature conserved across phyla?  Ectopic expression of SptP in the intestinal epithelium of C. 
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elegans significantly reduced PMK-1 activation by western analysis and these animals subsequently 
became more sensitive to S. Typhimurium-mediated killing.  The contact between the host and 
bacteria could be mediated by the T3SS and its subsequent translocation of SptP into epithelial cells; 
indeed it may be this interaction that causes the persistent lethal infection of C. elegans by S. 
Typhimurium (Tenor et al., 2004).   
 
The persistence of the infection may also be a result of S. Typhimurium resistance to host antimicrobial 
compounds.  Upon infection with S. Typhimurium, C. elegans responds with the defensive expression 
of two innate immunity peptides abf-2 (Kato et al., 2002) and spp-1 (Alper et al., 2007) to limit the 
colonisation of the bacteria (Alegado and Tan, 2008).  Additionally, persistent-defective bacterial 
mutants (for SPI-2, phoP and ΔpSLT) could be rescued by the suppression of spp-1 by RNAi in the 
host, implying that the resistance of Salmonella to spp-1 is a feature of colonisation and persistence in 
the worm (Alegado and Tan, 2008). 
 
Genes involved in the unfolded protein response (UPR) are also required for S. Typhimurium infection 
where they are regulated by the apoptotic regulator CED-1.  C. elegans mutants for ced-1 are 
hypersensitive to Salmonella and Candida-mediated killing (Haskins et al., 2008, Means et al., 2009) 
and microarray analysis of these mutants identified a cluster of pqn/apu UPR genes that were 
significantly down-regulated (Haskins et al., 2008).  Survival analyses of knock-down mutants for a 
number of the genes in this cluster via RNAi additionally showed that these animals were 
hypersensitive to S. Typhimurium infection, suggesting a role in C. elegans immunity to these bacteria.  
Additionally, there is greater pharyngeal destruction and invasion by S. Typhimurium in ced-1 mutant 
animals, thus it appears that the UPR defence is a response to S. Typhimurium-induced damage in the 
animal, and the UPR pathway acts to preserve the integrity of organ structures (Haskins et al., 2008). 
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C. elegans mutants for the autophagy genes bec-1 and lgg-1 are also hypersensitive to infection with 
S. Typhimurium (Jia et al., 2009).  Autophagy, the process of recycling cellular components via 
lysosomal degradation, is regulated by the DAF-2 pathway in C. elegans and is implicated in the 
clearance of intracellular bacteria in the mammalian innate immune response.  The basis of this 
hypersensitivity was not mediated by the link between autophagy and apoptosis, but instead the 
autophagy pathway appeared to limit bacterial replication in the intestinal epithelium (Jia et al., 2009).  
On day two of a S. Typhimurium infection, a small number of intracellular bacteria were seen in wild 
type worms, predominantly as debris in autophagosomes, although some were intact, whereas bec-1 
RNAi animals were overwhelmed by the infection and had a number of Salmonella-containing vacuoles 
(SCVs) and intact bacteria in the epithelial layer.  By day four of the infection, the epithelial cells were 
almost entirely destroyed in the bec-1 knock-down animals and there was intracellular replication of the 
bacteria; this was not true in the wild type animals suggesting that autophagy protects the structure of 
the intestine from S. Typhimurium (Jia et al., 2009). 
 
Taken together, there are limitations of the C. elegans infection model with respect to mammalian 
pathogenesis due to the predominantly extracellular nature of the infection.  However, the fact that 
Salmonella is one of the few human pathogens to initiate a persistent infection in the worm is 
encouraging and, once understood, may be particularly informative. 
 
1.4.3 Serratia marcescens 
It was a study with the Gram-negative bacterium S. marcescens which first suggested that C. elegans 
has an inducible immune response (Mallo et al., 2002).  S. marcescens is an environmental bacterium, 
which causes disease in a number of organisms; plants, invertebrates and vertebrate hosts.  In 
humans it is an opportunistic pathogen associated with hospital-acquired infections and, as many 
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strains are intrinsically antibiotic resistant, the pathogen represents an ongoing public health challenge 
(Kurz et al., 2003).   
 
In C. elegans, S. marcescens establishes a persistent intestinal infection, arising from an avoidance of 
the pharyngeal grinder.  The bacteria progressively destroy the animal tissues, resulting in a grossly 
distended intestine, before the worm dies with a maximum survival of just 6 days (Mallo et al., 2002, 
Kurz et al., 2003).  Notably, a small number of bacteria become intracellular, although this is a very 
rare event (Kurz et al., 2003).  The C. elegans response to the bacteria involves the up-regulation of a 
number of putative pathogen-response proteins, including lysozymes, NLPs and lectins, a subset of 
which appeared to be largely under the control of the DBL-1/TGF-β pathway (Mochii et al., 1999).  dbl-
1 knockout animals, which are unable to signal through the TGF-β cascade, are hypersensitive to 
infection suggesting a central role of this pathway in the host response to Serratia (Mallo et al., 2002).  
A comparative approach found that the expression profiles of genes induced following S. marcescens 
infection were distinct from those induced upon infection with the natural nematode pathogen M. 
nematophilum, although the gene families induced were similar, suggesting that C. elegans can mount 
responses tailored to the specific infection and must therefore have a pathogen recognition system of 
some sort (Mallo et al., 2002, O'Rourke et al., 2006).  Indeed, the over-expression of one principal 
response lysozyme, lys-1, was enough to increase the animals’ resistance to infection (Mallo et al., 
2002).   
 
This work was followed by the exploitation of C. elegans as a high-throughput screen for S. 
marcescens transposon mutants with attenuated virulence (Kurz et al., 2003).  Some of the mutants 
identified in the screen were also attenuated in the alternative infection models D. melanogaster and 
an in vitro cell-based assay.  Characterisation of these mutants revealed novel mechanisms required 
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for full virulence of the pathogen; these included genes involved in iron uptake, LPS synthesis (the 
bacteria lacked the O-antigen) and haemolysin production.  Additionally, this screen was indicative of 
P. aeruginosa pathogenesis, as orthologues of two genes identified in the S. marcescens mutants (one 
uncharacterised, the other involved in sequestering iron) were also attenuated for virulence in C. 
elegans when disrupted in P. aeruginosa (Kurz et al., 2003). 
 
To evaluate the interaction between C. elegans and S. marcescens from an evolutionary perspective, 
the relationship between natural worm and pathogen isolates was examined (Schulenburg and 
Ewbank, 2004).  The interaction varied with respect to the pathogen strain and the C. elegans micro-
population in question.  Although animals from the same population responded in a similar way to each 
pathogen strain, the four populations assayed showed clear differences in resistance and susceptibility 
phenotypes to the various S. marcescens strains (there was no general trend), thus supporting a 
genetic basis for host resistance, pathogen virulence and the interaction itself.  It was postulated that 
these observed differences are likely to represent the co-evolution of the bacteria and host as both 
struggle to get ahead in the evolutionary “arms race” (Schulenburg and Ewbank, 2004).  This work 
showed the potential that C. elegans has for a model to study the adaptations the host and pathogen 
make as they co-evolve together, although whether C. elegans and S. marcescens interact in their 
natural environments remains to be seen. 
 
1.4.4 Escherichia coli 
In the laboratory, nematodes are cultured using E. coli OP50 as the sole food source.  This is a non-
pathogenic food source, and animals live for 2-3 weeks in these conditions (Brenner, 1974).  However, 
there is evidence that even OP50 is pathogenic to both aging animals in standard growth conditions 
and to younger animals when grown on rich media (Couillault and Ewbank, 2002).  This is a feature 
Chapter 1: Introduction 
30 
 
held in common with the infection of higher vertebrates with these Gram-negative bacteria: generally, 
E. coli is found in the intestine of humans and other mammals as part of the commensal gastro-
intestinal flora, where it is harmless and can even offer protection to the host against other virulent 
pathogens (Crossman et al., 2010).  Even virulent enteric isolates rarely cause anything more than an 
acute bout of food poisoning in the healthy host; however, these isolates are opportunistic pathogens 
which can cause severe disease in immuno-compromised individuals (Crossman et al., 2010).   
 
C. elegans has been applied as a pathogenesis model for understanding the molecular basis of 
Enteropathogenic E. coli (EPEC) infection.  Killing of C. elegans by EPEC correlated with the 
accumulation of bacteria in the animal gut over a few days, rather than by a toxin-mediated mechanism 
(Mellies et al., 2006).  This colonisation is dependent upon the global regulator, Ler, and although 
nematodes infected with a ler mutant strain did not die any slower than other EPEC isolates, far fewer 
bacteria were found in the animals’ intestine suggesting that only a few number of bacteria are required 
for a successful colonisation and that this interaction with the host is lethal.  The C. elegans-EPEC 
model has its limitations, however, as other virulence factors required in mammalian systems, such as 
the T3SS, are not essential for the C. elegans model, hence the modes of EPEC infection of 
invertebrate and vertebrate hosts appear to be far removed (Mellies et al., 2006).   
 
The EPEC infection process described above is one of “slow” killing, analogous to the mechanism of 
“slow” killing by P. aeruginosa.  Similarly, EPEC also exhibits a “fast” killing process, mediated by 
secreted toxins when grown on a rich medium supplemented with tryptophan.  C. elegans killing was 
modulated by p38 MAPK and insulin signalling; daf-2 and age-1 mutations (insulin signalling) rendered 
the animals resistant to the infection, whereas mek-1 and sek-1 mutations (p38 MAPK signalling) led to 
hypersensitivity (Anyanful et al., 2005).   
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This group went on to show that a 30 minute exposure to fast-killing EPEC, followed by a recovery 
period in normal culture conditions, led to a 4 fold increase in animal survival upon a subsequent 3 
hour “fast kill” exposure, a phenomenon they describe as ‘conditioning’.  A three hour recovery on 
OP50 was optimal; any more or less time reduced the subsequent animal survival rate during the three 
hour secondary infection.  It was further shown that a primary exposure to avirulent EPEC strains and 
to other bacterial species could still provide protection against a secondary wild type EPEC infection.  
The conditioning response was dependent upon both insulin and p38 MAPK signalling, and mediated 
by the DAF-16 regulated genes the saposin spp-1 and the aquaporin aqp-1, which suppress the 
conditioning response when mutated (Anyanful et al., 2009). 
 
1.4.5 Staphylococcus aureus 
S. aureus is a common Gram-positive bacterium that causes a range of minor infections, which 
occasionally become serious, in many animals.  It is a major pathogen of livestock, and in humans a 
leading cause of hospital-acquired infections, for both of which it employs an array of virulence factors.  
In humans, the bacteria are commensals in around 30% of the population.  There are 10 dominant 
lineages of S. aureus, although no one lineage in associated with infectious disease, indicating that the 
host background is extremely important for the progression of the disease.  Its relevance becomes 
more and more critical given the establishment of extensively antibiotic resistant strains, notably the 
emergence of Methicillin-resistant Staphylococcus aureus (MRSA) during the 1990s, reviewed in 
(Lindsay, 2010).     
 
In C. elegans, intact bacteria accumulate in the gut of the animal and it is this colonisation that 
eventually overwhelms the host, leading to death (Garsin et al., 2001, Sifri et al., 2003).  Nematodes 
can be rescued from the lethality of the infection by transfer to a non-pathogenic food source, enabling 
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the clearing of the bacteria from the animals’ intestines.  This recovery is dependent upon a critical 
exposure threshold, the length of which is strain-dependent, not having been reached.  This correlates 
with the observation that infected animals have normal feeding behaviour and locomotion until this 
threshold is achieved and the infection becomes lethal (Sifri et al., 2003).   
 
The infection of C. elegans by S. aureus appeared to result from an active process rather than from the 
formation of an evasive biofilm, which is the principal component of S. epidermidis-mediated killing in 
C. elegans (Begun et al., 2007).  Indeed, there was a rapid initial colonisation of the intestine by S. 
aureus, followed by additional bacterial accumulation at the rectum and an apparent adhesion of the 
intestinal bacteria to the apical surface of the epithelium.  This colonisation was coupled with gross 
intestinal distension and a Dar (deformed anal region) phenotype, dependent upon both β-catenin and 
ERK MAPK signalling (Irazoqui et al., 2010a).  As the infection progressed to 12 hours, the architecture 
of the epithelium was disrupted: the microvilli had shortened and the epithelial cells themselves had 
lost volume and had started to ‘bleb’ into the lumen.  Later, the architecture was completely destroyed 
by the bacteria and later still, the entire animal had been degraded leaving just a ghost of the cuticle.  
Interestingly, this systematic destruction was not dependent upon the S. aureus cytolysins, as bacterial 
strains lacking these virulence factors still caused the same cytopathology as wild type (Irazoqui et al., 
2010a). 
 
Isolates of S. aureus mutated for crucial virulence factors, such as the global virulence regulators agr 
and sarA, in mammalian hosts are attenuated in C. elegans killing, indicating that these genes are also 
required for full pathogenesis in the worm model.  From the host perspective, nematodes which are 
unable to signal through the p38 MAPK cascade (sek-1 and nsy-1 mutants) are hypersensitive to 
infection with S. aureus, indicating that the p38 MAPK pathway is largely responsible for eliciting a host 
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immune response to infection (Sifri et al., 2003).  Another signalling cascade, analogous to the 
vertebrate β-catenin (bar-1) and homeobox (egl-5) transcription factors, also up-regulates C. elegans 
immune factors in response to S. aureus infection, particularly clec-60 and lys-5 (Irazoqui et al., 2008).  
Mutant animals for bar-1 and egl-5 are more susceptible to S. aureus than wild type; the bacteria 
actively divide in the intestine of these animals and they mount a repressed defence response that is 
not capable of lysing the bacterial cells: together this leads to increased damage of the intestinal 
epithelium.  This phenotype is more severe than the hypersensitivity of p38 MAPK mutants, suggesting 
that the independent bar-1/egl-5 pathway is the predominant pathway for initiating the immune 
response to S. aureus infection.  The importance of this pathway in S. aureus pathogenesis is mirrored 
in higher vertebrates, where it activates NFкB-mediated gene expression (Irazoqui et al., 2008), again 
highlighting the potential C. elegans has as a model for pathogenesis.   
 
Microarrays for wild type animals’ gene expression at eight hours of S. aureus infection showed a 
further 382 genes whose expression was modulated upon infection (Irazoqui et al., 2010a).  Of these, 
a subset of the genes up-regulated more than 4-fold above expression levels in non-pathogenic 
conditions were putative antimicrobial and detoxification peptides.  These genes appeared to be 
induced in a series of induction waves in at least two different groups (Irazoqui et al., 2010a) and could 
be indicative of the severity of S. aureus infection, facilitating further pathogenesis screens with the C. 
elegans model. 
 
1.4.6 Cryptococcus neoformans 
C. neoformans is an encapuslated yeast, ubiquitous in the environment.  As a pathogen, it causes 
disease in a number of animals.  In humans it is primarily a pathogen of the immuno-compromised, 
notably co-infecting AIDS patients.  After the primary infection, the fungus can disseminate to the 
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central nervous system and cause severe meningitis; a key component of this spread is the ability of 
the yeast to survive and reproduce in macrophages.  However, Cryptococcus is beginning to emerge 
as a pathogen of immuno-competent individuals since a hypervirulent C. gattii variant is responsible for 
a continuing outbreak of cryptococcosis on Vancouver Island, Canada, and thus has significant clinical 
relevance (Ma and May, 2009). 
 
Killing of C. elegans by C. neoformans is rapid, with considerable killing from just day 2 of infection 
(Mylonakis et al., 2002, van den Berg et al., 2006).  The yeast cells accumulate in the intestine of the 
host causing gross distension, but the infection is not persistent as animals can be rescued from the 
pathogen by transfer to normal culture conditions.  The mechanism of pathogenesis is not clear, but a 
number of genes and features required for mammalian pathogenesis are also essential for the worm 
model (Mylonakis et al., 2002, Tang et al., 2005).  A surprising exception was the finding that acapsular 
yeast, although attenuated, did not impede nematode killing, but that instead this mutation inhibited the 
accumulation of intestinal yeast cells, implying that neither the capsule nor the fungal accumulation are 
essential for the lethality (Mylonakis et al., 2002).  This, coupled with the discovery that heat-killed 
yeast also killed C. elegans, suggested that the pathogenesis of the worm may be mediated by a toxic 
interaction between the host and pathogen.  The lethality generated by C. neoformans was not thought 
to be a by-product of the inability of the animals to utilise yeast as a food source: other Cryptococcus 
species such as C. laurentii and C. kuetzingii did not impair C. elegans survival, and animals were 
readily able to propagate on these lawns when they were the sole food source (Mylonakis et al., 2002). 
 
C. elegans appears to be a particularly effective model host for C. neoformans pathogenesis.  
Significantly, infected animals are cultured at 25°C, which is the ideal temperature for cryptococcal 
growth.  As the yeast infects mammalian hosts at 37°C and is carried in avian hosts at 42°C, modelling 
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the infection at 25°C could be informative of novel and ‘authentic’ pathogenic behaviour of the yeast 
itself.  Further, as mentioned above, there is much cross-over between the virulence factors required 
for mammalian and C. elegans pathogenesis.  Remarkably, the production of mating factor α (MFα) 
pheromone, which is essential for full virulence and is thus activated in mammals, is also activated in 
C. elegans (Mylonakis et al., 2002).  In the mammalian host, macrophages have an essential role in 
eliminating the infection.  Two host scavenger receptors, SCARF1 and CD36 are required to recognise 
β-glucans on the invading yeast and elicit a host defence by activating macrophages.  In C. elegans, 
the orthologues of these receptors, CED-1 and C03F11.3, are crucial to activating a defence response 
following recognition of the pathogen (Means et al., 2009).  This highly specific conservation between 
two seemingly divergent host groups underscores the significance of innate immunity in response to 
fungal pathogens. 
 
1.5 Signalling in the C. elegans immune response 
 1.5.1 MAP-kinase pathways 
The Mitogen-Activated Protein Kinase (MAPK) pathways utilise a sequential cascade to amplify and 
transmit a signal elicited upon an external stimulus, with a biological response.  In C. elegans,  there 
are three main cascades: the ERK MAPK, JNK MAPK and p38 MAPK pathways, which each respond 
to different stimuli and trigger distinct responses, such as proliferation, differentiation, broad stress 
responses and apoptosis (Seger and Krebs, 1995).  In contrast, the pathways have some basal 
activity, which in the case of the p38 MAPK pathway is dependent upon long-chain fatty acids 
(Nandakumar and Tan, 2008). 
 
A forward screen of 1,400 mutant worms for an enhanced susceptibility phenotype (esp) to P. 
aeruginosa, strain PA14, identified two mutations as being crucial for the host response to the 
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infection.  The esp genes were identified by single nucleotide mapping and subsequent gene 
sequencing and were found to be a MAPKK homologue, sek-1 and a MAPKKK homologue, nsy-1.  
The immune function of the p38 MAPK cascade was confirmed by RNAi knockdown of pmk-1, a p38 
orthologue in C. elegans, as this too resulted in the esp phenotype (Kim et al., 2002).   
 
Subsequent work from this group examined the potential role of c-Jun N-terminal kinase (JNK) 
signalling in the immune response, as it had been implicated in the animals’ response to heavy metal 
stress (Mizuno et al., 2004).  By utilising knockout animals for components of the JNK pathway in C. 
elegans to identify positive regulators of the pathway, combined with a reverse genetic screen to 
identify negative regulators, the group described interactions between the JNK and p38 MAPK 
cascades at two levels.  Firstly, that the activation of p38 (PMK-1) required the synergistic activity of 
the upstream MAPKK, SEK-1, and the corresponding component of the JNK pathway, MEK-1, to 
achieve maximal bacterial resistance, though SEK-1 is sufficient to activate PMK-1 alone.  Secondly, 
that the MAP Phosphatase VHP-1 negatively regulates both cascades at the level of the MAPK, either 
by inhibiting PMK-1 or KGB-1 (Kim et al., 2004).  This seemingly substantial and significant cross-talk 
between pathways suggests that complex immune and stress responses are regulated by the 
integration of diverse signals in C. elegans (Figure 5). 
 
In the example of the soil-dwelling bacterium Bacillus thuringiensis, a pathogen that C. elegans is likely 
to encounter in its natural environment, two key genes are induced during the host response to the 
Bacillus toxin Cry5B; ttm-1 and ttm-2, both of which are under the regulation of the p38 MAPK pathway 
(Huffman et al., 2004).  Although their function is essential for resistance to the toxin (RNAi knockdown 
of these genes results in animals unchanged from wild type in standard culture conditions, but renders 
the animals hypersensitive to E. coli expressing the toxin) their method for host protection remains 
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unknown (Huffman et al., 2004).   In support of cross-talk between the MAPK pathways, there also 
appears to be a role for the JNK cascade in regulating immunity to B. thuringiensis, but this is unclear 
and may only arise from the mis-regulation of a coordinated stress response by both the p38 and JNK 
pathways, as animals lacking components of the JNK pathway were hypersensitive to both Cry5B and 
CdCl2 which had been used as a stress control (Huffman et al., 2004). 
 
Next, the induction of nlp-1 in the epidermis by D. coniospora is dependent upon the p38 MAPK 
cascade.  An upstream kinase regulator, NIPI-3, was identified through a forward screen in this work; 
NIPI-3 acts specifically to induce nlp-1 expression in response to fungal infection, rather than its 
induction in response to injury (Pujol et al., 2008a).  From the same screen, the group characterised 
another mutant that failed to induce nlp-1 upon Drechmeria infection.  Epistasis analysis placed this 
gene, tpa-1 a homologue of protein kinase Cδ, downstream of nipi-3, but upstream of the MAPKK sek-
1 (Figure 5) to regulate the antifungal and wounding response of C. elegans (Ziegler et al., 2009).   
 
Additionally, expression of nlp-29 is dependent upon NIPI-3, and an even greater level of specificity to 
D. coniospora infection occurs downstream of nipi-3 in the form of the C. elegans Protein Kinase C  
homologues, tpa-1 and pkc-3; activation of the pathway through TPA-1 or PKC-3 is essential for an 
antifungal response by the host.  The role of PKC in this system is dependent upon G-protein 
signalling, principally via the Gα subunit, gpa-12, which itself acts upstream of two phospholipase C 
genes, plc-3 and egl-8 (Ziegler et al., 2009).  Thus the activation of C. elegans innate immunity in 
response to D. coniospora infection is remarkably complex and continues to reflect the mechanisms of 
immunity in vertebrate systems.   
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Furthermore, TPA-1 was found to regulate a diacylglycerol (DAG)-controlled immune response by 
influencing its downstream component Protein kinase D (DFK-2; Figure 5).  This immune regulation 
was both p38-dependent and –independent (Ren et al., 2009).  However, as with many mutant 
phenotypes, questions remain as to the specificity of the pathogen sensitivity phenotype of dfk-2 
mutant animals, since the loss of Protein kinase D is likely to lead to universal disruption of immune 
regulation. 
 
The p38 MAPK signal is transduced by a single downstream transcription factor; ATF-7, a member of 
the activating basic-region leucine zipper transcription factors.  It appears as though ATF-7 typically 
acts to repress PMK-1-controlled genes, but switches to an activating form upon phosphorylation by 
PMK-1 (Shivers et al., 2010).   
 
The third of the MAPK cascades, the Extracellular-signal-regulated kinase (ERK) pathway, has been 
described in the host response to infection with M. nematophilum and S. aureus where it was shown 
that the limited activation of the ERK MAPK response causes the Dar phenotype (Hodgkin et al., 2000, 
Irazoqui et al., 2010a).  It is yet unclear whether this phenotype is a defence mechanism of the host or 
a virulence mechanism by the bacteria (Nicholas and Hodgkin, 2004).   
 
The conservation of the MAPK cascades in C. elegans has demonstrated that the pathways are an 
ancient mechanism for defence against pathogenic attack (Kim et al., 2002).  The discovery that C. 
elegans does not have an NFкB orthologue, although it does employ a ubiquitin/proteasome pathway 
(Alper et al., 2008), implies that the p38 cascade preceded the NFкB response during evolution (Wang 
et al., 2006).   
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Figure 5: Signalling pathways activated during the innate immune response of C. elegans 
Four main signalling pathways operate in parallel in the immune response of C. elegans to a range of 
pathogens.  From left to right: the TGF-β/DBL-1 pathway (purple), the Toll-like/TIR-1 response which 
operates in hand with the p38 MAPK cascade (blue and green), and the IGF/DAF-2 pathway (orange). 
 
 
 
 
Image modified from (Irazoqui et al., 2010b) 
 ATF-7 
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1.5.2 Toll-like Pathway 
 The identification of a major immunity signalling receptor, Toll, was heralded in 1995 (Lemaitre et al., 
1995), 10 years after the receptor was first described in Drosophila as being essential for dorsal-ventral 
polarity during development (Anderson et al., 1985).  This further work with Toll mutant flies identified a 
role for the receptor in innate immunity; the animals were found to be hypersusceptible to fungal 
infection due to the down-regulation of the antifungal peptide drosomycin by the absence of the 
Spätzle-Toll-Cactus pathway, presumably caused by the subsequent mis-regulation of the downstream 
transcription factor, Dorsal (Lemaitre et al., 1995, Lemaitre et al., 1996). 
 
Later, mammalian Toll-like receptors (TLRs) were described with orthologous roles in the vertebrate 
immune response.  Interestingly, the TLRs of mammals are more canonical Pathogen Recognition 
Receptors (PRRs) than their Drosophila counterparts, responding directly to microbial signatures, 
rather than the host-produced cytokine spätzle.  These receptor-complexes are now known to signal 
through the Toll/IL-1 resistance (TIR) domains of their associated cytoplasimc adapter proteins, and 
the signal is transduced either through the p38 MAPK pathway, or the NFĸB pathway (Lemaitre, 2004).  
As C. elegans has no NFĸB protein (Wang et al., 2006, Medzhitov, 2001), the Toll-pathway must 
therefore signal through the p38 MAPK pathway if it is orthologous to the Drosophila/mammalian Toll 
pathway.  The only two homologues for the Toll-signalling pathway in C. elegans are tol-1, a TLR gene 
essential for the early development of the worm, and tir-1, a homologue of the vertebrate TIR-protein 
SARM, which is the adapter protein for TLR4 (WormBase).   
 
Down-regulation of TIR-1 by RNAi was found to reduce expression of the aforementioned infection-
inducible antimicrobial NLPs, NLP-31 and NLP-29, whereas there was no modulation of nlp-31 
expression by TOL-1, indicating that TIR-1 acts independently of TOL-1 to activate antifungal 
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responses in C. elegans (Couillault et al., 2004).  The work further showed that TOL-1 and TIR-1 do 
not even physically interact.  Inactivation of tir-1 alone also significantly reduced wild type animals’ 
survival with both D. coniospora and S. marcescens.  A validated yeast-two-hybrid screen produced 
two proteins that could physically interact with tir-1, and may therefore transduce the immune response 
signal, although these proteins, RAB-1 (a small GTPase) and R53.4 (a mitochondrial ATP-subunit f-
synthase), had, and still have, no other described function in innate immunity in C. elegans (Couillault 
et al., 2004)(WormBase).   
 
A publication from the Ausubel group just one month later placed tir-1 as an upstream activator of the 
p38 MAPK pathway, as the activated form of pmk-1 was significantly decreased in animals lacking tir-1 
(Liberati et al., 2004).  In this study, the TIR protein is operating in a fashion more comparable to Toll 
signalling in Drosophila and mammals.  A further link between the Toll pathway and p38 MAPK 
cascade has been described through the collective activation of the C. elegans ABC transporter, pgp-
5, which is induced in, and required for,  the animals’ immune (notably to P. aeruginosa) and stress 
responses (especially to heavy metals).  Animals combining mutations for pgp-5 and components of 
the p38 MAPK pathway or tir-1 were hypersensitive to PA14 infection, confirming tir-1 as an upstream 
component of the p38 MAPK cascade (Figure 5; (Kurz et al., 2007).  This hypersensitivity was not 
found when pgp-5 mutation was combined with others corresponding to key components of the JNK 
MAPK and other main immunity pathways (Kurz et al., 2007) implying that C. elegans can generate 
specific and highly regulated responses. 
 
In all three examples, the association between the Toll receptor and TIR adapter are uncoupled in the 
C. elegans immune response, suggesting that Toll-mediated immunity arose after the split from 
pseudocoelomates and acoelomates.   
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Concurrently, the concept arose that animals were able to distinguish between different bacterial and 
fungal food sources, actively seeking non-pathogenic, high quality food, and avoiding pathogenic and 
other poorer food sources, all mediated under neurological control.  Animals lacking tol-1 were unable 
to avoid S. marcescens, but there appeared to be no other role of the Toll receptor in C. elegans 
immunity (Pujol et al., 2001).  One further publication examined the function of the TOL-1 protein in S. 
enterica pathogenesis, and found a direct role for TOL-1 in the innate immune response of C. elegans 
to Gram-negative pathogens.  In this study, TOL-1 prevented the pharyngeal invasion of S. enterica 
and was required to induce two antimicrobial peptides, abf-2 and hsp-16, which are both strongly 
expressed in the pharynx (Tenor and Aballay, 2008).   
 
Alternative work supported the ‘active food choice’ hypothesis.  It was shown that the hunt for ‘good’ 
food is enhanced if the animals have prior exposure to ‘good’ food (Shtonda and Avery, 2006), a study 
which corroborated the learning behaviour that the Bargmann group had observed the year before 
(Zhang et al., 2005).  In this work, the group showed that the olfactory behaviour of C. elegans 
changed after exposure to pathogenic bacteria; an observed increase in serotonin was thought to be a 
negative stimulus associated with the odour of pathogenic food sources (Zhang et al., 2005).  The TIR-
1 protein was found to mediate this olfactory choice by regulating the asymmetry of the two AWC 
neurons, located on the left and right side of the head.  Briefly, TIR-1 patterns NSY-1 (the C. elegans 
p38 MAPKKK) at the post-synaptic regions, suggesting that the olfactory choice behaviour is instigated 
at the AWC synapse (Chuang and Bargmann, 2005).  Further work confirmed that tol-1 does mediate 
avoidance behaviour against S. marcescens in C. elegans (Pradel et al., 2007).  Here, animal genetics 
was combined with bacterial knockouts to identify components both in the host and pathogen that 
contribute to this behaviour.  The detection and avoidance of S. marcescens required the AWB 
chemosensory neurons and TOL-1, which operate in complementary pathways, in the host and the 
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production of cyclic lipodepsipentapeptide, serrawettin W2 in the bacteria.  Surprisingly, animals 
lacking tol-1 are still able to learn aversive olfactory behaviour against other bacteria however, so there 
must be a comprehensive mechanism or mechanisms that feed into an animal’s choice of food (Pradel 
et al., 2007). 
 
 1.5.3 TGF-β-like pathway 
It is well known that the neuronally-expressed gene dbl-1 (previously named cet-1) encodes one of four 
ligands in the C. elegans Transforming Growth Factor (TGF)-β-like signalling pathway, that binds and 
activates the Sma-6/DAF-4 receptor complex.  Together, this pathway controls body size and the 
position of the male vas deferens in a dose-dependent manner, mediated downstream by a number of 
Smad proteins (Suzuki et al., 1999, Morita et al., 1999).  However, there is also evidence of the role of 
dbl-1-regulated signalling in the C. elegans immune response.   
 
The pathway appears to control a number of immune response factors, including lectins and 
lysozymes both constitutively (Mochii et al., 1999) and upon S. marcescens infection (Mallo et al., 
2002).  In support of this, there is expression of both DBL-1 and SMA-6 in the intestine, where together 
they appear to directly regulate the expression of these antimicrobial genes (Mochii et al., 1999), 
although the mechanism of this DBL-1-mediated activation remains unknown.  In support of this, 
knock-down of dbl-1 results in a heightened susceptibility of these mutant animals to S. marcescens 
and P. aeruginosa infection (Mallo et al., 2002, Ewbank, 2006).   
 
Upon D. coniospora infection, paracrine signalling through neuronally expressed dbl-1 activates the 
cnc cluster in the epidermis in a manner which provides pathogen resistance in the cuticle, analogous 
to cytokine-based signalling in higher vertebrates (Zugasti and Ewbank, 2009).  Although the SMA-6 
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receptor was required for the up-regulation of cnc-2 in response to the fungal infection, the other 
downstream Smad genes were not required, suggesting that dbl-1 utilises an alternative signalling 
transduction cascade in this instance (Figure 5).  The strength of cnc-2 induction was also directly 
dependent upon the expression levels of dbl-1 (Zugasti and Ewbank, 2009).  The neuroimmune 
regulation theory in C. elegans continues to gather substance (Kawli and Tan, 2008, Styer et al., 2008, 
Zugasti and Ewbank, 2009, Reddy et al., 2009) and further study into such phenomena may help 
unearth the identity of the pathogen receptors in the animals, which remain elusive to date.   
 
 1.5.4 Insulin-like pathway 
The endocrine signalling pathway is remarkably conserved across phyla and is one of the best 
characterised pathways in C. elegans (Mukhopadhyay et al., 2006).  Here, DAF-2 is the single receptor 
of this Insulin Growth Factor I (IGF)-like cascade and its activity is to shorten life span by sequestering 
the forkhead transcription factor, DAF-16, in the cytoplasm and thus DAF-2 negatively regulates the 
activation of downstream effectors (Figure 5).  DAF-16 directs the transcription of a number of target 
genes when IGF activity is inhibited through limited signalling, dietary restriction, increased JNK 
signalling (which can directly phosphorylate DAF-16) (Oh et al., 2005) and mutations in the DAF-2 
receptor or in other upstream kinases, such as age-1 (a PI3-kinase) and akt-1/2 (Lee et al., 2001, Lin 
et al., 2001, Baumeister et al., 2006).  The dephosphorylation of DAF-16 enables it to translocate into 
the nucleus and regulate an array of genes that include those involved in development, metabolism, 
longevity, stress and immune responses (Jensen et al., 2006, Murphy et al., 2003, McElwee et al., 
2003, Yu et al., 2008a, Lee et al., 2003, Bolm et al., 2004).  
 
Interestingly, long-lived daf-2 mutant animals were found to be resistant to a number of bacterial 
pathogens (Garsin et al., 2003), providing the first evidence that ageing and immunity may be coupled 
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in C. elegans.  Further work has corroborated this hypothesis, including the identification of a number 
of DAF-16 regulated genes as antimicrobials (McElwee et al., 2003, Yu et al., 2008a, Murphy et al., 
2003).  On the other hand, a microarray study investigating the transcriptional outputs of the parallel 
DAF-2 and p38 MAPK pathways, with respect to immunity, found that PMK-1 and not DAF-16, directly 
regulated a plethora of antimicrobial genes, suggesting that the p38 MAPK pathway has a critical role 
in immunity whereas the role of DAF-2 signalling is simply a consequence of the more general stress 
response elicited through this pathway (Troemel et al., 2006).  Indeed, daf-16 mutant animals have 
comparable survival rates to wild type animals on a number of pathogens (Garsin et al., 2003, van den 
Berg et al., 2006), suggesting that insulin signalling is not a vital component of the immune response of 
wild type animals in the laboratory setting.  Instead, the group propose that DAF-16 is activated 
through a non-canonical pathway that they call the “defence response pathway” induced in animals 
destined to become sterile, which may be a link between immunity and reproduction (Miyata et al., 
2008). 
 
However, it is believed that continuous over-expression of daf-16 has deleterious effects on pathogen 
susceptibility (Singh and Aballay, 2009).  daf-2(e1370);daf-16::gfp animals which have continuous 
nuclear accumulation of DAF-16 become more sensitive to P. aeruginosa infection than the resistant 
daf-2(e1370) or daf-16::gfp animals alone, though this is not suppressed to wild type levels.  It was 
found that the nuclear export of DAF-16 is required to achieve the optimal amount of the active protein 
in the nucleus; a translocation dependent upon the heat-shock family transcription factor HSF-1 (Singh 
and Aballay, 2009), a protein that had already been linked to the DAF-2 pathway in the immune 
response (Singh and Aballay, 2006). 
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Work from our laboratory examined the survival of male worms to infection with C. neoformans (van 
den Berg et al., 2006).  It was already known that male animals have an extended lifespan, partially 
attributable to the costs of reproduction but largely dependent upon the depression of insulin-like 
signalling in the animal (Gems and Riddle, 2000).  The work showed that phenotypically (interestingly 
not genotypically) male animals have extended survival upon exposure to C. neoformans.  This 
resistance is also principally, but not entirely, dependent upon the activity of DAF-16, indicating that 
longevity and immunity may have co-evolved through the DAF-2 pathway (van den Berg et al., 2006).  
Our laboratory went on to show that the constitutively higher DAF-16 expression levels in the 
gonochoristic Caenorhabditis nematodes of remanei and brenneri, resulted in both a longer lifespan 
and a stronger immune response than found in their hermaphroditic counterparts (Amrit et al., 2010).  
 
Additionally, it is well-established that germline ablation has a resounding effect on lifespan extension 
in DAF-16 expressing worms (Lin et al., 2001, Smelick and Ahmed, 2005, Arantes-Oliveira et al., 2002, 
Hsin and Kenyon, 1999, Berman and Kenyon, 2006).  The germline also appears to negatively 
modulate DAF-16 activation and thus confers sensitivity to P. aeruginosa, such that sterile mutants 
with a proliferating germline are resistant to the infection (Evans et al., 2008a).  In these cases, the 
DAF-2 pathway influences both aging and immunity through similar means. 
 
On the other hand, DAF-2-mediated responses to aging and immunity can be uncoupled. For instance, 
mutants for components of the pathway downstream of daf-2 and age-1, such as pdk-1 and sgk-1, 
uphold their extended lifespan, but are not resistant to bacterial pathogens in the same way as mutant 
animals lacking their upstream kinases.  Similarly, akt-1 and -2 mutant animals show enhanced 
survival to bacterial infections, but only a slightly longer lifespan than wild type (Evans et al., 2008a).  
The resistant mutants from this pathway are better able to clear the infection, have fewer bacteria 
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colonising the intestine and respond harder to the infection with a much greater induction of 
antimicrobial genes than wild type worms and sgk-1 mutants.  Together this suggests that DAF-2 
signalling in the immune response utilises different components than those exploited during lifespan 
regulation (Evans et al., 2008a) in order to tailor appropriate biological responses. 
 
DAF-2 is also suggested to negatively regulate the role of autophagy in pathogen resistance, 
especially in response to S. Typhimurium.  daf-2(e1370) animals show enhanced lysosomal 
degradation of bacteria and have fewer bacteria in the intestine.  Further, the bacterial resistance of 
DAF-2 mutants or DAF-16 over-expressors is suppressed to wild type survival with bec-1 and lgg-1 
RNAi, genes that are involved in the autophagy response, implying that autophagy, through the DAF-2 
pathway, has a significant role in C. elegans pathogenesis by S. Typhimurium (Jia et al., 2009). 
 
1.6 Conclusion 
C. elegans has been shown to be susceptible to a wide range of bacterial and fungal pathogens and 
these virulent pathogens cause a number of symptoms and utilise a number of mechanisms for killing 
in the worm model.  One of the most advantageous functions of the C. elegans system is its suitability 
for high-throughput screening for both mutated pathogens, in order to identify attenuated and hyper-
virulent strains, and as a first stage for testing novel pharmaceutical compounds. 
 
However, the application of the C. elegans model towards human disease has significant limitations 
that must be recognised.  Firstly, although there is some conservation of the mechanisms of 
pathogenesis between C. elegans and higher vertebrates (Alper et al., 2008), there are huge 
differences.  A critical mechanism of virulence in mammalian hosts is for these pathogens to become 
internalised and then spread throughout the host; whereas in C. elegans the infections, save for only a 
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couple of examples to date, do not become intracellular.  Further, in mammalian systems, pathogenic 
infection does not occur solely at one site, as is the case with C. elegans pathogenesis; infections are 
generally tissue-specific before spreading systemically, and thus cause wide-reaching symptoms.  
Therefore, it is still unclear as to which pathogens actually elicit a bona fide infection in C. elegans, 
rather than simply causing lethality via accumulation in the intestine. 
 
Secondly, many of the human pathogens that are studied in C. elegans have adapted to 37°C.  
Exposure to this temperature for extended periods of time is lethal to C. elegans, thus assays are 
carried out at 25°C.  We must therefore recognise that a number of pathogen virulence factors may not 
be expressed as they are induced only at 37°C.  In the same vein, the “novel” virulence mechanisms of 
pathogens identified through the C. elegans model may simply be the adaptation of the pathogen to 
this new temperature, which could explain why some of the hits are not conserved in tissue culture 
systems or in the mouse model. 
 
Thirdly, there are considerable differences between the immunity profiles of C. elegans and of higher 
vertebrates.  C. elegans has a remarkably simple innate immune system and is thus dependent upon 
the secretion of antimicrobial peptides to counter pathogen attack alone.  Higher vertebrates, on the 
other hand, have both a more complex innate system and an additional, highly specialised, adaptive 
system, which together permits great versatility in the immune response.  Although there is some 
conservation in the pathways that control the immune response in both animals; since the vertebrate 
response has likely evolved from a common predecessor to the primitive C. elegans response, there 
are still large inconsistencies.  One example is the Toll-like receptor pathway which represents a 
significant arm of innate immunity that was first identified in Drosophila (Medzhitov, 2001).  In the 
Chapter 1: Introduction 
49 
 
vertebrate immune response it has a fundamental role and yet its function in C. elegans is limited 
(Pujol et al., 2001, Aballay et al., 2003, Liberati et al., 2004, Tenor and Aballay, 2008).   
 
Perhaps the solution is for the exploitation of the C. elegans model in pathogenesis to not have a 
human disease focus.  Rather than looking at animal survival and the process that achieves the end-
point of mortality in these studies, it may be more informative to utilise the wealth of genetic resources 
in this animal and closely examine the earlier processes of infection in order to understand further the 
molecular interaction between the pathogen and the host.  Subsequently, instead of relating results to 
human disease, it may be more fruitful if they were examined in the light of the evolution of the immune 
system throughout the animal and plant kingdoms.  
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1.7 Scope of this thesis 
The nematode Caenorhabditis elegans is now firmly established as a powerful model system for the 
study of host-pathogen interactions (Sifri et al., 2005, Schulenburg et al., 2004, Ewbank, 2002).  The 
animal shares many of the mechanisms of innate immunity with higher vertebrates, including several 
pathways that control the expression of universal defence factors in response to pathogenic infection 
(Ewbank, 2006).  There are key differences, however, including the lack of a cell-mediated immune 
system or a complement-like response in C. elegans.  Instead, the animal relies upon secreted 
antimicrobial molecules for a systemic immune response to pathogenic challenge (Schulenburg et al., 
2004).   
 
One such factor, lysozyme, is an evolutionarily ancient defence enzyme that is believed to be actively 
lytic against a range of microbes (Bachali et al., 2002).  Whereas many organisms have only one or 
two lysozyme genes, C. elegans has a family of at least ten differentially regulated genes (Figure 4) 
that are predicted to show significant functional diversity (Thomas, 2006, Schulenburg and Boehnisch, 
2008).  Within the C. elegans lysozyme family, lys-7 has been the most extensively studied.  
Expression of this molecule is strongly induced upon exposure of the animal to the pathogenic bacteria 
Serratia marcescens (Mallo et al., 2002), Microbacterium nematophilum (O'Rourke et al., 2006) and 
Salmonella Typhimurium (Evans et al., 2008b).  Furthermore, lys-7 knockout animals show enhanced 
susceptibility to M. nematophilum, indicating that lys-7 has a protective function against this pathogen 
(O'Rourke et al., 2006).   
 
We, and others, have previously shown that the fatal fungal human pathogen Cryptococcus 
neoformans kills C. elegans (Mylonakis et al., 2002, van den Berg et al., 2006).  A preliminary gene 
expression study of two C. elegans strains, daf-2(e1370) and fem-1(hc17)IV, that are intrinsically 
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resistant to killing by the fungus revealed that lys-7 expression was strongly and constitutively induced 
in these animals (R. C. May, unpublished data).  We therefore hypothesised that LYS-7 may play an 
important role in mediating resistance towards C. neoformans.   
 
This thesis examines: 
I. The role of LYS-7 in the innate immune response of C. elegans to a range of human 
pathogens, with particular emphasis on both C. neoformans and the enteric bacteria 
Salmonella Typhimurium 
II. The upstream signalling pathways that control the expression of LYS-7 during the immune 
response, including signalling mediated by the tyrosine kinase ABL-1 and the TGF-β and 
IGF pathways 
III. The molecular determinants of immune interactions between S. Typhimurium and C. elegans 
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2.0  MATERIALS AND METHODS 
 
2.1 Maintenance of C. elegans 
2.1.1 C. elegans strains used 
The strains used for this work were N2 (C. elegans wild type; Bristol isolate), RB1285 lys-7(ok1834), 
RB1286 lys-7(ok1385), XR1 abl-1(ok171), RB1252 rga-6(ok1316), BX107 fat-5(tm420), CF1038 daf-
16(mu86), RB2071 ced-3(ok2734), NU3 dbl-1(nk3), KU4 sek-1(km4) and RB829 abi-1(ok640) which 
were kindly provided by the C. elegans Genetics Center and the C. elegans Knockout Consortium.  
The strains clec-60(tm2319) and abi-1(tm494) were kindly provided by Shohei Mitani’s laboratory in 
Tokyo.  Two further strains, abl-1(n1691) and abl-1(n1963) were provided by the Horvitz laboratory, in 
Boston, MA.  Additionally, 14 double mutant animals were generated during the study by crossing 
(Hope, 1999): FB0016 and FB0017 both lys-7(ok1384)abl-1(ok171), FB0018 lys-7(ok1384)rga-
6(ok1316), FB0019 and FB0020 both lys-7(ok1384)fat-5(tm420), FB0021 and FB0022 both lys-
7(ok1384)daf-16(mu86), FB0023 and FB0024 both abl-1(ok171)daf-16(mu86), FB0025 and FB0026 
both abl-1(ok171)ced-3(ok2734), FB0027 abl-1(ok171)sek-1(km4), FB0028 lys-7(ok1384)sek-1(km4) 
and FB0029 abl-1(ok171)dbl-1(nk3). 
 
2.1.2 Culturing and maintenance of animal stocks 
Nematodes were cultured using standard methods as described previously (Brenner, 1974, Hope, 
1999).  Briefly, animals were maintained in 9cm petri dishes on a modified agar substrate, nematode 
growth medium (NGM; 1.7% agar, 0.25% peptone, 0.3% NaCl, 5µg/ml Cholesterol, with the addition of 
1mM CaCl2, 1mM MgSO4 and 25mM KPO4, pH6, after autoclaving).  These plates were seeded with a 
lawn of Escherichia coli OP50, a natural uracil mutant strain and the standard food source of the 
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Caenorhabditis nematodes, and incubated at 15-20°C.  Animals were transferred to new plates as 
food sources became limited. 
 
2.1.3 C. elegans bleaching protocol 
This protocol was used to generate staged animal cultures and to remove any contamination from C. 
elegans stock plates.  Animals were washed off newly starved stock plates (9cm) in 3ml M9 buffer 
(22mM KH2PO4, 42mM Na2HPO4, 80mM NaCl, 1mM MgSO4 (Hope, 1999)) and the suspension was 
transferred into 1.5ml centrifuge tubes and centrifuged at 6,500g for 30s.  The supernatant was 
removed to leave 0.5ml in the tube.  80µl 5M NaOH and 160µl Sodium hypochlorite was added and the 
tubes were shaken vigorously for 2 min.  The tubes were then filled with M9, centrifuged as above and 
the supernatant removed; this washing step was repeated twice and on the 2nd time 200-400µl M9 
buffer was added to the tube.  The tubes were rolled overnight to keep the animals oxygenated and 
transferred onto OP50 plates the following day, where the cultures developed synchronously. 
 
2.1.4 Generation of male animals by heat-shock treatment 
5 late larval four (L4) stage hermaphrodites were transferred onto 6cm NGM plates seeded with OP50 
and incubated at 30°C for 6h before being allowed to self-fertilise at 20°C.  The frequency of 
spontaneous male generation by loss of the second X chromosome is increased 10-fold under these 
conditions (Hope, 1999).  F1 male progeny were picked from plates 3-4 days after heat-shock. 
 
2.1.5 Generation of double mutant animals by crossing 
Five or more L4 male animals (of strain one) were transferred onto a 6cm NGM OP50 plate onto which 
two hermaphrodite L4 animals (of strain two) had already been transferred.  The animals were allowed 
to mate at 20°C for 48h.  Approximately 50% male progeny indicated the mating had been successful 
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and subsequently four L4 F1 hermaphrodites from each cross were singled onto small seeded plates 
and allowed to self.  More than thirty F2 progeny from each of these F1 worms were typed using the 
single worm lysis method and deletion PCR reaction, described in 2.4.1-2.4.2, and the aplimers were 
separated by electrophoresis on a 1% agarose gel.  Animals with the genotype of interest were 
selected, grown up and frozen down. 
 
2.1.6 Freezing of C. elegans stocks 
Frozen stocks of worm strains were produced by washing off freshly starved L1 animals in 4ml M9 
buffer, and aliquoted into 4x1.8ml labelled cryovials.  500µl sterile M9 buffer with 30% glycerol (v/v) 
was added to this worm suspension.  Cryovials were then insulated in a freezing blanket to achieve 
8°C cooling per hour and frozen at -80°C.  One vial was thawed after 24 hours, put on NGM plates 
and left to incubate overnight at 20°C. The plate was examined the following day to check the viability 
of the frozen stock.  Once this was ascertained, the remaining tubes were then transferred from the 
freezing blanket into cryo boxes and stored at -80°C. 
 
2.2 Characterisation of mutant animals 
2.2.1 Lifespan analysis 
15-30 animals at L4 stage were picked from 9cm animal stock plates onto 6cm NGM plates seeded 
with 30µl OP50 and incubated at 20ºC.  Animals were transferred to new seeded plates every one to 
two days during the fertile stage.  The plates were scored for survival each day using a Leica M7.5 
stereomicroscope and death was determined as a failure to respond to a mechanical stimulus.  Data 
are representative of 100-200 animals, exact numbers are presented in the figure legends. 
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2.2.2 Brood size analysis 
L4 hermaphrodites were singled onto 6cm NGM plates seeded with OP50; three plates of each strain.  
The animals were transferred to new plates one to two times daily during the fertile period.  The 
progeny on the previous plates were allowed to grow up to around the L3 stage when they were 
counted using a Leica M7.5 stereomicroscope; the total brood size for each hermaphrodite was 
determined once all plates had been counted. 
 
2.2.3 Statistical analysis 
Lifespan replicates were checked for consistency prior to being combined into single survival curves in 
Microsoft Excel using a macro-based template to calculate Kaplan-Meier survival probabilities every 24 
hours.  The curves represent data from at least three individual experiments.  Differences in survival 
were tested with a non-parametric log-rank analysis and assessed for significance using Chi squared.  
P-values below 0.05, after correcting for multiplicity, were taken to be significant.  The data in the 
lifespan curves are presented as the proportion of animals surviving. 
 
2.3 C. elegans infection assays 
2.3.1 Bacterial and fungal strains used and their respective growth conditions 
Strains, sources and growth requirements are shown in Tables 1 and 2. 
 
2.3.2 Bacterial survival method 
20µl of an overnight bacterial culture was inoculated onto 6cm NGM plates, supplemented with the 
appropriate antibiotic if required, and lawns were allowed to grow at room temperature for 12h.  15-30 
animals at the L4 stage were picked onto each plate and transferred to newly seeded plates every one-
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two days as eggs were laid.  Animal survival was examined at 25°C and scored every 24h using a 
Leica M7.5 stereomicroscope.  Death was determined as a failure to respond to a mechanical stimulus. 
 
2.3.3 Fungal survival method 
20µl of an overnight fungal culture was inoculated onto 6cm NGM plates supplemented with kanamycin 
(30 µg/ml) and lawns were allowed to grow at room temperature for 12h.  15-30 L4 animals were 
picked onto each plate and incubated at 25ºC.  Survival was scored every 24h using a Leica M7.5 
stereomicroscope.  Death was determined as a failure to respond to a mechanical stimulus. 
 
2.3.4 C. elegans bacterial CFU analysis 
Infection load was assessed through viable counts.  The assay was modified from (Kawli and Tan, 
2008); L4 animals were infected with S. Typhimurium strain L1019 as per survival assays.  After a 
defined period, ten replicates of six animals each were incubated in 200µl M9 buffer containing 25mM 
levamisole hydrochloride (Sigma) and ampicillin (1mg/ml) for one hour.  This was to paralyse the 
animals, preventing pharyngeal pumping and defecation, and kill any bacteria present on the cuticle of 
the worm.  The ampicillin was subsequently removed by three washes of 200µl M9 with 25mM 
levamisole hydrochloride.  The animals were lysed in this buffer for 10s using the Precellys 24 Lysis 
and Homogeniser.  Lysates were serially diluted in M9 and then plated onto LB plates containing 
kanamycin (30µg/ml) to select for L1019.  Colonies were counted by eye and scaled to the original 
concentration per nematode. 
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 Table 1: Bacterial and fungal strains and their respective growth requirements 
 
 
 Strain Strain details Overnight Culture Medium C. elegans media Source/Reference 
Escherichia coli OP50 Uracil auxotroph 
LB (1% tryptone, 1% 
NaCl, 0.5% yeast extract),  
shaking at 37°C 
NGM (Brenner, 1974) 
Cryptococcus 
neoformans 
H99 
(serotype A) 
Clinical isolate from 
Hodgkin’s disease patient, 
USA 
YPG (1% yeast extract, 
1% peptone, 2% glucose) 
+ kanamycin (30µg/ml), 
shaking at 25°C. 
NGM  
+ Kan (30µg/ml) 
Joe Heitman, Duke 
University 
(Franzot et al., 1999) 
Pseudomonas 
aeruginosa PAO1 
Standard reference strain, 
wound isolate LB, shaking at 37°C NGM 
Piddock Lab, University of 
Birmingham 
(Stover et al., 2000) 
Staphylococcus 
aureus 
NCTC 8532 
(ATCC 12600) 
Standard type strain, 
clinical isolate from pleural 
fluid 
LB, shaking at 37°C NGM 
Piddock Lab, University of 
Birmingham 
(Piddock et al., 1999) 
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Table 2: S. Typhimurium strains and their respective growth conditions
 
Strain Details Overnight Growth Conditions C. elegans media Source/Reference 
Salmonella enterica 
serovar Typhimurium 
SL1344 
Standard reference 
strain, calf isolate, 
1978 
LB, shaking at 37°C NGM 
Piddock Lab, University of 
Birmingham 
(Wray and Sojka, 1978) 
LT2 
(ATCC 700720) 
Attenuated reference 
strain,  
clinical isolate 1948  
LB, shaking at 37°C NGM 
Piddock Lab, University of 
Birmingham 
(Lilleengen, 1948) 
14028s 
(ATCC 14028) 
Standard reference 
strain, isolated from 
chicken tissues 
LB, shaking at 37°C NGM 
Piddock Lab, University of 
Birmingham 
(Bailey et al., 2008) 
L1019 SL1344 +  GFPmut2 
LB + kanamycin 
(30µg/ml), 
shaking at 37°C 
NGM  
+ Kan (30µg/ml) 
Blair and Piddock, Unpublished, 
University of Birmingham 
JF2691 SL1344 rpoS mutant 
LB + ampicillin 
(50µg/ml),  
shaking at 37°C 
NGM  
+ Amp (50µg/ml) 
Foster Lab, University of South 
Alabama 
(Lee et al., 1995) 
χ4996 LT2 rpoS mutant 
LB + ampicillin 
(50µg/ml),  
shaking at 37°C 
NGM  
+ Amp (50µg/ml) 
Curtiss Lab, Washington 
University 
(WilmesRiesenberg et al., 1997) 
χ8000 LT2 rpoSSL1344 
LB + tetracycline 
(12.5µg/ml in EtOH),  
shaking at 37°C 
NGM  
+ Tet (12.5µg/ml) 
Curtiss Lab, Washington 
University 
(WilmesRiesenberg et al., 1997) 
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2.3.5 S. Typhimurium persistence analysis 
L4 animals were infected with S. Typhimurium SL1344 as per the survival assays.  After a six hour 
exposure, these animals were washed 3 times in M9 solution and shifted onto NGM plates seeded with 
20µl OP50.  Animals were transferred to newly seeded plates every one-two days as eggs were laid.  
Survival was examined at 25°C and scored every 24h using a Leica M7.5 stereomicroscope.  Death 
was determined as a failure to respond to a mechanical stimulus. 
 
2.3.6 C. elegans bacterial load microscopy analysis 
Animals at the L4 stage were infected with GFP-expressing S. Typhimurium strain L1019, as per the 
survival assays, either as a constant or persistent-shift infection.  After a defined period, five replicates 
of six worms were transferred onto agarose pads on a microscope slide and paralyzed with an M9 
solution containing 10mM Sodium azide.  These slides were then imaged on a Nikon SMZ1000 
stereomicrosope at 4x magnification, with a HR Plan Apo lens.  An intensilight C-HGFI (Nikon) with a 
GFP filter set were used for fluorescence illumination.  Digital images were captured with Nikon DS-Fi1 
camera and NIS elements (v3.0) software.  Images were processed in Adobe Photoshop.  Those 
images presented are representative of the data set. 
 
2.3.7 Statistical analysis 
The bacterial CFU analysis was carried out in Microsoft Excel and subsequently tested for significance 
using the Students’ T-test (2 tailed, equal variance).  All survival replicates were checked for 
consistency prior to being combined into single survival curves in Microsoft Excel using a macro-based 
template to calculate Kaplan-Meier survival probabilities every 24 hours.  Each curve represents at 
least three independent experiments.  Differences in survival were tested with a non-parametric log-
rank analysis and assessed for significance using Chi squared.  P-values below 0.05, after correcting 
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for multiplicity, were taken to be significant.  The data in the survival curves are presented as the 
proportion of animals surviving. 
  
2.4 Molecular Biology 
2.4.1 Single worm lysis 
Single worms were lysed in a 5µl reaction comprising 1xPCR buffer (0.1M Tris-Hcl pH 8.3, 0.5M KCl, 
15mM MgCl2, 200µg/ml gelatine), 60µg/ml proteinase K and ddH2O, incubated at 60°C for 90 min 
then 95°C for 15 min.  Lysates were stored at 4°C for up to a month, if not used immediately. 
 
2.4.2 Confirmation of deletion alleles by PCR 
1µl of single worm lysate was added to 9µl PCR mix (1xDreamTaq buffer, 0.01mM dNTPs, 0.4mM of 
each primer, ddH2O and 0.5 units DreamTaq DNA polymerase (Fermentas)).  PCR was carried out on 
a SensoQuest Labcycler and the product was amplified through 35 cycles (94°C, 0.2s; 55°C, 0.2s; 
72°C, 120s).  Nested PCRs used 0.3µl of the first product as a template for the second reaction.  The 
fat-5 products required alternative parameters for amplification (Wicks et al., 2001) (35 cycles: 95°C, 
40s; 58°C, 40s; 72°C, 40s).  Primer sequences can be found in Table 3.  The products were 
electrophoresed along a 1% agarose gel to confirm the presence of each genetic knockout. 
 
2.4.3 Deletion mapping by DNA sequencing 
PCR reactions were carried out as above.  10ng of this amplified product was mixed with 3.2pmol 
primer and ddH2O to a final volume of 10µl.  This sample was labelled, purified and sequenced (on the 
capillary sequencer ABI 3730) using the full sequencing service provided by the Genomics Facility in 
the Biosciences Department at the University of Birmingham.  Sequences were analysed by 
ChromasPro v1.42 and mapped to the C. elegans genome using WormBase (www.wormbase.org).   
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Table 3: Primers for single-worm PCR
Gene Name Primer sequence (5’-3’) Product size (bp) Reference/Source 
lys-7 Forward TCCATCAAAATTGGCAACAA WT: 2400 KO: 1600 Kindly provided by Robin May Reverse CGGCGAAATAAATTTTGGAA 
abl-1 
External Forward TTTTGCTTTCAACTCGCCTT 
WT: 3300 
KO: 800 C. elegans Knockout Consortium 
External Reverse ATATGCCTCCCTCCTTTGCT 
Internal Forward GTCTTCTGCTTTCGAATCGG 
Internal Reverse TTCATATATCCACCGGCCAT 
fat-5 Forward TTGCCTCCGGCAAACAGACT WT: 1100 KO: 300 (Brock et al., 2006) Reverse ATTCTCAGGCTTGAGCTCAG 
clec-60 Forward TCTGCCATCCAGACTGCAGT WT: 1400 KO: 900 WormBase Reverse CTTCCTATACCGACCGTCGA 
C01F4.2 
External Forward ACTGATTTTGAGGTGGTGGC 
WT: 3200 
KO: 2400 WormBase 
External Reverse TAAAACCGGGAATGGAGTTG 
Internal Forward GTCTCGCCACGACGAATTAT 
Internal Reverse AAATTTCAGTTCGCATTCCG 
daf-16 
Forward GCGCCTTTGTCTCTCTATCG F+R WT: 11744 
KO: 764 
I+R WT: 1343 
KO: No product 
Primer 3 (v0.4.0) Internal – F AAATGATTCAGGGGGAAAGG 
Reverse GACGATCCAGGAATCGAGAG 
ced-3 
External Forward CAAAAGGACGCTCTGCCTAT 
WT: 1100 
KO: 400 WormBase 
External Reverse TGTCGTGTCGAGACCAGGTA 
Internal Forward AGCAGATCGATTGTTGTTCAAG 
Internal Reverse TTGGTCCCAAAAACCAAAAA 
abi-1 
Forward TCTCCAAAAATACCTTTTTCCAA F+R WT: 1171 
KO: 61 
I+R WT: 950 
KO: No band 
Primer 3 (v0.4.0) Internal – F TGGAAGATCATGTCGGTTCA 
Reverse CGAACGGCTACGTTAGGAAG 
sek-1 
Forward AACGCAGGTCACTCGTTTCT F+R WT: 2470 
KO: 393 
F+I WT: 984 
KO: No band 
Primer 3 (v0.4.0) Internal – R GTACCTTGGCCATGCTGTTT 
Reverse ATTTATTCCGTCCACGTTGC 
dbl-1 The deletion is ~6kb and not sequenced, thus the allele was followed via the recessive sma phenotype 
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2.4.4 RNA isolation and cDNA preparation 
Total RNA was extracted from each strain on three independent occasions.  Full plates of staged L4 
animals were homogenised in 400µl lysis buffer (Qiagen) using the Precellys 24 Lysis and 
Homogeniser.  RNA was isolated from these lysates with the column-based “RNeasy Mini Kit” (Qiagen) 
according to the manufacturer’s instructions save for one change: at the final elution step, the flow-
through was pipetted back onto the column membrane instead of using a further 30µl RNAse-free 
water to achieve a more concentrated sample.  Each RNA sample was DNase treated with “DNA-free” 
(Ambion, Inc.) after isolation, in accordance with the manufacturer’s instructions, and subsequently 
quantified using the Nanodrop ND1000 microspectrophotometer (NanoDrop Technologies, Inc.).  
cDNA was synthesised from all RNA extractions using the SuperScript II method (Invitrogen) with 
random primers (Promega) in a SensoQuest Labcycler, assuming a 1:1 conversion.  The absence of 
genomic DNA was confirmed by PCR of these cDNA products (34 cycles: 94°C, 25s; 55°C, 30s; 72°C, 
60s), the amplimers of which were separated by electrophoresis on a 2.5% agarose gel.   
 
2.4.5 Quantitative real-time PCR 
Quantitative real-time PCR (qRT-PCR) was performed on each cDNA sample in triplicate using SYBR 
Green chemistry in accordance with the manufacturer’s instructions.  The 2x SensiMix (dU) SYBR 
Green kit (Quantace) was chosen to provide increased sensitivity in the assay, although reactions were 
run at a volume of 25µl, not 50µl.  In each reaction MgCl2 had a final concentration of 3mM, primers 
(sequences can be found in Table 4) were used at 20mM and a template concentration of 2.5ng was 
used.  Each plate contained a set of negative controls.  Each plate was run using the ABI Prism 7000 
sequence detection system with the following thermal cycling conditions: 37°C, 10min; 95°C, 10 min; 
95°C, 15s; 55°C, 30s; 72°C, 30s; steps 3-5 were repeated for 40 cycles. 
 
 63 
 
 
 
 
Table 4: Primers for qRT-PCR 
 
 
Gene Name Primer sequence (5’-3’) Product size (bp) Reference/Source 
lys-7 
Forward GTCTCCAGAGCCAGACAATCC 
143 Kindly provided by Claudia Boehnisch 
Reverse CCAGTGACTCCACCGCTGTA 
abl-1 
Forward TGCATCAGAGGAGTTTGAGA 
178 Primer 3 (v0.4.0) 
Reverse ATTGTCAGCGTCAGTGCTT 
fat-5 
Forward CGATTTGTACGAGGATCCGGTG 
201 (Brock et al., 2006) 
Reverse CAGTGGGAGACACTGTTGATGC 
clec-60 
Forward TCACAACGGACTCAGTATGG 
197 Primer 3 (v0.4.0) 
Reverse CAGTCGTCAGTGGCTTGATA 
C01F4.2 
Forward AAAGTCAATGGCGTCTTTTC 
154 Primer 3 (v0.4.0) 
Reverse GCATTCTCATCAACATCCAA 
daf-16 
Forward GCGAATCGGTTCCAGCAATTCCA 
171 Kindly provided by Francis Amrit (Amrit et al., 2010) Reverse ATCCACGGACACTGTTCAACTCGT 
gpd-3 
Forward TGAAGGGAATTCTCGCTTACACC 
154 Kindly provided by Francis Amrit (Amrit et al., 2010) Reverse GAGTATCCGAACTCGTTATCGTAC 
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2.4.6 Statistical analysis 
The qRT-PCR was normalised to gpd-3 expression using the Comparative Ct method in Microsoft 
Excel (Bookout and Manglesdorf, 2003, Amrit et al., 2010), and tested for statistical significance using 
the Students’ T-test (2 tailed, equal variance, paired).   
 
2.5 Recombinant lysozyme 
 2.5.1 Gateway Cloning 
The lys-2, lys-5 and lys-7 genes were cloned from N2 cDNA using sequence-specific Worm ORFeome 
primers (sequences can be found in Table 5) (Lamesch et al., 2004, Walhout et al., 2000), which are 
compatible with the Invitrogen Gateway Cloning System (Hartley, 2006, Hartley, 2002, Walhout et al., 
2000, Nallamsetty and Waugh, 2007).  5µl of cDNA was added to 45µl PCR mix (1xPhusion HF buffer, 
800µM dNTPs, 0.5µM of each primer, ddH2O and 0.5 units Phusion DNA polymerase (Finnzymes)).  
PCR was carried out on an MJ Research TETRAD2 DNA Engine (Bio-Rad) and the product was 
amplified through 35 cycles (98°C, 0.1s; 72°C, 30s) following an initial 30s denaturation at 98°C.  The 
PCR amplicons were sequenced at the DNA Core Facility at Massachusetts General Hospital, Boston, 
MA.  Sequences were analysed using ApE v1.17 and WormBase (www.wormbase.org).   
 
Subsequently, the One Tube Format Gateway (Invitrogen) recombination reaction was used.  Briefly, 
2µl attB DNA (PCR product), 1.3µl attP DNA (pDONR 201 entry vector (Invitrogen); 150ng/µl), 3µl BP 
Clonase II enzyme (Invitrogen) and 8.7µl TE Buffer pH 8.0 was gently mixed in a 1.5ml centrifuge tube 
and incubated overnight at 25°C.  10µl of this reaction was added to 2µl destination vector (pDEST-
527 (addgene); 150ng/µl) and 3µl LR Clonase II enzyme (Invitrogen) to add a His-tag to the protein.   
The mixture was vortexed briefly and incubated at 25°C for 8h.  2µl 20mg/ml Proteinase K solution 
(Invitrogen) was added to the mixture and the tube incubated at 37°C for 10 min.  1µl of the  
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Table 5: Primers for lysozyme cloning  
 Red text represents the attB cloning sites for Gateway recombination technology 
  
Gene Name Primer sequence (5’-3’) Product size (bp) Reference/Source 
lys-2 
Forward GGGGACAAGTTTGTACAAAAAAGCAGGCTTGATCAAGCTTCTAGTTTCTTTTAC 
840 Worm ORFeome v3.1 (Lamesch et al., 2004) Reverse GGGGACCACTTTGTACAAGAAAGCTGGGTAGTTTCCGACAAATCCTCCGACA 
lys-5 
Forward GGGGACAAGTTTGTACAAAAAAGCAGGCTTGAAGCATTTTTTCATTACAATCCTTC 
648 Worm ORFeome v3.1 (Lamesch et al., 2004) Reverse GGGGACCACTTTGTACAAGAAAGCTGGGTATGGAATGTAGTTCATATCAACAG 
lys-7 
Forward GGGGACAAGTTTGTACAAAAAAGCAGGCTTGGCCCACAAATCGATTGTCAT 
852 Worm ORFeome v3.1 (Lamesch et al., 2004) Reverse GGGGACCACTTTGTACAAGAAAGCTGGGTAAATTTTCAGACTTCCTTGCACAAA 
pDESTsequenceoligo GGCGTAGAGGATCGAGATCG For sequencing ApE 1.17 
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recombination mix was used to transform 50µl One Shot TOP10 Chemically Competent E. coli cells 
(Invitrogen) according to the manufacturer’s instructions.  Recombinants were allowed to grow on LB-
ampicillin (50µg/ml) plates at 37°C overnight.  Colonies were grown overnight in 4ml LB broth, 37°C 
shaking, and the pDEST-527 vectors containing the lysozyme sequence of interest were extracted 
using a QIAprep miniprep kit (Qiagen) according to the manufacturer’s instructions.  The plasmids 
were sequenced using the pDESTsequenceoligo (sequence in Table 5) at the DNA Core Facility at 
Massachusetts General Hospital, Boston, MA.  Sequences were analysed and mapped using ApE 
v1.17 and WormBase (www.wormbase.org). 
 
 2.5.2 BL21-AI transformation 
BL21-AI One Shot Chemically Competent E. coli cells (Invitrogen) were transformed, by heat shock, 
with 5ng recombined pDEST-527 vectors, according to the manufacturer’s instructions.  Transformants 
could be stored on LB-ampicillin plates at 4°C for up to one week without significant loss of protein 
induction. 
 
 2.5.3 BL21-AI expression 
5ml test inductions were assayed in accordance with the manufacturer’s expression guidelines.  After a 
3h induction at 37°C, the samples were spun down and the cell pellets were resuspended in LDS 
sample buffer (106mM Tris HCl, 141mM Tris Base, 2% Lithium Dodecyl Sulfate, 10% (w/v) glycerol, 
0.51mM EDTA, 0.22mM SERVA Blue G250, 0.175 mM Phenol Red, pH 8.5), 500mM DTT and heated 
at 70°C for 10 min.   
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2.5.4 Western blot analysis 
Clones were analysed by western blot to determine the best expressers.  The NuPAGE Novex Bis-Tris 
System (Invitrogen) was used in an XCell SureLock Mini-Cell (Invitrogen); samples were run on a 
NuPAGE Novex 12% Bis-Tris Gel 1.0mm 10 well, with NuPAGE MOPS SDS running buffer and 
NuPAGE Antioxidant (for reducing samples in the cathode chamber).  The proteins were resolved 
down the gel for 50 min at 200V.  The proteins were transferred onto 0.22µm nitrocellulose membrane 
using the XCell II Blot Module Kit (Invitrogen) and NuPAGE transfer buffer, in accordance with the 
manufacturer’s instructions; proteins were allowed to migrate for 1h at 32V.  The membrane was 
blocked in 10% milk powder with PBS-T (1xPBS tablets (Oxoid), ddH20, Tween 1:1000) for 1h or 
overnight and then incubated in 1° antibody, mouse-anti-His (Sigma) at 1:2000 in PBS-T for 1h or 
overnight.  The membrane was washed three times in PBS-T for 10 minutes each, and incubated in 2° 
antibody, rabbit-anti-mouse-HRP (Jackson ImmunoResearch) at 1:5000 in PBS-T, for 45 min.  The 
membrane was washed three times as before and incubated in 10ml Immobilon Western 
Chemiluminescent HRP substrate (Millipore) for two min.  The membrane was drip-dried, exposed to 
BioMax MR Autoradiography Film (Kodak) and developed using an X-OMAT  
2000A automatic processor (Kodak). 
 
2.5.5 LYS-7 predicted structure  
The LYS-7 283 amino acid sequence (cosmid C02A12.4.1; WormBase) was submitted to the Phyre 
(Protein homology/analogy recognition engine) Program v0.2 from Imperial College London 
(www.sbg.bio.ic.ac.uk/phyre)(Kelley and Sternberg, 2009).  This method utilises threading and 
homology modelling to predict the protein structure.  The model with the highest sequence ID is 
presented in this thesis. 
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2.5.6 LYS-7 sequence analysis in comparison to other GH25 lysozymes 
C. elegans LYS-2, LYS-5 and LYS-7, S. coelicor cellosyl, A. fumigatus GH25, and E. histolytica 
lysozyme amino acid sequences were taken from the Universal Protein Resource (UNIPROT; 
www.uniprot.org)(Apweiler et al., 2010) and the subsequent .clustalw file was aligned using T-COFFEE 
(Tree based consistency objective function for alignment evaluation; www.tcoffee.org) multiple 
sequence alignment program (Notredame et al., 2000).  The sequences were analysed with ESPript 
2.2 (Easy sequencing in postscript; www.espript.ibcp.fr/ESPript/ESPript/) in order to identify and 
annotate secondary structures, similarities and conserved sequences (Gouet et al., 1999).  The 
alignment was further annotated for signal and pro-peptide sequences, and catalytic and functional 
residues by eye (A. L. Lovering, personal communication).   
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3.0   BALANCED IMMUNITY IN C. ELEGANS 
 
3.1 Introduction 
The defensive enzyme LYS-7, a member of the C. elegans lysozyme gene family, is believed to be 
particularly important in the immune response of the nematode to a number of pathogens (Mallo et al., 
2002, O'Rourke et al., 2006, Evans et al., 2008b).   
 
Preliminary work from our group examined the host-basis for the heightened resistance of two C. 
elegans strains, daf-2(e1370) and fem-1(hc17)IV, to killing by the fungal pathogen, Cryptococcus 
neoformans.  This work revealed that lys-7 expression was strongly and constitutively induced in these 
animals (R. C. May, unpublished data).  We therefore hypothesised that LYS-7 may play an important 
role in mediating resistance of the worm towards C. neoformans.   
 
This chapter examines the immunological function of LYS-7 during C. elegans infection with a number 
of human pathogens, including C. neoformans.  It subsequently describes an immunological balance, 
with respect to C. neoformans and the bacteria S. Typhimurium, which is mediated by a compensatory 
relationship between LYS-7 and the tyrosine kinase, ABL-1.  We further consider the physiology of this 
balance, finding it to be independent of pathogen load, immune priming or infection persistence. 
 
3.2 Results 
3.2.1 lys-7 mutant animals are hyper-susceptible to killing by Cryptococcus neoformans 
Given the published role of LYS-7 as an important immunity factor (O'Rourke et al., 2006, Evans et al., 
2008b, Mallo et al., 2002), coupled with the finding by our group that it is over-expressed in two C. 
neoformans-resistant C. elegans strains (R. C. May, unpublished), we tested whether the loss of LYS-7 
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would render animals hypersensitive to cryptococcal killing.  In line with this prediction, a lys-7 
knockout strain (ok1384) showed severely reduced survival following exposure to the fungus (Figure 
6).  However, this phenotype does not reflect a general loss of fitness in these animals, since neither 
brood size (Table 6) nor longevity under non-pathogenic conditions (Figure 7) differed from that of wild 
type animals.    
 
3.2.2 lys-7 mutant animals are resistant to killing by Salmonella Typhimurium  
In order to establish whether the loss of LYS-7 influenced immunity to other pathogens, we exposed 
lys-7 knockout animals to three organisms previously shown to be pathogenic towards C. elegans; the 
Gram-positive bacterium Staphylococcus aureus (Sifri et al., 2003) and two Gram-negative bacteria 
Pseudomonas aeruginosa (Mahajan-Miklos et al., 1999, Tan et al., 1999, Darby et al., 1999) and 
Salmonella enterica serovar Typhimurium (Labrousse et al., 2000, Aballay et al., 2000).  The 
susceptibility of lys-7 knockout animals to S. aureus (Figure 8) and P. aeruginosa (Figure 9) was 
indistinguishable from that of the wild type strain, suggesting that the loss of LYS-7 does not damage 
the worm immune response to all pathogens.  In marked contrast, however, lys-7 knockout animals are 
strongly resistant to killing by S. Typhimurium (Figure 10).  Moreover, the hypersensitivity and 
resistance survival phenotypes of the C. elegans mutants observed on C. neoformans and S. 
Typhimurium were upheld with an additional, independent, allele: lys-7(ok1385) (Figures 11 and 12).  
We refer to this phenomenon as “balanced immunity”, to indicate a process whereby increased 
resistance to one pathogen comes at the cost of increased susceptibility to another. 
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Figure 6: lys-7(ok1384) mutant animals are hypersensitive to C. neoformans infection 
Animals were exposed to C. neoformans and monitored daily for survival. The survival of these 
animals is significantly lower than wild type animals, p<0.0001, [lys-7(ok1384) n=106; N2 n=151] 
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Table 6: lys-7(ok1384) brood size in non-infectious conditions 
lys-7 knockout animals are unimpaired in their ability to produce young, data represent mean ± S.D. 
 
 
 
Figure 7: lys-7(ok1384) survival in non-infectious conditions 
lys-7(ok1384) knockout animals have a normal lifespan in non-infectious conditions, p>0.2 [lys-
7(ok1384) n=129; N2 n=199] 
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Figure 8: lys-7(ok1384) survival on S. aureus 
Animals were exposed to S. aureus and monitored daily for survival. No difference between lys-
7(ok1384) and wild type survival was detected, p>0.05, [lys-7(ok1384) n=131; N2 n=168]. 
 
 
Figure 9: lys-7(ok1384) survival on P. aeruginosa 
Animals were exposed to P. aeruginosa and monitored daily for survival. No difference between the 
two strains was detected, p>0.2, [lys-7(ok1384) n=104; N2 n=111]. 
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Figure 10: lys-7(ok1384) survival on S. Typhimurium 
Animals were exposed to S. Typhimurium SL1344 and monitored daily for survival. The mutant 
animals exhibited an enhanced survival to S. Typhimurium; p<0.0001, [lys-7(ok1384) n=191; N2 
n=242]. 
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Figure 11: lys-7(ok1385) survival on C. neoformans 
Animals were exposed to C. neoformans and monitored daily for survival. This independent lys-7 
knockout strain showed a similar hypersensitivity to the infection, p<0.001 [lys-7(ok1385) n=101; N2 as 
Figure 6]. 
 
Figure 12: lys-7(ok1385) survival on S. Typhimurium 
Animals were exposed to S. Typhimurium SL1344 and monitored daily for survival. These animals 
were again resistant to the infection, p<0.0001 [lys-7(ok1385) n=169; N2 as Figure 10]. 
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3.2.3 Resistance to S. Typhimurium is mediated by genetic compensation 
In order to identify genes that may compensate for the loss of lys-7 and thus confer the observed 
resistance to S. Typhimurium, we characterised gene expression changes in the lys-7 mutant animals 
with a rudimentary whole-genome microarray analysis (see Appendix 1.0).  This analysis identified only 
four genes that are up-regulated in both lys-7 knockout strains (ok1384 and ok1385) in comparison to 
wild type animals.  These genes were: abl-1 (2.65 ± 0.94 fold up-regulation), a tyrosine kinase (Deng 
et al., 2004) which additionally has a putative immunity role in C. elegans (Burton et al., 2006); fat-5 
(1.82 ± 0.15 fold up-regulation), a fatty acid desaturase (Watts and Browse, 2000); clec-60 (1.59 ± 
0.08 fold up-regulation), a C-type lectin (O'Rourke et al., 2006) that is a member of a gene family 
proposed to be putative immune recognition factors (Schulenburg et al., 2008); and rga-6 (1.92 ± 
0.089 fold up-regulation), a Rho-GTPase activating protein with high orthology to the human Rho-
GTPase activating protein ARHGAP6 (Potet et al., 2009). 
 
We obtained knockout strains for each of these genes and tested their susceptibility to killing by C. 
neoformans (Figure 13) and S. Typhimurium (Figure 14).  Remarkably, animals lacking either abl-1 or 
rga-6 were hypersensitive to C. neoformans but resistant to S. Typhimurium infection; a survival 
pattern which phenocopies that of the lys-7 knockout animals. fat-5 knockout animals show slight 
resistance to S. Typhimurium but a normal susceptibility to C. neoformans, whilst clec-60 mutant 
animals are indistinguishable from wild type animals in their survival following exposure to either 
pathogen.   
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Figure 13: abl-1 and rga-6 mutant animals phenocopy lys-7 susceptibility to C. neoformans 
Knockout strains for the four genes which were identified by a microarray to be up-regulated in the lys-
7 mutant background were tested for sensitivity to C. neoformans. The survival of abl-1(ok171) and 
rga-6(ok1316) animals is significantly lower than wild type animals, p<0.0001 and p<0.01 respectively. 
The remaining animals are unchanged from wild type survival, p>0.2 [N2 n=186; abl-1(ok171) n=130; 
rga-6(ok1316) n=192; fat-5(ok460) n=100; clec-60(tm2319) n=110]. 
 
Figure 14: abl-1, rga-6 and fat-5 mutant animals phenocopy lys-7 resistance to S. Typhimurium 
Animals were exposed to S. Typhimurium and monitored daily for survival. abl-1(ok171), rga-6(ok1316) 
and fat-5(tm420) animals exhibit enhanced resistance to the pathogen, p<0.0001 in each case. clec-
60(tm2319) animals have survival patterns that reflect those of wild type animals, p>0.2 [N2 n=170; 
abl-1(ok171) n=222; rga-6(ok1316) n=100; fat-5(ok460) n=162; clec-60(tm2319) n=125]. 
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We next used qRT-PCR to assess whether lys-7 expression was altered in these knockout animals 
under normal culture conditions.  lys-7 expression remained unchanged in fat-5, clec-60 and rga-6 
knockout animals, but, interestingly, was significantly up-regulated in abl-1 mutants (Figure 15).  
 
To address the compensation in survival between animals lacking lys-7 and the three candidate genes 
(abl-1, fat-5 and rga-6) identified by resistance analysis, we generated a series of double mutants and 
tested their susceptibility to infection with C. neoformans and S. Typhimurium.  Whilst lys-
7(ok1384);abl-1(ok171) double mutants remained sensitive to killing by C. neoformans (Figure 16), the 
resistance to S. Typhimurium exhibited by both single mutants was completely abolished (Figure 17).  
In contrast however, the other double mutants (rga-6(ok1316);lys-7(ok1384) and fat-5(ok460);lys-
7(ok1384)) remained sensitive to killing by C. neoformans (Figure 18) and resistant to killing by S. 
Typhimurium (Figure 19) suggesting that the loss of lys-7 is dominant in these animals, although we do 
note that the degree of resistance has been slightly reduced in the case of rga-6.  Taken together, 
these data indicate that, of the three candidate genes, only abl-1 shows full phenocopying and 
reciprocal regulation with lys-7 in response to these two pathogens.   
 
In support of these data, we tested the survival of two further abl-1 null alleles, n1961 and n1963 
(Hurwitz et al., 2009), on C. neoformans (Figure 20) and S. Typhimurium (Figure 21) and, in both 
cases, observed a consistent balanced immunity phenotype.  Further, there is no loss or gain of fitness 
in abl-1(ok171) animals; their survival upon S. aureus infection (Figure 22), lifespan in normal culture 
conditions (Figure 23) and brood size (Table 7) analyses were all unchanged from those of wild type 
animals. 
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Figure 15: abl-1 mutant animals up-regulate lys-7 expression 
Changes in lys-7 expression between the four array genes and N2 were determined by the qRT-PCR 
analysis of total RNA for each strain. abl-1(ok171) animals significantly up-regulate lys-7 expression 
with an average induction of 6.8 fold, p<0.05, whereas lys-7 expression is unchanged from wild type in 
the remaining mutant backgrounds. These data represent the mean of three independent experiments 
± S.E.M. 
 
 
 
 
Chapter 3: Balanced Immunity in C. elegans 
80 
 
 
Figure 16: lys-7;abl-1 double mutants are sensitive to C. neoformans 
abl-1(ok171)lys-7(ok1384) double mutants were infected with C. neoformans at the L4 stage and 
monitored daily for survival. The double mutant nematodes were hypersensitive to the infection, 
p<0.0001, similar to their corresponding single mutants [abl-1(ok171)lys-7(ok1384) n=133; N2 n=150]. 
 
Figure 17: lys-7;abl-1 double mutants are sensitive to S. Typhimurium 
abl-1(ok171)lys-7(ok1384) double mutants were infected with S. Typhimurium at the L4 stage and 
monitored daily for survival. The resistance exhibited by the single mutants to the infection has been 
completely suppressed to wild type survival levels in the double mutants; p>0.2, [abl-1(ok171)lys-
7(ok1384) n=110; N2 n=94]. 
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Figure 18: lys-7;fat-5 and lys-7;rga-6 double mutants phenocopy lys-7 on C. neoformans 
Animals were exposed to C. neoformans and monitored daily for survival. Double mutants between lys-
7 and fat-5 or lys-7 and rga-6 were hypersensitive to the infection in comparison to wild type survival, 
p<0.0001 in both cases, [N2 n=207; lys-7(ok1384)fat-5(tm420) n=100; lys-7(ok1384)rga-6(ok1316) 
n=100]. 
 
Figure 19: lys-7;fat-5 and lys-7;rga-6 double mutants phenocopy lys-7 on S. Typhimurium 
Animals were exposed to S. Typhimurium and monitored daily for survival. The resistance to S. 
Typhimurium exhibited by the lys-7 knockout strain, was either unaltered (fat-5) or only slightly reduced 
(rga-6) by these secondary mutations [N2 n=170; lys-7(ok1384)fat-5(tm420) n=100; lys-7(ok1384)rga-
6(ok1316) n=100]. 
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Figure 20: abl-1(n1961) and abl-1(n1963) survival on C. neoformans 
Animals were exposed to C. neoformans and monitored daily for survival. These independent abl-1 
alleles showed a similar hypersensitivity to the infection as abl-1(ok171) animals, p<0.0001 in both 
cases, [abl-1(n1961) n=150; abl-1(n1963) n=152; N2 n=325]. 
 
Figure 21: abl-1(n1961) and abl-1(n1963) survival on S. Typhimurium 
Animals were exposed to S. Typhimurium SL1344 and monitored daily for survival. These animals 
were resistant to the infection in a manner similar to the abl-1(ok171) animals, p<0.0001 in both cases, 
[abl-1(n1961) n=150; abl-1(n1963) n=127; N2 n=278]. 
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Figure 22: abl-1(ok171) survival on S. aureus 
Animals were exposed to S. aureus and monitored daily for survival. No difference between abl-
1(ok171) and wild type survival was detected, p>0.2, [abl-1(ok171) n=120; N2 as Figure 8]. 
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Table 7: abl-1(ok171) brood size in non-infectious conditions 
abl-1 knockout animals are unimpaired in their ability to produce young, data represent mean ± S.D. 
 
 
 
Figure 23: abl-1(ok171) survival in non-infectious conditions 
abl-1(ok171) knockout animals have a normal lifespan in non-infectious conditions, p>0.2 [abl-1(ok171) 
n=142; N2 n=159]. 
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It should be noted here that we have been unable to validate the up-regulation of abl-1 in either lys-7 
mutant background by qRT-PCR, where expression levels appear unchanged from wild type (Figure 
24).  Unfortunately the lack of a functional antibody for C. elegans ABL-1 has also prevented us from 
determining the protein levels of ABL-1 in lys-7 mutant animals.  Thus we presume that the loss of 
LYS-7 induces ABL-1 activity via a post-transcriptional mechanism, such as the activation of its kinase 
activity.   
 
3.2.4 The physiology of S. Typhimurium infection in the mutant animals is unchanged 
from wild type  
We wondered whether the resistance of lys-7(ok1384) and abl-1(ok171) single mutant animals to S. 
Typhimurium challenge may result from a lower bacterial load, for instance due to a reduced 
pharyngeal pumping rate or more effective clearance from the intestinal tract. To test this, we infected 
wild type, lys-7 and abl-1 animals with S. Typhimurium L1019 (a S. Typhimurium SL1344 strain 
carrying the pUA66pacpP plasmid which encodes GFPmut2; a kind gift from Jessica Blair and Laura 
Piddock, University of Birmingham) and examined animals for infection differences both 
microscopically (Figure 25) and through viable counts (Figure 26).  We found no discernable difference 
between any of the strains, save for a slight disparity between the knockout strains on day 4 of the 
infection that had resolved by day 5.   
 
 
 
 
 
 
Chapter 3: Balanced Immunity in C. elegans 
86 
 
 
 
 
 
 
 
 
Figure 24: lys-7 mutant animals do not change abl-1 expression 
abl-1 mRNA expression is unchanged from wild type in both lys-7 mutant backgrounds, determined by 
the qRT-PCR analysis of total RNA for each strain. These data represent the mean of three 
independent experiments ± S.E.M. 
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Figure 25: Microscopic analysis of a constant S. Typhimurium infection in C. elegans 
Bacterial load was assessed microscopically using a GFP-expressing S. Typhimurium, strain L1019, across a five day infection. No difference in infection 
load was identified between the strains. 
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Figure 26: C. elegans bacterial load during a constant S. Typhimurium infection 
Bacterial load was assessed through viable counts per worm. Generally, there was no difference 
between any of the strains, p>0.2, although there is a slight disparity between abl-1(ok171) and lys-
7(ok1384) on day 4 of the infection, p<0.05 [abl-1(ok171) n=60; lys-7(ok1384) n=60; N2 n=60]. 
 
Figure 27: C. elegans survival following a six hour S. Typhimurium infection 
Bacterial persistence following a six hour S. Typhimurium infection was examined by daily survival. 
The lys-7(ok1384) and abl-1(ok171) single mutants were tolerant to the infection under these 
conditions in comparison with wild type animals’ survival, p<0.01 and p<0.0001 respectively, [lys-
7(ok1384) n=90; abl-1(ok171) n=86; N2 n=96]. 
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We also considered the possibility that the difference in susceptibility may result from lys-7 and abl-1 
knockout animals being better able to limit S. Typhimurium proliferation within the gut.  To test this, we 
restricted the animals’ exposure to the pathogen to just six hours and then shifted them to the normal 
feeding bacteria E. coli OP50.  This regime has previously been shown to lead to persistent 
colonisation of C. elegans by S. Typhimurium (Labrousse et al., 2000).  Under these conditions both 
lys-7 and abl-1 animals retain their strong resistance phenotypes (Figure 27), but we observed no 
consistent difference in S. Typhimurium colonisation between the mutants and wild type animals 
microscopically (Figure 28).  Indeed, as we find no difference in S. Typhimurium colonisation between 
the two mutant animal strains and wild type, we conclude that lys-7 and abl-1 knockout animals are 
more “tolerant” (i.e. a gain in survival with no change in pathogen levels, dependent upon damage 
limitation) to the S. Typhimurium infection as opposed to being “resistant” (Raberg et al., 2009).   
 
Since C. elegans are fed on a live bacterial foodstuff (E. coli OP50) prior to infectious challenge, we 
considered the possibility that the loss of lys-7 or abl-1 may result in an altered response of C. elegans 
to OP50, such that there is a general up-regulation of defensive enzymes in these animals that 
subsequently enhances tolerance to S. Typhimurium.  To investigate this further, animals were raised 
on antibiotic-killed OP50 to the fourth larval stage, and then exposed to S. Typhimurium infection and 
assayed daily for survival.  However, under these conditions lys-7 and abl-1 mutant animals show the 
same strong tolerance phenotype to Salmonella infection (Figure 29).   
 
We thus deduce that neither Salmonella load nor Salmonella persistence are altered in lys-7 or abl-1 
mutant animals, nor can the heightened tolerance of these animals be explained by a pre-existing 
induction of the animals’ immune response in response to E. coli OP50. 
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Figure 28: Microscopic analysis of a six hour S. Typhimurium infection in C. elegans 
Bacterial load was assessed microscopically using a GFP-expressing S. Typhimurium, strain L1019, across a five day infection. No difference in infection 
load was identified between the strains. 
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Figure 29: Immune priming is not causative of C. elegans tolerance to S. Typhimurium 
lys-7 or abl-1 mutant animals reared to L4 stage on kanamycin-killed OP50, show identical patterns of 
S. Typhimurium tolerance, p<0.0001 versus N2 in both cases, as those reared on normal (live) OP50 
[lys-7(ok1384) n=93; abl-1(ok171) n=113; N2 n=96]. 
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3.3 Conclusion 
The lysozyme LYS-7 has been well-described in C. elegans as an essential antimicrobial molecule 
(Mallo et al., 2002, O'Rourke et al., 2006, Evans et al., 2008b, Schulenburg and Boehnisch, 2008) that 
is assumed to actively degrade invading pathogens (Kerry et al., 2006, Murphy et al., 2003).  In 
addition, lys-7 expression is known to be up-regulated in long-lived daf-2 mutant animals (Murphy et 
al., 2003), which are resistant to a number of pathogens (Garsin et al., 2003).   
 
In this work, we show that LYS-7 is a specialised defence molecule that protects animals against C. 
neoformans-mediated killing, since lys-7 knockout animals are hyper-susceptible to this organism; a 
function that is presumably attributable to the secondary chitinase (anti-fungal) activity exhibited by 
most lysozymes (Jolles, 1996).  Remarkably, however, lys-7 acts simultaneously as a susceptibility 
factor for C. elegans to the Gram-negative bacterium Salmonella enterica serovar Typhimurium, as the 
loss of lys-7 more than doubles the median survival of Salmonella-challenged animals.   
 
C. elegans raise an immune response that consists entirely of defensive molecules upon pathogenic 
challenge (Schulenburg et al., 2004).  Generally, the secretion of these molecules is maintained in 
balance, such that the loss of a defensive factor by mutation causes susceptibility to one (or a small 
number) of pathogens (Mallo et al., 2002, O'Rourke et al., 2006).  We now find, however, that the loss 
of an immune factor can simultaneously trigger greater tolerance to another pathogen through genetic 
compensation; in this example we show that the susceptibility trade-off requires a balancing 
mechanism mediated by the activity of LYS-7 and the tyrosine kinase ABL-1. 
 
As a non-receptor tyrosine kinase that is expressed in the tail ganglia of the nematode (WormBase) we 
hypothesised that ABL-1 would act upstream of LYS-7 in the signalling pathway controlling the 
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balanced immunity phenotype; a hypothesis that we explore further in chapter four.  However, in a 
manner similar to the lys-7 mutant animals, we find that abl-1 mutant worms are hypersusceptible to 
killing by C. neoformans.  Since these animals show up-regulation of lys-7, a gene that we 
demonstrate to be important for cryptococcal resistance, we must therefore conclude that ABL-1 
regulates immunity at two levels (by the up-regulation of lys-7 and by a second, lys-7 independent 
pathway), both of which are required for wild type resistance to C. neoformans.  
 
In the response to S. Typhimurium, lys-7 and abl-1 mutant animals display an increased tolerance to 
the pathogen, a phenotype that is suppressed in the double mutant.  The physiological rationale for this 
tolerance in the lys-7 and abl-1 single mutants remains unclear, since these animals did not exhibit any 
differences in bacterial colonisation following either a constant or minimal exposure to the pathogen.  
Further, the phenotype cannot be attributed to immunological ‘priming’ due to growth on live E. coli 
OP50.  These data therefore suggest that the loss of lys-7 or abl-1 enhances tolerance to Salmonella 
at the level of the host (for instance, in repairing tissue damage or neutralising bacterial toxins), rather 
than by a bacteriocidal mechanism. 
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4.0   SIGNALLING CONTROL OF BALANCED IMMUNITY 
 
4.1 Introduction 
In the previous chapter we describe an immunological balance in C. elegans, whereby increased 
tolerance to one pathogen comes at the cost of increased sensitivity to another.  We found that this 
susceptibility trade-off was mediated by two genes, lys-7 and abl-1; but what are the underlying signals 
that control this phenotype?   
 
C. elegans innate immunity is regulated by four major signalling cascades; the p38 MAPK (Kim et al., 
2002, Shivers et al., 2010), IGF (Garsin et al., 2003, McElwee et al., 2003, Troemel et al., 2006), TGF-
β (Mochii et al., 1999, Mallo et al., 2002, Zugasti and Ewbank, 2009), and Toll-like pathways (Couillault 
et al., 2004, Pujol et al., 2001, Pradel et al., 2007) (Figure 5).  In addition, there is also a published role 
for a protective PCD response to S. Typhimurium (Aballay and Ausubel, 2001, Aballay et al., 2003), 
which, given the regulatory function of ABL-1 in apoptosis (Deng et al., 2004, Salinas et al., 2006), may 
be important for balanced immunity.   
 
We have described an increased tolerance of lys-7 and abl-1 mutant animals to S. Typhimurium, in 
which the mutants exhibit improved survival to the pathogen without any change in pathogen levels.  
As Toll-mediated signalling likely renders animals resistant to infections (i.e. a gain in survival with a 
decrease in pathogen load) mediated through avoidance behaviour (Pujol et al., 2001) and olfactory 
learning (Pradel et al., 2007) we did not pursue the function of the Toll pathway in this example of 
immunological balance. 
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In this chapter we examine the role of three of the main immunity signalling pathways in C. elegans, as 
well as two ABL-network proteins, CED-3 and ABI-1, in the balanced immunity phenotype.  We find 
that the balance is independent of p38 MAPK and apoptotic signalling; instead, it appears to be 
mediated by the activity of the IGF and TGF-β pathways. 
 
4.2. Results 
4.2.1 The balanced immunity phenotype is independent of apoptotic signalling 
ABL-1 is known to regulate apoptosis in C. elegans (Deng et al., 2004, Salinas et al., 2006).  Since 
germ line apoptosis has previously been reported to protect C. elegans against S. Typhimurium 
infection (Aballay and Ausubel, 2001), (although we note that conflicting data have recently been 
reported by others (Jia et al., 2009)), we postulated that the loss of abl-1 may lead to an increase in 
apoptosis that, in turn, protects the animal against killing by S. Typhimurium.  Instead, we find that ced-
3(ok2734) mutant animals are marginally tolerant to a S. Typhimurium infection.  Furthermore, an abl-
1;ced-3 double mutant, in which apoptosis is blocked by the loss of the caspase CED-3,  did not differ 
from the abl-1 single mutant in sensitivity towards either C. neoformans (Figure 30) or S. Typhimurium 
(Figure 31).  Thus, the role of abl-1 in regulating immunity does not appear to involve its function as an 
apoptotic factor. 
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Figure 30: abl-1(ok171) hypersensitivity to C. neoformans is independent of apoptosis 
abl-1(ok171)ced-3(ok2734) double mutants, in which apoptosis is blocked, were infected with C. 
neoformans at the L4 stage and monitored on a daily basis. The survival of these animals did not 
deviate from that of the abl-1 single mutant, p>0.2, on this pathogen [abl-1(ok171)ced-3(ok2734) 
n=100; ced-3(ok2734) n=100; N2 as Figure 18; abl-1(ok171) as Figure 13]. 
 
 
Figure 31: abl-1(ok171) tolerance to S. Typhimurium is independent of apoptosis 
abl-1(ok171)ced-3(ok2734) double mutants, in which apoptosis is blocked, were infected with S. 
Typhimurium and monitored daily for survival. The survival of these animals phenocopied the tolerance 
of the abl-1 single mutants, p>0.2 [abl-1(ok171)ced-3(ok2734) n=125; ced-3(ok2734) n=125; N2 as 
Figure 19; abl-1(ok171) as Figure 14]. 
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4.2.2 The ABL-1 interacting protein (ABI-1) phenocopies the ABL-1 immunity profile 
In vertebrates, several ABL-interacting (abi) proteins act in concert with ABL to mediate diverse 
downstream effects (Dai and Pendergast, 1995, Dai et al., 1998, Tani et al., 2003, Proepper et al., 
2007, Stuart et al., 2006).  In C. elegans there is only a single abi homologue, ABI-1, which has 
recently been shown to interact with ABL-1 in vitro (Hurwitz et al., 2009).  We therefore tested a 
possible function for ABI-1 in C. elegans immunity by challenging abi-1(ok640) mutant animals with C. 
neoformans and S. Typhimurium.   
 
The susceptibility of these nematodes to C. neoformans (Figure 32) and resistance to S. Typhimurium 
(Figure 33) is very similar to that of abl-1 mutant animals, suggesting that ABI-1 and ABL-1 act in the 
same way to mediate immunological balance in C. elegans.  Regrettably, we have thus far been 
unable to generate an abl-1;abi-1 double mutant for epistasis analysis, suggesting that this 
combination may be lethal. 
 
4.2.3 Balanced immunity is mediated through the activity of DAF-16 and DBL-1 
To further tease apart the mechanism regulating immunological balance in the lys-7 and abl-1 
knockout animals, we examined the potential role of three of the best characterized immunity pathways 
in C. elegans; the p38 MAPK pathway (Kim et al., 2002, Troemel et al., 2006), the TGF/DBL-1 
signalling pathway (Kurz et al., 2003, Sifri et al., 2003, Zugasti and Ewbank, 2009) and the IGF/DAF-2 
signalling pathway (Garsin et al., 2003, van den Berg et al., 2006, Evans et al., 2008a).  We generated 
a series of double mutants lacking essential components of each of these pathways in combination 
with a secondary mutation for either lys-7 or abl-1 and then tested the susceptibility of these double 
mutants to both C. neoformans and S. Typhimurium. 
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Figure 32: abi-1(ok460) animals are hypersensitive to C. neoformans infection 
Animals lacking the abl-1 interacting protein, abi-1(ok460) were infected with C. neoformans and 
monitored for survival. These animals phenocopied the abl-1(ok171) hypersensitivity in comparison 
with wild type survival, p<0.0001 [abi-1(ok640) n=150; N2 as Figure 20]. 
 
Figure 33: abi-1(ok460) animals are tolerant to S. Typhimurium infection 
abi-1(ok460) animals phenocopy the abl-1(ok171) tolerance to S. Typhimurium in comparison with wild 
type animals, p<0.0001 [abi-1(ok640) n=127; N2 as Figure 21], indicating that abi-1 acts in a similar 
manner to abl-1 in regulating immunological balance. 
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Single mutants lacking the C. elegans homologue of the p38 MAPKK, sek-1, exhibited an enhanced 
susceptibility phenotype to infection with both C. neoformans (Figure 34) and S. Typhimurium (Figure 
35), consistent with previous reports (Kim et al., 2002, Troemel et al., 2006).  However, this sensitivity 
to S. Typhimurium is completely rescued upon the introduction of a secondary mutation for lys-7; these 
double knockouts instead mimic the strong resistance exhibited by the lys-7 single mutants.  
Conversely, lys-7;sek-1 double mutants behave like neither single mutant upon C. neoformans 
infection.  Regrettably, abl-1;sek-1 double knockout animals are very sick even under non-infectious 
conditions (Figure 36), precluding us from testing these animals upon pathogen exposure.  
Nevertheless, our data exclude the possibility that the S. Typhimurium resistance exhibited by lys-7 
animals is mediated by sek-1. 
 
The C. elegans TGF-β homologue, dbl-1, is hypersensitive to infection with C. neoformans (Figure 37), 
but unchanged from wild type survival when infected with S. Typhimurium (Figure 38).  As dbl-1 is 
closely linked to lys-7 on chromosome V, we were unable to generate a dbl-1;lys-7 double knockout 
mutant.  However, we were able to produce dbl-1;abl-1 double mutant animals. These animals were 
extremely sensitive to both C. neoformans (Figure 37) and S. Typhimurium (Figure 38), suggesting a 
role for the TGF-β pathway in the balance mechanism.   
 
Finally, since the forkhead transcription factor DAF-16 acts downstream of the DAF-2/IGF pathway to 
regulate the expression of many genes involved in stress, immunity and aging (Mukhopadhyay et al., 
2006), we asked whether DAF-16 may play a role in the resistance of abl-1 and lys-7 mutant animals 
towards S. Typhimurium.  Indeed, double mutants lacking either abl-1 or lys-7 together with an 
additional mutation for daf-16 remained hypersensitive to infection with C. neoformans (Figure 39), but 
tolerance to S. Typhimurium was suppressed to levels similar to daf-16 single mutants (Figure 40).   
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Figure 34: sek-1(km4) a p38 MAPK pathway mutant is hypersensitive to C. neoformans 
lys-7(ok1384)sek-1(km4) double mutant animals behave neither as lys-7(ok1384) nor sek-1(km4) 
single mutants, p<0.0001 in both cases, and instead find an intermediate-susceptible phenotype when 
challenged with cryptococcal infection [lys-7(ok1384)sek-1(km4) n=100; sek-1(km4) n=100; N2 as 
Figure 20; lys-7(ok1384) as Figure 6 which was a temporally independent experiment]. 
 
Figure 35: The p38 MAPK pathway has no role in the tolerance phenotype to S. Typhimurium 
lys-7(ok1384) mutation rescues the hypersensitivity of the sek-1(km4) mutants, leading to a resistant 
phenotype in comparison to the wild type strain, p<0.0001, [lys-7(ok1384)sek-1(km4) n=100; sek-
1(km4) n=150; N2 as Figure 21; lys-7(ok1384) as Figure 10, which was a temporally independent 
experiment], indicating that the p38 MAPK pathway does not mediate the balance mechanism.   
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Figure 36: abl-1;sek-1 nematodes have a greatly reduced lifespan in non-infectious conditions 
abl-1(ok171)sek-1(km4) animals are very sick, clear, mutants even in non-infectious conditions. 
Temperatures of both 20°C and 25°C were examined to rule out any temperature-based effect.  
Representative data for N2 survival is shown for comparison  [abl-1(ok171)sek-1(km4) 25°C n=50; abl-
1(ok171)sek-1(km4) 20°C n=50; N2 as Figure 23]. 
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Figure 37: The TGF-β pathway is important in C. neoformans pathogenesis 
Although both abl-1(ok171) and dbl-1(nk3) single mutants are hypersensitive to C. neoformans 
infection in comparison with wild type worms, p<0.0001 in both cases, this effect is exacerbated when 
the mutations are coupled together [abl-1(ok171)dbl-1(nk3) n=100; dbl-1(nk3) n=100; N2 as Figure 20; 
abl-1(ok171) as Figure 13]. 
 
Figure 38: The TGF-β pathway greatly suppresses S. Typhimurium tolerance 
abl-1(ok171)dbl-1(nk3) double knockout animals are hypersensitive to S. Typhimurium infection, 
p<0.0001, indicating that TGF-β is required for the balance mechanism [abl-1(ok171)dbl-1(nk3) n=100; 
dbl-1(nk3) n=150; N2 as Figure 21; abl-1(ok171) as Figure 14]. 
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Figure 39: C. neoformans hypersensitivity is dependent upon insulin signalling 
Animals were exposed to C. neoformans and monitored daily for survival. Both daf-16(mu86) double 
mutants remain hypersusceptible to cryptococcal infection and their survival is unchanged from that of 
the single parent strains; p>0.2, [abl-1(ok171)daf-16(mu86) n=100; lys-7(ok1384)daf-16(mu86) n=100; 
daf-16(mu86) n=100; N2 as Figure 18; abl-1(ok171) as Figure 12; lys-7(ok1384) as Figure 6]. 
 
Figure 40: S. Typhimurium tolerance is modulated by the forkhead transcription factor daf-16 
daf-16(mu86) mutation significantly suppresses the tolerance phenotypes of the single mutants when 
infected with S. Typhimurium; p<0.0001 in both cases, indicating that DAF-16 is required for 
immunological balance [abl-1(ok171)daf-16(mu86) n=101; lys-7(ok1384)daf-16(mu86) n=100; daf-
16(mu86) n=100; N2 as Figure 19; abl-1(ok171) as Figure 13; lys-7(ok1384) as Figure 10]. 
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4.3 Conclusion 
With respect to the regulation of this balance, the picture is highly complex.  abl-1 is expressed broadly 
during embryogenesis but is more limited to the pharynx and tail ganglia post-development (Deng et 
al., 2004).  These data are consistent with a signalling function for abl-1 in regulating this 
immunological balance; indeed there is a precedent for neuronal regulation of immunity (Chuang and 
Bargmann, 2005, Styer et al., 2008, Reddy et al., 2009, Zugasti and Ewbank, 2009).  In support of this, 
we show that the loss of the ABL-1 interacting protein ABI-1 produces a similar phenotype to the loss 
of ABL-1, suggesting that it too has a role in the regulation of immunity. 
 
These data rule out the involvement of the p38 MAPK pathway, since its loss does not suppress the 
abl-1 or lys-7 tolerance phenotypes.  Instead, however, both TGF-β and DAF-16 appear to play 
important roles in the regulation of immunological balance.  As a single mutant, dbl-1 is unchanged 
from wild type survival upon infection with S. Typhimurium, although these animals are hypersensitive 
to C. neoformans infection.  Yet once this knockout is coupled with a further mutation for abl-1, the 
double mutant animals become extremely sensitive to both infections.  Moreover, the data here show a 
strong modulation in the resistance of the lys-7 and abl-1 mutants to S. Typhimurium infection by DAF-
16, since a secondary mutation for daf-16 suppresses the tolerance phenotype of these single 
knockout animal strains.  Taken together, these data suggest that the loss of abl-1 or lys-7 confers 
resistance towards S. Typhimurium through interplay between DAF-16 and TGF-β.  Interestingly, lys-7 
itself is a known DAF-16 target (Yu et al., 2008a, McElwee et al., 2003, Murphy et al., 2003), thereby 
providing a potential feedback mechanism to regulate the activity of the pathway (Figure 49). 
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5.0   THE ROLE OF RpoS 
 
5.1 Introduction 
The C. elegans-S. Typhimurium interaction is particularly interesting as it is one of the few human 
pathogens to initiate a persistent infection in the worm (Labrousse et al., 2000, Aballay et al., 2000).  
Despite primarily being an extracellular interaction, and as such not a bona fide Salmonella infection, 
the model has revealed a number of virulence factors from the bacteria and immunity genes from the 
worm that are essential for a successful host-pathogen interaction, some of which are also required in 
mammalian infections (Aballay and Ausubel, 2001, Aballay et al., 2003, Alegado and Tan, 2008, Tenor 
et al., 2004). 
 
Our observations and data from chapter three have shown that the host expression of the antimicrobial 
proteins lys-7 and abl-1 in wild type C. elegans during an S. Typhimurium infection is detrimental, since 
inactivation of either gene more than doubles median animal survival.  Similarly, the data in chapter 
four examines the host mechanisms that underlie this increased tolerance.  In this chapter, we turn our 
attention to the pathogen and examine the Salmonella dependence of the balanced immunity 
phenotype.   
 
We first considered S. Typhimurium strain dependence for the animals’ augmented survival.  This 
analysis identified altered tolerance profiles in the worm model for three common S. Typhimurium 
reference strains, SL1344, 14028s and LT2.  Based on these differences, we hypothesised that C. 
elegans sensitivity may, in part, be regulated by the activity of the Salmonella alternative sigma factor 
RpoS.  In the final part of this chapter, we present preliminary data in support of this hypothesis, and 
propose future experiments to test this in more detail.   
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5.2 Results 
 5.2.1 The tolerance phenotype is suppressed upon S. Typhimurium LT2 infection 
As described in chapter three, the lys-7 and abl-1 mutant animals are tolerant to an infection with the 
S. Typhimurium isolate SL1344.  In order to determine the strain dependence of this phenotype, two 
further isolates were tested, 14028s and LT2.  lys-7(ok1384) and abl-1(ok171) animals show a similar 
enhancement of survival upon 14028s infection (Figure 41), p<0.01 and p<0.001, respectively.  
However, this tolerance is suppressed to wild type survival levels when the animals are infected with 
the strain LT2 (Figure 42), p>0.2.  Thus these mutant animals exhibit enhanced tolerance to S. 
Typhimurium in a strain dependent manner.   
 
5.2.2 The sigma factor RpoS influences C. elegans survival to S. Typhimurium   
LT2 is an rpoS mutant S.  Typhimurium strain and is considered avirulent, whereas SL1344 and 
14028s are fully virulent in all tested models (WilmesRiesenberg et al., 1997).  Briefly, ATCC 700720, 
Lilleengen type 2 (LT2), is a clinical S. Typhimurium isolate originally isolated in the United Kingdom 
during 1948 from an individual presenting with gastroenteritis (Lilleengen, 1948).  It was used in one of 
the first phage-typing studies in Salmonella (Lilleengen, 1948, Rabsch, 2007) and has since been a 
significant strain in the development of the cellular and molecular understanding of Salmonellosis 
(McClelland et al., 2001).  Although once a virulent isolate in mice and humans (Lilleengen, 1948, 
Herzberg et al., 1965, Herzberg et al., 1972, Baumberg and Freeman, 1971), most LT2 descendents 
have become avirulent in mice, believed to be due to the inability of the bacteria to withstand the acidic 
environment of the host gastrointestinal tract and, in the case of systemic infection, the macrophage 
(Fang et al., 1992).   
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Figure 41: C. elegans survival on S. Typhimurium 14028s 
Animals were exposed to S. Typhimurium 14028s and monitored daily for survival. Both strains lys-
7(ok1384) and abl-1(ok171), were tolerant to the infection, p<0.01 and p<0.001 respectively, in 
comparison to the wild type strain [N2 n=120; lys-7(ok1384) n=123; abl-1(ok171) n=90]. 
 
Figure 42: C. elegans survival on S. Typhimurium LT2 
Animals were exposed to S. Typhimurium LT2 and monitored daily for survival. No difference between 
any of the three strains was detected, p>0.2 in each case.  Representative data for N2 survival on S. 
Typhimurium SL1344 is shown for comparison [N2 n=80; lys-7(ok1384) n=71; abl-1(ok171) n=92; N2 
SL1344 as Figure 14]. 
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This avirulence is entirely dependent upon the acquisition of a single mutation in mouse virulence gene 
B (mviB) during laboratory passage that has since been described as a point mutation in the start 
codon of rpoS, an alternative sigma factor, that substantially reduces the expression levels of RpoS 
(Lee et al., 1995, WilmesRiesenberg et al., 1997, Swords et al., 1997a).  Interestingly, C. elegans 
survival data from a previous study, which included a superficial examination of the pathogen 
requirements for the Salmonellae-C. elegans interaction, suggested that the RpoS sigma factor was 
important in S. Typhimurium virulence in the worm (Labrousse et al., 2000).  We therefore asked 
whether the RpoS locus was necessary for the augmented survival of the mutant animals. 
 
We hypothesised that the tolerance of the lys-7 and abl-1 knockout animals to a virulent S. 
Typhimurium infection would return when these animals were infected with the strain χ8000.  This 
strain is LT2 with a complemented rpoSSL1344 allele in cis (rpoSSL1344zxx-5181::Tn10(dTc)).  Indeed, 
upon complementation of the LT2 rpoS mutation, the tolerance phenotype of the lys-7(ok1834) and 
abl-1(ok171) animals strongly returns (Figure 43), p<0.0001.  Thus the restoration of RpoS is enough 
to restore the increased survival of the C. elegans mutants, although it should be noted that the 
survival patterns of the wild type and mutant animals do not entirely reflect those upon exposure to 
SL1344. 
 
In the same vein, we anticipated that the tolerance phenotype would be lost upon infection of the 
animals with an SL1344 rpoS insertional inactivated mutant strain.  However, this strain JF2691 
(rpoS::Apr from P22(SF1005) x SL1344) continues to induce the tolerance phenotype of the mutant 
animals (Figure 44), p<0.0001.  These data therefore suggest that either RpoS does not determine the 
strain dependence of the C. elegans infection tolerance, or that an intermediate level of RpoS 
expression, as found in LT2, is critical to the phenotype.     
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Figure 43: C. elegans survival on S. Typhimurium χ8000 
rpoSSL1344 was complemented in χ4996 (LT2, rpoS::Apr), to restore RpoS expression to wild type in 
LT2.  Animals were infected with this strain and monitored daily for survival. Virulence was restored 
and lys-7(ok1384) and abl-1(ok171) were once more tolerant to the infection, p<0.0001 in both cases 
[N2 n=120; lys-7(ok1384) n=120; abl-1(ok171) n=120]. 
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Figure 44: C. elegans survival on S. Typhimurium JF2691 
Animals were exposed to S. Typhimurium JF2691, an rpoS insertional inactivated mutant in an SL1344 
background, and monitored daily for survival. The two mutant C. elegans strains were tolerant to the 
infection, p<0.0001 in both cases [N2 n=142; lys-7(ok1384) n=82; abl-1(ok171) n=83]. 
 
Figure 45: C. elegans survival on S. Typhimurium χ4996 
Animals were infected with χ4996, a strain with an rpoS insertional inactivation mutation in an S. 
Typhimurium LT2 background, and monitored daily for survival. Both mutant strains were tolerant to 
the infection, p<0.05, in comparison to the wild type strain.  Representative data for N2 survival on S. 
Typhimurium SL1344 is shown for comparison [N2 n=121; lys-7(ok1384) n=121; abl-1(ok171) n=122; 
N2 SL1344 as Figure 14]. 
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To address this, the animals’ survival was next assessed on strain χ4996 which has an rpoS 
insertional inactivation mutation in an LT2 background (rpoS::Apr from P22(JF2690) x LT2).  In this 
case, the tolerance phenotype of the mutant strains returns (Figure 45) p<0.05, suggesting that the 
sigma factor RpoS does indeed influence C. elegans survival to S. Typhimurium.  However, the 
increased survival of the animals to this strain is not as marked as that observed against SL1344; this 
may be due to the attenuated survival of the wild type animals, N2, which have an TD50 of 6 days upon 
χ4996 infection versus 4 days upon SL1344 infection.   
 
Together, these data suggest that the most plausible hypothesis is that balanced immunity is 
dependent upon the level of RpoS expression in Salmonella. 
 
5.3 Conclusion 
The observation that the augmented survival of the mutant animals is present in SL1344 and 14028s 
infection but absent upon LT2 infection reveals that the heightened tolerance of these animals to S. 
Typhimurium infection is not dependent upon a strain effect as both SL1344 and 14028s represent the 
paradigm of Salmonella infection; instead, the suppression of tolerance in LT2 must be specific to this 
isolate.  Based on previous data demonstrating the importance of RpoS to mouse (Swords et al., 
1997b, Fang et al., 1992) and C. elegans (Labrousse et al., 2000) virulence, and as the level of RpoS 
is reduced in LT2 (WilmesRiesenberg et al., 1997), we tested the involvement of RpoS in the C. 
elegans balanced immunity phenotype.   
 
RpoS is a principal subunit of RNA polymerase, which is believed to be a ‘master regulator’ of bacterial 
responses to a number of stress conditions (Hengge-Aronis, 2002).  It is particularly important in the 
stationary growth phase response, but is also required in the early stages of a systemic S. 
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Typhimurium infection (Nickerson and Curtiss, 1997).  In mammalian infections, RpoS mutations limit 
intracellular proliferation of the bacteria (Cano et al., 2001) and RpoS activity is important for inducing 
the expression of a number of virulence factors, including the spv virulence plasmid (Fang et al., 1992, 
Norel et al., 1992, Guiney et al., 1995, Gulig et al., 1993, Heiskanen et al., 1994) that is crucial for S. 
Typhimurium virulence (Gulig et al., 1992, Gulig and Doyle, 1993, Williamson et al., 1988b, Williamson 
et al., 1988a).   
 
Indeed, RpoS does appear to be important in Salmonella tolerance by C. elegans.  In LT2 isolates, the 
level of RpoS, and thus murine virulence, is compromised by the inefficiency of its unusual UUG start 
codon (Lee et al., 1995, Swords et al., 1997a, WilmesRiesenberg et al., 1997).  This mutation appears 
to be enough to suppress the extended survival of the C. elegans mutants when infected with this 
strain, given that the expression of rpoSSL1344 in LT2 is enough to recover the tolerance phenotype.  In 
this way, our data from C. elegans reflect behavioural observations of S. Typhimurium isolates in other 
models, including mammalian cells and hosts. 
 
Moreover, from our data it is possible to assemble the survival phenotype of the lys-7(ok1384) and abl-
1(ok171) animals into three groups, which are dependent upon the condition of the Salmonella rpoS 
gene: 
1. Wild type RpoS activity (strains SL1344, 14028s and χ8000); lys-7 and abl-1 mutant animals 
have increased tolerance to the infection 
2. No RpoS activity (strains JF2691 and χ4996); the mutant animals have increased tolerance to 
the infection 
3. A low level of RpoS activity (strain LT2); the mutant animals are sensitive to the infection. 
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Interestingly, rpoS insertional inactivation mutations in both SL1344 and LT2 do not suppress the 
tolerance of the mutants.  It is now well established that a total absence of RpoS expression in S. 
Typhimurium results in avirulence (Fang et al., 1992, Norel et al., 1992).  However, RpoS expression 
that is too high and/or inappropriate can also lead to avirulence (Swords et al., 1997a).  Thus it 
appears to be the intermediate level of RpoS expression that is crucial for the tolerance phenotype in 
C. elegans.  Expression levels of the spvABCD locus are reduced to an intermediate level (i.e. higher 
than rpoS::Apr, but lower than wild type) in LT2 (Chen et al., 1995, Obyrne and Dorman, 1994, 
WilmesRiesenberg et al., 1997).  Potentially the intermediate expression of one of these genes 
mediates S. Typhimurium tolerance in C. elegans; in rpoS insertional inactivation mutant strains it is 
not expressed, in wild type strains it is expressed too highly; thus the optimal level of expression for C. 
elegans survival is in an LT2 background. 
 
In order to test this hypothesis, it would be interesting to examine the C. elegans survival phenotype 
upon infection with an rpoS mutant in SL1344, whereby the single point mutation in the start codon of 
LT2 (Lee et al., 1995) has been recapitulated in this wild type background by site-directed 
mutagenesis.  An alternative approach would be to make use of an inducible promoter on rpoS in order 
to titrate the level of induction and assess the parameters that are required for balanced immunity.  
Work is on-going in the laboratory to address these essential experiments.  
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6.0   RECOMBINANT LYSOZYME 
 
6.1 Introduction 
In chapter three we established that the loss of the antimicrobial protein LYS-7 in C. elegans renders 
animals highly vulnerable to a fungal infection from C. neoformans, yet this mutation simultaneously 
confers resistance to another pathogen, the bacterium S. Typhimurium.  We considered the 
mechanism of action of LYS-7, where we assume that the enzyme hydrolyses the β-1,4 linkages of N-
acetylglucosamine present in both peptidoglycan and chitin (Jolles, 1996), and how this could 
contribute to the balanced immunity phenotype.  However, very little is known about the activity of C. 
elegans antimicrobials secreted during the innate immune response and most descriptions are inferred 
from sequence data and through orthologous protein comparisons.  Thus we sought to express LYS-7 
in vitro, along with LYS-2 (another clade one lysozyme; see figure 4) and LYS-5 (a clade two 
lysozyme) as controls. 
 
With the onset of whole genome sequencing during the 1990s, a new era of biology was born; that of 
functional genomics.  The C. elegans genome was the first multicellular genome to be sequenced (C. 
elegans Sequencing Consortium, 1998) and it subsequently spawned the C. elegans ORFeome 
project; an attempt to clone and characterise each predicted ORF from the C. elegans sequence 
(Walhout et al., 2000).  To facilitate such an enormous task, the team utilised a novel cloning strategy 
called Gateway recombinational cloning (Walhout et al., 2000, Hartley et al., 2000), now available 
commercially from Invitrogen (Figure 46).  This method enables a gene to be cloned and easily 
transferred into a number of expression vectors by site-specific recombination based on the integration 
and excision of the lambda bacteriophage into, and out of, the E. coli genome (Hartley et al., 2000).   
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Figure 46: The Invitrogen Gateway Cloning System 
In the BP reaction, the PCR product is recombined with the donor vector, pDONR-201, to produce an 
entry clone.  At this point, the entry clone intermediate can be isolated from DH5α cells in order to 
facilitate the recombination of this clone into a number of different expression vectors.  In our protocol, 
however, the LR reaction was performed immediately after the BP reaction, giving rise to an N-terminal 
His-tagged ORF in pDEST-527. 
 
  
 
 
 
Image adapted from (Nallamsetty and Waugh, 2007) 
 -201 
 
(pDEST-527 His6 fusion) 
His 6 
His 6 
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We sought to exploit the Vidal ORFeome and Gateway technology in order to express C. elegans 
recombinant lysozyme, as the method is specific, simple and amenable to multiple expression hosts.  It 
is important to note that the attB-tailed primer design of the ORFeome eliminates all sequence motifs 
between att sites, preventing any internal translation initiation and enabling entry vectors to be cloned 
into both N- and C-terminal fusion expression vectors (Walhout et al., 2000), thus, should expression in 
E. coli fail, the system could be adapted to an alternative host such as baculovirus.  However, it should 
be recorded that the Vidal group have thus far failed to produce a LYS-7 Gateway clone, although 
LYS-2 and LYS-5 are successfully part of the ORFeome v3.1 (http://worfdb.dfci.harvard.edu/).   
 
6.2 Results 
 6.2.1 In vitro expression of C. elegans genes lys-2, lys-5 and lys-7 in E. coli 
In order to generate recombinant lysozyme proteins we generated clones for expression in E. coli, as it 
is a fast, relatively inexpensive and scalable system.  Firstly, the three lysozyme genes were 
successfully amplified from C. elegans N2 cDNA with the C. elegans ORFeome primers (Table 5).  
These attB-flanked PCR products were cloned into the destination vector pDEST-527 (Figure 47) using 
Gateway technology (Invitrogen) in order to generate His-tagged recombinant protein.  From here, the 
vectors were transformed into a number of E. coli expression hosts and were induced for expression at 
a range of temperatures (16°C, 25°C, 30°C and 37°C) and times (3h, 6h, 8h and overnight; data not 
shown). 
 
These preliminary investigations revealed the best expression to occur with BL21-AI One Shot 
Chemically Competent E. coli (Invitrogen), a host designed specifically for the expression of toxic 
genes, such as lysozyme, due to the tight regulation of the T7 RNA polymerase; in BL21-AI cells, the 
T7 RNAP is under the control of the araBAD promoter and is thus inducible by L-arabinose. 
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lys-7 39...840
AttL1 1...14
LacI 5874...4918
T7 6388...6407
ATG 6476...6478
attB1 6522...6528
attR1 6522...6528
pDEST-527xlys-
7
6528 bp
M13 origin 1530...1985
F1 ori 1547...1853
Gateway recomb1 1...7
attB1 1...14
attB2 876...870
attR2 890...877
AttL2 876...870
attB2 890...877
ColE1 origin 3058...3740
AmpR 2762...2103
Gateway Recomb2 883...877
His6 6491...6508
LacO 6407...6429
 
 
 
 
Figure 47: pDEST-527xlys-7 plasmid map 
The lys-7 ORF was recombined into pDEST-527 using the Gateway site-specific recombination system 
(Invitrogen).   
 
 
 
Plasmid map created in ApE v1.17.                                                                                                       
The lys-7 sequence is taken from WormBase and the pDEST-527 sequence from AddGene Inc. 
 
7 
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SDS-PAGE and immunoblotting analysis demonstrated that small-scale pilot inductions of LYS-2, LYS-
5 and LYS-7 in BL21-AI cells could produce polyhistidine-tagged proteins for all three cDNAs using this 
system (Figure 48), offering the potential for large-scale experiments and subsequent protein 
purification. 
 
6.3 Conclusion 
We have been able to express three C. elegans lysozymes in E. coli, indicating that the Gateway and 
BL21-AI expression system we describe here is a reliable and successful method.  Unfortunately, due 
to limitations of time, we have been unable to develop this part of the project much further.  The next 
stage will be to induce large-scale preparations to increase protein expression, before target protein 
isolation and subsequent purification with a nickel-affinity column.  Provisional experiments have 
shown that overnight inductions at 16°C is a regime that produces consistent expression with minimal 
background, and that the proteins are amenable to isolation by sonication (W. Grey, unpublished).    
 
Once we have achieved pure protein, it would be very interesting to assess the in vitro hydrolysis 
activity of the three proteins against a benchmark of hen egg-white lysozyme (using a standard 
Micrococcus lysodeiltikus lysis assay) (Shugar, 1952).  Having assayed the standard activity, we shall 
look to test the lysozyme and chitinase activity of the enzymes against a range of bacteria and fungi, 
including S. Typhimurium and C. neoformans.  
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Figure 48:  Expression of recombinant lysozymes lys-2, lys-5 and lys-7 in BL21-AI cells 
C. elegans lysozymes lys-2, lys-5 and lys-7 were cloned into pDEST-527 vectors using the Gateway 
(Invitrogen) system and transformed into BL21-AI cells.  5ml log-phase cells were induced for 3 hours 
at 37°C to test protein induction.  Cells were lysed in LDS buffer and clones analysed using SDS-
PAGE and immunoblotting with an anti-His antibody.  Expression of all three lysozymes was 
achievable using the BL21-AI system; blot A for lys-7 and blot B for lys-2 and lys-5. 
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The sequence alignment between LYS-7 and five other lysozyme-like proteins (Figure 52) shows that 
LYS-7 and LYS-2 have no DXE motif, whereas the sequences of the other enzymes all do.  DXE is 
most likely one of the essential catalytic components of the enzyme (Korczynska et al., 2010) and the 
LYS-7 residues at this point, Q150 X151 T152, will not compensate for the nonexistence of DXE (A. L. 
Lovering, personal communication).  What then, is the significance of this absence of the DXE motif in 
LYS-7?  Interestingly, the D59 catalytic residue is conserved in LYS-7; together, these suggest that 
LYS-7 may be an atypical lysozyme (A. L. Lovering, personal communication).  It is essential, 
therefore, to produce a high-resolution structure of LYS-7, as this is likely to indicate a mode of action 
for the protein due to the absence of DXE.  The predicted structure (Figure 51) identifies a Chalaropis-
type lysozyme fold, which enables these enzymes to hydrolyse β-1,4 N-, 6 O-diacetylmuramidase such 
as those residues present in the S. aureus cell wall, in addition to their classical action on β-1,4 N-
acetylglucosamine linkages (Rau et al., 2001).    
 
However, there are some problems with the lys-7 construct as it currently stands.  Firstly, the 
bioinformatic software WoLF PSORT (http://psort.nibb.ac.jp/) predicts that LYS-7 is a secreted protein.  
This makes sense given the predicted antimicrobial function of this protein acting in the intestinal 
lumen of C. elegans.  Moreover, the conserved cysteine residues in the sequence alignment imply that 
disulphide bonds are utilised to stabilise the secreted protein (A. L. Lovering, personal communication) 
and, additionally, there is the precedent that most lysozymes are secreted (Jolles, 1996, Nickel et al., 
1998).  Consistent with this hypothesis, the sequence alignment suggests that the first 50 residues of 
LYS-7 are a putative signal and pro-peptide sequence.  Currently, the signal sequence is presumably 
retained in the recombinant protein, which may disturb the folding of the protein and its subsequent 
activity; the cloning and crystallisation attempt need only be of the mature, isolated protein.  Second, 
we had omitted the introduction of a cleavage site between the lys-7 ORF and the attB sites, 
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preventing the cleavage of the His-fusion protein to liberate the native target protein.  Consequently 
work is on-going in the laboratory to re-clone and express the truncated protein, in order to alleviate 
both of these concerns. 
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7.0   DISCUSSION 
 
Many studies have made use of the nematode C. elegans to study the molecular basis of host-
pathogen interactions. Although the nematode immune system is much simpler than that of 
vertebrates, it is nonetheless clear that many mechanisms and pathways are conserved between 
phyla.      
 
7.1 Balanced Immunity 
In vertebrates the phenomenon of immunological trade-off, whereby resistance to one class of 
pathogens comes at the cost of increased susceptibility to others, has been well documented.  For 
example, it is well established that the activity of one immune pathway can inhibit that of another, so as 
to ensure the correct regulation of the system overall (Kim et al., 2007).  In humans, immunological 
balance is typified by the Th1/Th2 response, which influences predisposition to autoimmune disease 
(Nicholson and Kuchroo, 1996) and sensitivity to particular classes of pathogenic infection (Koguchi 
and Kawakami, 2002).  
 
Recently, analogous balance phenotypes have been described in the fly model.  For instance, a 
mutation in the melanisation cascade of Drosophila can increase both tolerance and resistance to 
some infections whilst simultaneously decreasing tolerance and resistance to other pathogens (Ayres 
and Schneider, 2008).  Similarly, mutations in the tumour necrosis factor pathway (Schneider et al., 
2007, Brandt et al., 2004), the Toll-Dorsal pathway (Gordon et al., 2008) or global changes in a series 
of immunity genes (Lazzaro et al., 2006), lead to increased susceptibility to some pathogens but 
improved immunity to others.  However, as yet there are few reports of similar balance mechanisms in 
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other invertebrates, nor has the underlying mechanism for invertebrate immunological balance been 
fully elucidated. 
 
In chapter three, we present data which demonstrate that innate immunity in C. elegans also involves 
immunological balance.  This response is mediated by two genes, the lysozyme lys-7 and the tyrosine 
kinase abl-1, which appear to be reciprocally regulated.  We have shown that single knockouts of these 
genes initiate a specific susceptibility trade-off by rendering animals hypersensitive to infection with C. 
neoformans, but tolerant to S. Typhimurium.  In addition, we show in chapter five that the tolerance 
towards S. Typhimurium depends on the function of the bacterial sigma factor RpoS.  LYS-7 has been 
described as an essential antimicrobial molecule in the C. elegans immune response (Mallo et al., 
2002, O'Rourke et al., 2006, Evans et al., 2008b, Schulenburg and Boehnisch, 2008) that is assumed 
to actively degrade invading pathogens (Kerry et al., 2006, Murphy et al., 2003).  Previous work in our 
group had identified LYS-7 as an important anti-cryptococcal immune factor (R. C. May, unpublished), 
but its dual role as a susceptibility factor in S. Typhimurium pathogenesis was surprising.  In contrast, 
the role of the abl-1 in C. elegans immunity is still unclear.   
 
In vertebrates, ABL1 is a recognized oncogene (Sirvent et al., 2008), but its only known involvement in 
infection is as a target for manipulation by invading pathogens (Backert et al., 2008).  Its C. elegans 
homologue, abl-1, has a multifaceted role in germline apoptosis: ABL-1 specifically inhibits germline 
apoptosis in animals following ionizing radiation, but does not prevent apoptosis in response to other 
mutagens (Deng et al., 2004).  Conversely, ABL-1 also acts as a pro-apoptotic factor upon the 
subjection of nematodes to abiotic stress (Salinas et al., 2006).  Additionally, ABL-1 inhibits the 
engulfment of apoptotic cells by acting independently of the two described cellular engulfment 
pathways (Hurwitz et al., 2009).  In the immune response, abl-1 expression is down-regulated in the 
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animals’ response to infection with the Gram-negative pathogen Serratia marcescens (Wong et al., 
2007).  Furthermore, abl-1 is central to a successful infection of the animal with S. flexneri (Burton et 
al., 2006), although the mechanism that the authors propose for this involvement is unclear, given that 
these bacteria are not intracellular pathogens in the nematode.  We recognise that our finding that abl-
1 mutants are resistant to killing by S. Typhimurium contrasts with this previous publication (Burton et 
al., 2006).  Furthermore, there are significant discrepancies between the lifespans of the C. elegans 
strains reported in this work, and those determined by our laboratory and others (Mylonakis et al., 
2002, Styer et al., 2005, Diard et al., 2007).  There are at least two possible reasons for these 
differences; firstly problems with the strains used in this work, although we have confirmed the identity 
of our C. elegans lines by PCR and utilised a number of distinct bacterial reference strains.  Next, we 
note that the Aballay group both maintain their C. elegans strains and run their survival assays on 
modified NGM; containing 0.35% peptone, instead of 0.25% (Burton et al., 2006).  It is known that a 
richer growth medium elicits a more virulent pathogenesis of the nematode host by the infecting 
bacteria (Tan et al., 1999), yet as the survival of wild type animals on SL1344 is comparable in both 
our laboratories (TD50 of approximately 4 days) this media modification cannot account for the survival 
differences we observe.  Thus the rationale for these discrepancies remains unclear. 
  
7.2 The regulation of balanced immunity in C. elegans 
Based on the expression profile of ABL-1 in adult nematodes we suggested in chapter three that the 
role of ABL-1 in balanced immunity is regulatory, through a signalling response.  We find that abl-1 
mutant C. elegans strains are hypersusceptible to cryptococcal killing whilst showing up-regulation of 
lys-7, a gene that we demonstrate to be important for cryptococcal resistance.  In this manner and 
given that lys-7;abl-1 double mutant animals remain overly susceptible to C. neoformans whilst losing 
the tolerance phenotype to S. Typhimurium, the data suggest that the function of ABL-1 in the trade-off 
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is two-fold.  Firstly, we find that ABL-1 regulation is mediated through a LYS-7-dependent pathway 
which must operate in conjunction with an, as yet uncharacterised secondary, LYS-7-independent 
pathway.  We find that both of these pathways are required for wild type resistance to C. neoformans, 
but that the activation of either downstream cascade is required for the tolerance response to 
Salmonella.   
 
Having described this susceptibility trade-off between C. neoformans and S. Typhimurium 
pathogenesis, we then provide data in chapter four that probe the downstream nature of the ABL-1-
regulated pathways that mediate the immunological balance response upon the loss of abl-1 or lys-7.  
 
Firstly, our data rule out the involvement of the p38 MAPK pathway, as the loss of sek-1 does not 
suppress the abl-1 or lys-7 phenotypes.  Instead, the data are consistent with a role for the ABL-1-
interacting protein, ABI-1, alongside ABL-1 in the regulation of the balance, since knockout animals for 
abi-1 phenocopy the balanced immunity response of lys-7 and abl-1 knockout animals to C. 
neoformans and S. Typhimurium.  ABI-1 can act both downstream and upstream of ABL-1 (Hurwitz et 
al., 2009, Dai and Pendergast, 1995, Yu et al., 2008b, Juang and Hoffmann, 1999, Tani et al., 2003, 
Lin et al., 2009), although based on our data we feel that the most likely state is that ABI-1 acts 
upstream of ABL-1 to influence a downstream cascade, and subsequently, LYS-7 activity.   
 
We next examined the role of the two other major immunity pathways, TGF-β/DBL-1 and IGF/DAF-2, in 
the balance mechanism.  We were able to produce dbl-1;abl-1 double mutant animals which were 
found to be extremely sensitive to both C. neoformans and S. Typhimurium infection, suggesting a role 
for the TGF-β pathway in the balance.  Furthermore, in the tolerance response to S. Typhimurium, we 
found both immunomodulatory effects of lys-7 and abl-1 to act through the forkhead transcription factor 
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DAF-16, as a mutation for lys-7 or abl-1 coupled with one for daf-16, suppresses the tolerance 
phenotype.  The most likely explanation is that the loss of either abl-1 or lys-7 must activate DAF-16 in 
an attempt to compensate for the immunological impairment. 
 
We believe that each of these pathway components is required for wild type sensitivity to C. 
neoformans, but not for wild type sensitivity to S. Typhimurium infection; in this latter case the 
pathways act to initiate the heightened tolerance response.  This hypothesis is confirmed by our 
observations that the daf-16 and dbl-1 single mutants, as well as the lys-7;abl-1 double mutants (where 
the compensatory mechanism is suppressed), have wild type resistance to S. Typhimurium infection, 
but are sensitive to C. neoformans.  With a similar assumption, we believe that the abl-1;dbl-1 
hypersensitivity to both pathogens could be due to a number of pleiotropic effects, thus we interpret 
these results purely as a suppression of the abl-1 tolerance phenotype to wild type survival levels.   
 
Collectively, our data suggest a signalling cascade mediated by the ABL-1-dependent inhibition of 
TGF-β/DBL-1 (Naka et al., 2010), which results in the activation of DAF-16 by DBL-1, since TGF-
β/DBL-1 is known to activate FOXO/DAF-16 in vertebrates (Lee et al., 2001, Seoane et al., 2004).  
Together this culminates in the induction of lys-7 expression.  The secondary ABL-1-dependent, LYS-
7-independent, uncharacterised pathway must also be dependent upon DAF-16 and its subsequent 
activation of immune effectors (Figure 49).  Interesting, lys-7 itself is a known DAF-16 target (Yu et al., 
2008a, McElwee et al., 2003, Murphy et al., 2003), thereby providing a potential feedback mechanism 
to regulate the activity of the pathways.   
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Figure 49: Proposed pathway regulating balanced immunity 
We propose that ABL-1 inhibits DBL-1-mediated activation of DAF-16, having inferred this interaction 
from that of their mammalian homologues (Naka et al., 2010).  Upon the loss of abl-1, the repression of 
DBL-1 is removed and the transcription factor drives the activation of lys-7, resulting in increased 
tolerance to S. Typhimurium infection.  On the other hand, upon the loss of lys-7, there is a feedback 
mechanism that triggers an ABL-1-mediated response, which is also DAF-16-dependent, that 
ultimately leads to the reciprocal resistance phenotype through the activation of downstream targets.  It 
is necessary for either one of these pathways to be activated through the loss of lys-7, abl-1 or abi-1 to 
confer tolerance to Salmonella.  Conversely, during C. neoformans infection, both response pathways 
must be intact for wild type resistance to the fungus.  The position of abi-1 in this model remains to be 
confirmed, both by epistatic analysis and through the qRT-PCR analysis of downstream gene 
expression. 
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In this manner, our data suggest the modulation of the C. elegans immune response by lys-7 and may, 
accordingly, introduce a novel function for this defensive enzyme.  Currently, there is only one report of 
non-enzymatic activity of invertebrate lysozyme (Zavalova et al., 2006), but the immunomodulatory role 
of cationic antimicrobial compounds (CAMPs) has been previously described in vertebrate systems, 
although the mechanisms of this effect are not yet understood (Bowdish et al., 2005, Yu et al., 2007).  
In this context, we note that the considerable lysozyme repertoire in C. elegans (Schulenburg and 
Boehnisch, 2008, Ito et al., 1999) could be partly explained by their divergence into modulators of the 
immune response.  Moreover, the sequence comparisons would support such a hypothesis, given that 
LYS-7 lacks the catalytic DXE motif and is therefore likely to have atypical lysozyme activity (Figure 
52). 
 
Previous work from our group has shown that DAF-16 activity does not modulate animal sensitivity to 
S. Typhimurium; this pathogen shows similar levels of lethality in both the hermaphroditic 
Caenorhabditis species and gonochorisitic species, which have higher levels of DAF-16 (Amrit et al., 
2010).  Furthermore, DAF-2 mutants also show the same patterns of susceptibility to S. Typhimurium 
as wild type animals (Amrit et al., 2010).  Thus it would appear that DAF-16 is involved with regulating 
the immunological balance per se, consistent with the hypothesis that the IGF pathway does not confer 
pathogen-specific responses in C. elegans but is associated with the basal innate immune response as 
a whole (Troemel et al., 2006).  The finding that daf-2 mutants are not resistant to S. Typhimurium 
infection is surprising in this context, as daf-2 knockout animals are known to up-regulate lys-7 
expression (Murphy et al., 2003).  It would seem, therefore, that the balanced immunity phenotype is 
not dependent upon the up-regulation of a single component of the pathway, rather that it is reliant 
upon the trade-off mechanism as a whole.  One way to test this would be to examine the survival of a 
lys-7 over-expressing C. elegans strain, recently made in our laboratory (C. M. L. Boehnisch, 
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unpublished), to S. Typhimurium in order to establish whether the up-regulation of lys-7 is enough to 
confer a tolerance phenotype.   
 
Given time, there are a number of potential experiments that would help test the model outlined in 
Figure 49.  For instance, it will be important to quantify the levels of lys-7 expression in abi-1 mutant 
worms by qRT-PCR, as our model currently suggests that ABI-1 regulates immune balance through 
the LYS-7-dependent pathway.  If so, an abi-1;lys-7 double mutant should phenocopy the survival of 
abl-1;lys-7 double mutants.  Furthermore, we were unable to test a dbl-1;lys-7 double mutant due to 
the close proximity of these two genes on chromosome V, but a double knockdown should be 
achievable using a single knockout worm coupled with RNAi to suppress the expression of the second 
gene.  If DBL-1 does indeed regulate the DAF-16-mediated activation of LYS-7, dbl-1;lys-7 double 
mutants should be tolerant to S. Typhimurium through the compensatory activity of the secondary ABL-
1-dependent pathway.  Lastly, expression levels of lys-7 should also be measured in the abl-1;dbl-1 
double knockouts to verify that abl-1 negatively regulates the TGF-β pathway, as Figure 49 suggests.  
 
One further thing to note here is an additional discrepancy between the data presented in this thesis 
and that published by the Aballay laboratory.  We find that dbl-1(nk3) knockout animals are not more 
sensitive to S. Typhimurium infection than wild type animals and hence conclude that the TGF-β 
pathway is not involved in the C. elegans immune response to this pathogen in the wild type scenario.   
Conversely, the Aballay group have published that dbl-1(nk3) mutants are hypersensitive to a number 
of human pathogens, including S. Typhimurium (Tenor and Aballay, 2008).  Again, having confirmed 
our animal and bacterial strains we conclude that the animals and bacterial strains must have 
undergone microevolution in both laboratories and that these changes could account for the survival 
differences we observe.     
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7.3 LYS-7-mediated toxicity in S. Typhimurium pathogenesis 
In the balanced immunity phenotype, we describe a gain in tolerance of lys-7(ok1384) and abl-
1(ok171) animals to S. Typhimurium infection, as these strains have a pathogen burden comparable to 
that of N2 worms.  Hence there is no difference in resistance, since bacterial burden is the same, yet 
N2 animals succumb much faster to the infection.  We hypothesise that the ABL-1-dependent 
compensatory signalling is the means by which the tolerance mechanism is regulated in the host, yet 
what is the physiological nature of the gain of tolerance in the knockout animals?   
 
We postulated that immunopathology, a major cause of disease that significantly impacts the fitness of 
both the host and pathogen (Graham et al., 2005), may be the basis of the N2 sensitivity to S. 
Typhimurium infection and that the lys-7 and abl-1 mutant animals were better able to limit the damage 
caused by these bacteria during pathogenesis.  We have already established that the role of LYS-7 in 
C. neoformans pathogenesis is protective, whereas in S. Typhimurium infection, LYS-7 acts as a 
susceptibility factor.  We therefore hypothesise that there are deleterious consequences of the immune 
response elicited through the action of LYS-7 in defence against Salmonella infection, which together 
is actually detrimental to the host.  
 
There are at least two ways in which LYS-7 could generate such a damaging pathology.  For instance, 
LYS-7 may cleave a bacterial product from S. Typhimurium that is toxic to C. elegans or induces a 
harmful inflammatory response in a manner reminiscent of lipopolysaccharide (LPS)-mediated toxic 
shock in humans.  Alternatively, the action of LYS-7 may induce a stress response in the bacterium 
that, in turn, renders the infection more virulent.  In either scenario, a host that lacks LYS-7 does not 
experience this detrimental interaction and thus the animals are tolerant to S. Typhimurium-induced 
killing.  We know that LYS-7 is strongly induced upon S. Typhimurium infection (Evans et al., 2008b), 
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but this delayed induction may be too late to elicit a positive immune response against the pathogen; 
instead, it is possible that the constitutively higher level of LYS-7 present in abl-1 knockout animals 
allows them to overcome this negative interaction and limit Salmonella pathogenicity.  We know that 
abl-1(ok171) mutant animals do not experience a bactericidal resistance effect from increased LYS-7 
expression as its pathogen burden is unchanged from wild type of lys-7(ok1384) animals; rather this is 
a bacteriostatic response (Mine et al., 2004).  Together, this adds evidence for an alternative function 
for LYS-7 in C. elegans immunity.  In this respect, the dual nature of lys-7 is analogous to that of the 
Drosophila tumor necrosis factor homolog eiger, which modulates the pathogenesis of S. Typhimurium 
and other intracellular pathogens in the fly (Brandt et al., 2004, Schneider et al., 2007).   
 
Additionally, there is a precedent for such antimicrobial activity that is capable of promoting bacterial 
pathogenicity in the host.  For instance, when S. Typhimurium is exposed to sub-lethal concentrations 
of cationic antimicrobial peptides (AMPs) in vitro using a mammalian tissue culture system (we suggest 
this is analogous to LYS-7 expression levels in N2 worms), the bacteria respond by globally changing 
their protein composition by primarily activating their PhoP/PhoQ two-component virulence regulon, 
rendering the bacteria more resistant to antimicrobial action through major changes in the bacterial cell 
surface (Bader et al., 2003).  Indeed, these AMPs are able to directly activate the PhoP/PhoQ system 
and initiate the bacterial stress response (Bader et al., 2003, Kindrachuk et al., 2007).  RpoS activity 
was additionally induced by the antimicrobial peptides, leading to the transcription of its downstream 
genes, including katE, which causes the bacteria to become more resistant to oxidative stress 
generated as a defence mechanism by the host (Bader et al., 2003).  RpoS is itself stabilised by PhoP 
under low magnesium conditions in order to direct catalase activity (Tu et al., 2006), thus there has 
been some suggestion that this is also true during the AMP resistance response (Groisman and 
Mouslim, 2006). Moreover, resistance to antimicrobial peptides has been shown to significantly 
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contribute towards the persistence of S. Typhimurium in the C. elegans intestine (Alegado and Tan, 
2008).  It would be very interesting to investigate whether recombinant LYS-7 is also capable of 
activating the PhoP/PhoQ regulon to elicit a comparable response in vitro. 
 
It is interesting to note that the sigma factor RpoS has a pivotal role in this antimicrobial resistance 
phenotype as our data further show that the C. elegans tolerance phenotype is dependent upon the 
level of RpoS activity of the S. Typhimurium strain in question.  As rpoS is important for inducing the 
expression of a number of virulence factors in S. Typhimurium-mediated pathogenesis, it is inviting to 
postulate that RpoS may be responsible for modulating the cell wall structure and hence the 
expression of our proposed structural motif with which LYS-7 interacts to produce the lethal phenotype.  
As suggested above, perhaps the cleavage of this product by LYS-7 releases a toxic compound or 
activates a stress response from the bacteria.  Either way, it would appear that the mis-regulation, and 
thus the intermediate level of this product as found in an LT2 background, is a contributing factor to the 
tolerance phenotype (Figure 50).  However, the RpoS-dependency of the balanced immunity 
phenotype must still be held in concert with the immunity status of the host.  Such that in strains where 
there is no up-regulation of lys-7 (for instance in lys-7;daf-16 double mutants) the animals are still not 
tolerant to the S. Typhimurium infection; in these animals there can be no activation of the secondary 
LYS-7-independent pathway to compensate for the loss of lys-7. 
 
An outstanding question from the data is the nature of the catalytic mechanism of LYS-7.  As a 
lysozyme, albeit an unconventional one, LYS-7 is predicted to have 1,4 β-N-acetylmuraminidase 
activity (Figure 51).  The main target of this hydrolysis action is the peptidoglycan structure of the 
colonising pathogen, notably of Gram-positive bacteria, although lysozymes are also known to have 
antimicrobial activity against Gram-negative bacteria (Mine et al., 2004).  However, we have already  
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Figure 50: RpoS levels mediate tolerance in S. Typhimurium pathogenesis of C. elegans 
Low and high levels of RpoS such as those found in knockdown or wild type S. Typhimurium isolates 
respectively, facilitate the tolerance phenotype of the lys-7 and abl-1 knockout strains.  However, in S. 
Typhimurium isolates with intermediate levels of rpoS expression, such as LT2, the tolerance 
phenotype is not induced. 
 
 
 
 
 
RpoS level 
Tolerance 
Threshold 
Chapter 7: Discussion 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51: Predicted structure of LYS-7 
Threading and homology modelling was used to produce a predicted structure of the LYS-7 protein.  
This structure has an E number of 6.5e-24 and a 100% estimated precision.  The structure predicts the 
protein to be a member of the transglyscosidase superfamily with 1,4 β-N-acetylmuraminidase activity.  
The Chalaropsis lysozymes, of which LYS-7 is a member, display a specialist Ch-type fold; a modified 
α/β-barrel-like fold in which an eight-stranded β-barrel is flanked by just five α-helices. 
 
 
 
 
Structure produced using the Phyre program from Imperial College London,  
http://www.sbg.bio.ic.ac.uk/phyre/  
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alluded to a crucial mutation in the principal DXE motif in the LYS-7 sequence (Figure 52) which is 
likely to substantially alter the catalytic mechanism of LYS-7 (A. L. Lovering, personal communication).   
 
This motif is critical to the two-step hydrolysis reaction of the GH25/Chalaropsis family lysozymes of 
which LYS-7 is a member (Figure 51) (Rau et al., 2001, Nickel et al., 1998, Martinez-Fleites et al., 
2009, Korczynska et al., 2010), whereby the first reaction consists of the DXE residue attacking the 
peptidoglycan sequence to generate a 1,2 cyclic intermediate, followed by the secondary stabilisation 
of this structure by hydrolysis, which is conducted by the conserved Asp; residue D59 in LYS-7 (Figure 
52) (Martinez-Fleites et al., 2009).  As LYS-7 does not appear to have a conserved DXE motif, it 
cannot achieve the initial step in this reaction and must therefore rely on the generation of a cyclic 
intermediate by an alternative lysozyme.   
 
An alternative hypothesis is that LYS-7 may act on a peptide such as tracheal cytotoxin (TCT), which, 
interestingly, is naturally cyclic (Luker et al., 1993).  TCT is a 1,6 anhydro-cyclic muramic peptide; a 
native peptidoglycan fragment from Gram-negative bacteria that acts concurrently as a virulence factor 
of animal hosts, an immune response elicitor and, further, is associated with the pathogenesis of 
Bordetella pertussis (whooping cough) (Luker et al., 1993, Stenbak et al., 2004, Chang et al., 2006, 
Gentryweeks et al., 1988), amongst other infections.  This anhydro form of the monomer is crucial for 
achieving maximum immune-stimulatory activity (Stenbak et al., 2004, Chang et al., 2006).  However, 
as TCT is naturally cyclic, an enzyme with only one catalytic residue (such as LYS-7) would be able to 
reduce the 1,6 anhydro monomer.  If TCT is the moiety involved in the toxicity response to C. elegans 
during S. Typhimurium infection, we postulate that it is the LYS-7-treated, non-cyclic form of the 
peptide which elicits the toxic response in the host, a hypothesis which is consistent with the finding in
  
 
Figure 52: Sequence alignment of LYS-7 with 5 other related lysozymes 
A clustalw file was generated using UNIPROT sequences, aligned with T-COFFEE and analysed with ESPript. The signal sequence for LYS-7 is shown in blue, with the 
pro-peptide in green before the mature enzyme starts at LASY. The catalytic residues are highlighted within green boxes: firstly the conserved Asp at residue 9, and 
secondly the DXE motif at position 98-100. Surprisingly, this residue is missing in LYS-7 and LYS-2. Other conserved residues are structural (orange blocks), presumed 
substrate binding (blue blocks) and involved in the orientation of the substrate and catalytic residues (maroon block). Conserved Cys residues for disulphide bonds are 
highlighted in purple. 
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B. pertussis that the dehydration of TCT at carbons 1 and 6 is not important in toxicity (Luker et al., 
1993).   
 
In combination with the additional experiments I have suggested in chapter six, the in vitro testing of 
recombinant LYS-7 with mutations at conserved residues such as D59 and the crystal structure of the 
wild type protein, complexed with its natural substrate, will reveal the mechanism of action of LYS-7 
and hence help to solve the complex enigma of its function in the balanced immune response, and in 
C. elegans immunity in general.   
 
7.4 Conclusion 
In this thesis we describe a complex balance of immunity in C. elegans, mediated by a trade-off in the 
activity of ABL-1 and LYS-7 during the immune response to two human pathogens, C. neoformans and 
S. Typhimurium.  We find that there is a multifaceted role for ABL-1 in controlling the balance through 
two DAF-16-dependent pathways.  LYS-7, too, appears to directly modulate the host response to these 
pathogens: firstly, as a factor offering protection to the host in the case of C. neoformans infection, 
whilst concurrently acting as a susceptibility factor during S. Typhimurium pathogenesis.  In this latter 
role, LYS-7 most probably acts through the generation of a toxic peptidoglycan intermediate.  
Furthermore, we find that the tolerance phenotype of the lys-7 and abl-1 knockout worms is S. 
Typhimurium-dependent; given that this dependency corresponds to the activity of RpoS in the 
bacteria.  We therefore suggest that the pathogen-basis of the elicitor-based mechanism is under the 
control of RpoS. 
 
In conclusion we find that, as in vertebrates, a complex, reciprocally-regulated network of genes from 
both the host and pathogen, are involved in maintaining balanced immunity in C. elegans.  These data 
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suggest that immunological balance is an evolutionarily ancient phenomenon; therefore a more 
detailed investigation of this phenomenon in invertebrates may have significant implications for our 
understanding of orthologous mechanisms in vertebrates. 
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APPENDIX 
 
1.0 Microarray analysis  
The following work formed part of my undergraduate dissertation. 
 
Briefly, RNA was isolated (as described) and converted into cDNA probes.  These were indirectly 
labelled using a CyScribe post-labelling kits (Amersham GE Healthcare) according to the 
manufacturer’s instructions.  However, there were some slight modifications to the protocol as follows: 
at each elution step, 65µl elution buffer was used (instead of 60µl), in addition the labelling of amino 
allyl-modified cDNA with CyDYE reaction was carried out overnight.  Long oligomer-based spotted 
microarrays for the C. elegans genome were obtained from the Genome Sequencing Centre.  The pre-
soak and pre-hybridisation protocol was followed.  The probes were mixed; Control N2 (labelled with 
Cy3) with lys-7(ok1384) (labelled with Cy5) and N2 with lys-7(ok1385) (labelled with Cy5).  80pmol of 
each labelled cDNA was required to run the array; this determined the number of µl of each labelled 
probe used.  The hybridisation procedure for Eukaryotic DNA was followed.  The following day the 
slides were washed using the AdvaWash (Implen) system according to the standard operating 
procedure.  The wash buffers used were 1: 2xSSC 0.1% SDS; 2: 0.1xSSC 0.1% SDS; 3: 0.1xSSC.  
The washed slides were dried by centrifuging for 10 min at 1,500g.  The slides were scanned at the 
Functional Genomics and Proteomics Unit at the University of Birmingham, on the Axon 4000 Scanner 
according to the manufacturer’s instructions.  Each microarray was lined up with the C. elegans gal. file 
(from the C. elegans genome sequencing centre) and stored.  Throughout the protocol, RNA and 
cDNA quality and yield was confirmed by gel electrophoresis and OD260/280 analysis.  Once the 
microarray results were obtained, the data were normalized using the DNMAD program found on the 
GEPAS website (http://www.gepas.org) and used for subsequent analysis.  Genes of significant 
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change were determined – defined by an expression change of 1.5 fold.  Only those genes consistently 
up- or down-regulated in both lys-7 mutants versus N2 were identified.  The WormBase website 
(http://www.wormbase.org/) was used to annotate the genes of interest.  Additionally, the Babelomics 
website tool (http://www.babelomics.org) was used to examine gene ontology.  
 
1.1 Microarray data 
1.1.2     4 genes were consistently up-regulated across both arrays: 
Sequence 
ID 
Gene 
name 
Average fold 
induction 
Description 
M79.1c abl-1 2.65 ± 0.94 Src Homology, regulator of apoptosis 
W06D12.3 fat-5 1.82 ± 0.15 Fatty acid desaturase, predicted to be 
mitochondrial 
C01F4.1 rga-6 1.93 ± 0.08 Rho-GTPase activating protein 
ZK666.6 clec-60 1.59 ± 0.089 C-type lectin domain, required for resistance to M. 
nematophilum 
 
 
 
 
 
 
 
 
 
 
 
 
 1.1.3     43 genes were consistently down-regulated across both arrays: 
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Sequence ID Gene name Average fold 
reduction 
(Predicted) Function 
Y48E1B.10 gst-20 -1.75 ± 0.3 Glutathione S-transferase 
F28H7.8  -2.16 ± 0.14 Phosphatidylinositol transfer protein  
Y48E1B.8  -2.18 ± 0.62 Not characterised 
Y19D10A.9 clec-209 -2.38 ± 0.92 C-type lectin domain 
ZK1025.6 nhr-244 -2.21 ± 0.09 Nuclear hormone receptor family 
F57F4.3 gfi-1 -5.63 ± 0.5 Contains 21 ET modules 
K10C2.3  -2.40 ± 0.72 Aspartyl protease 
EGAP7.1 dpy-3 -2.88 ± 1.56 Cuticular collagen 
Y45G12C.3  -2.05 ± 0.75 Not characterised 
R11A5.3  -1.74 ± 0.17 Not characterised 
C14F5.2 zig-3 -2.37 ± 0.16 Immunoglobulin superfamily 
Y116A8C.5  -1.98 ± 0.17 Neprilysin 
ZK470.1  -1.93 ± 0.25 Peroxisomal membrane protein  
F43D9.1  -3.07 ± 0.82 Predicted membrane protein 
C23H5.8a  -1.95 ± 0.41 Not characterised 
F41A4.1 cutl-28 -3.71 ± 1.02 Not characterised 
F59F3.6  -1.93 ± 0.55 K+ ion transport domain 
F53C3.8  -2.12 ± 0.82 Not characterised 
D1053.1 gst-42 -1.66 ± 0.2 Glutathione S-transferase 
Y4C6B.6  -1.80 ± 0.25 Beta-glucocerebrosidase 
F52B11.3 noah-2 -2.58 ± 0.74 PAN and ZP domain-containing 
M03A1.3  -2.67 ± 1.08 ~10 predicted transmembrane sequences 
K10H10.2  -1.95 ± 0.03 Cystathionine beta-synthase 
C44H4.3 sym-1 -2.43 ± 0.79 Leucine rich repeats 
B0218.8 clec-52 -2.07 ± 0.63 C-type lectin domain 
F15D4.5  -2.61 ± 0.29 Not characterised 
F08F3.9  -1.82 ± 0.01 snRNA activating complex 
C32H11.12 dod-24 -2.70 ± 0.57 Acts downstream of Daf-16 
F22E5.1  -2.36 ± 1.14 Not characterised 
C38D9.2  -3.82 ± 0.43 Not characterised 
W01F3.3 mlt-11 -2.54 ± 0.99 Molting defective, serine protease inhibitor 
F41E7.4 fip-5 -1.85 ± 0.16 Fungus-induced protein 
Y46H3A.2 hsp-16.41 -2.01 ± 0.17 16-kD heat shock protein, expressed broadly 
D1086.3  -2.69 ± 0.22 Not characterised 
F16F9.2 dpy-6 -2.00 ± 0.25 Novel, conserved protein, calcium binding 
K02E10.4  -1.71 ± 0.16 Not characterised 
Y46H3A.3 hsp-16.2 -2.09 ± 0.1 Heat shock protein 
ZK829.3  -1.87 ± 0.51 Not characterised 
F46F2.3  -2.09 ± 0.05 Not characterised 
C37E2.2  -1.57 ± 0.01 Beta-2-glycoprotein 
C34G6.6a noah-1 -2.25 ± 1.01 PAN and ZP domain-containing 
T14B4.6 dpy-2 -2.51 ± 1.26 Unusual cuticular collagen 
T08G5.10 mtl-2 -1.59 ± 0.11 Metallothionein 
  
 
